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Abstract
Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) supplementation
commonly suggested during pregnancy confers many health benefits on offspring and more
recently improves fetal BAT development and induces myoblast trans-differentiation into
adiopocytes through activating PPARs expression. Embryonic myoblast is a highly flexible cell
showing great capacity to change its phenotype into adipocyte in response to EPA and DHA
supplementation in many in vitro models. However, a little is known about the identity of derived
adipocytes, whether, they change into brown or white adipocyte, and in vivo evidence is still
missing. Given that the myogeneis process is initiated at the mid of gestation and fetal BAT
development is formed at the late stage of pregnancy, we sought to investigate the effect of EPA
and DHA supplementation on fetal muscle growth and energy regulation. To achieve our goal, the
study was mapped in two patterns: three in vitro experiments, devoted to test the effect of
combined and isolated EPA and DHA on C2C12 undergoing differentiation into white and brown
adipocytes, and in vivo experiment devoted to investigate the effect of maternal ingestion of EPA
and DHA enriched diet on muscle growth, BAT activity, lipid metabolism regulation in liver, and
browning of sWAT. C2C12 cell have frequently been used as a representative model of myoblasts
in preclinical trials. In vitro, Cells were induced to differentiate into white or brown adipocytes
using hormonal cocktail in the absence (CON) or presence of (50 µm) EPA and (50 µm) DHA in
combination or separately. The results suggested that EPA and DHA treatments potentiate the
route of C2C12 trans-differentiation into white- like adipocytes with a greater potency of DHA in
compared to EPA. The effect was mediated via inhibiting myogenesis and mitochondrial
biogenesis processes and up-regulating the expression of WAT signature genes and impairing the
aquistion of brown adipocyte phenotype. Changing genes profile was concurrent with increasing

lipid droplets formation and impairing mitochondrial function. In vivo, mice were fed a diet
containing (3.05%) fish oil (FA) enriched with EPA and DHA or diet devoid of fish oil (CON)
throughout the entire period of gestation and lactation. The results showed partial inconsistency
with in vitro trials where transient increase in myogenesis regulating genes and MHC4 without
increasing muscle mass were observed in FA treated group. An increasing intramuscular fat
infiltration as a result of stimulating the expression of adipogenesis regulating genes was
predominant in FA treated group at day 1 and 21 post-parturition. Also, maternal EPA/ DHA intake
induced up-regulation the expression of fatty acids catabolism regulating genes in liver.
Stimulating BAT development and activity and browning of subcutaneous white adipose tissue
were demonstrated in FA treated group in weaned mice. Taken together, EPA and DHA
supplementation is associated with ectopic lipid accumulation in skeletal muscle but not on the
expense of myoblasts, and it can be suggested as an excellent therapeutic option to combat
childhood obesity as a result of their potential role in stimulating energy expenditure
transcriptional program.
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Chapter 1
Introduction and Review of Literature
1.1. Introduction
Various types of skeletal muscles contribute to the majority of body mass in adult
exceeding 40% of total body composing elements including blood, bones, and organs. The size
and number of muscle fibers might be reduced as a consequence to normal physiological process
like aging (Keller and Engelhardt, 2014; Hughes et al., 2017) or abnormal pathophysiological
disorders such as diabetes and sepsis (Bonaldo and Sandri, 2013; Gordon et al., 2013). During the
embryonic stage, mature multinucleated myotubes formation requires an alignment and fusion of
myoblasts. Multinucleated myotubes, in turn, are responsible for muscle contraction induced
mechanical forces (Relaix and Zammit, 2012). However, these muscle cell precursors hold a great
capacity to switch into other lineages such as adipocytes, osteocytes, and chondrocytes in response
to environmental stimuli (Yang et al., 2013).
Given the common origination of skeletal muscle cells and adipocytes from the same
ancestor stem cells, series of evidences have asserted the potential enforcement of skeletal muscle
precursor cells to change fate into adipocytes. In this context, two essential factors can induce
adipocytes derivation from muscle cells including pathophysiological processes and external
stimuli such as drugs or cytokines (Asakura et al., 2001; Yeow et al., 2001; Daniel et al., 2017).
However, cells reprogramming into another phenotypes is a complex process that requires
changing the genetic profile and cell signaling pathways (Frasch, 2016; Li et al., 2015). Infiltrated
adipocytes between muscle fibers are able to modulate energy balance inside the body by affecting
the processes of lipid utilization and sugar disposal (Poulos and Hausman, 2005; Gemmink et al.,
2017). According to Harper and Pethick (2004), an intramuscular adipocyte might be originated
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either from multipotent stem cells derived adipolast or skeletal cells precursors, myoblasts.
Adipogenesis is predominantly regulated by the nuclear receptor known as peroxisome
proliferator-activated receptor (PPAR) γ (Wang et al., 2013b). Tontonoz and Spiegelman, 2008,
tied the success of the adipogenesis process to inducement of PPARγ expression. Further, it has
been mentioned that adipocytes can also be originated from fibroblasts or myoblasts by enhancing
the expression of PPARγ (Tontonoz and Spiegelman, 1995; Cordani et al., 2014). Thus, maternal
administration of PPARγ activators such as n-3 polyunsaturated fatty acids (n-3 PUFAs) (Luo et
al., 2009) may impair the myogenesis process during embryonic stage and enhance the transdifferentiation of myoblast either into white or brown adipocytes. Lipid homeostasis is mainly
regulated by the two components of adipose tissue that are white and brown adipose tissue. The
function and location of these two tissues are profoundly different. Anatomically, White adipose
tissue located in different sites inside the body while brown adipose tissue presents only in special
areas and accounts for small portion of total body fat when compared to white adipose tissue.
Functionally, White adipose tissue is the site of lipid storage in the form of triacylglycerol (TG)
that can be utilized later to increase plasma level of free fatty acids based on body need. On the
other side, brown adipose tissue is the site where energy dissipated in the form of heat (Chusyd et
al., 2016; Chondronikola et al., 2016). Thus, expansion of each of these tissues may be directly
reflected on energy balance inside the body. It has been approved that nutrient supply during
pregnancy is important for both successful gestation and birth consequences (Grieger and Clifton,
2014; Akerele and Chema, 2016; Hollins-Martin, 2014). Fat is an essential element of maternal
diet because of its role as a source of energy. However, the type and ratio of fatty acids composing
a certain diet may considerably influence fetal health and metabolism once consumed during the
course of pregnancy and later in the postnatal stage (Emmett et al. 2015; Makrides, 2011). Based
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on series of epidemiological and experimental studies, the prevalence of many metabolic diseases
such as insulin resistance, cardiovascular diseases, high blood pressure, and obesity have been
shown to be positively or negatively modulated after long- term exposure to various fatty acids
during fetal and neonatal periods (Kabaran, and Besler, 2015; Ong and Muhlhausler, 2011).
Omega-3 fatty acids are highly suggested during pregnancy because of the wide range of health
benefits that have been observed upon increasing the content of EPA and DHA in maternal diet.
Many undesirable problems frequently happened during pregnancy, at parturition, and after birth,
including maternal depression (Emmett et al. 2015), reduced size of unborn baby (Emmett et al.
2015), premature birth (Olsen and Secher, 2002; Olsen et al., 2007) were noticed to be reduced in
response to consuming n-3 fatty acids enrich maternal diet, particularly EPA and DHA. In line
with that, excessive consumption of Omega-3 fatty acids during pregnancy is inversely associated
with occurrence of allergies and asthma in children (Miyata and Arita, 2015); while, it is closely
linked with improving fetal cognition function (Emmett et al. 2015). However, n−3 fatty acids are
biologically active compounds retaining a great capacity to modulate many cell signaling pathways
through different patterns, including: modifying gene expression, inducing biochemical and
physical changes of cell membrane structure, modulating the effect of various enzymes regulating
many cell signaling cascades, and enhancing eicosanoid synthesis (Seo et al., 2005). Transdifferentiation of myoblast into adipocytes is one of the biological processes that has been found
to be enhanced by EPA and DHA based on many in vitro studies (Luo et al., 2015; Qi et al., 2017).
However, many questions that might be raised are including: 1-what is the identity of inducible
adipocyte? 2- Is EPA and DHA treatment-induced myoblast reprogramming into adipocytes
reported in vitro still true in vivo? 3-Could maternal EPA and DHA ingestion confers a long-lasting
metabolic benefit on offspring similar to their effects in adults? Therefore, the main objective of
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the present study was to address all these important questions through achieving four important
specific aims including:
1. Investigating the in vitro combined effect of EPA and DHA on the differentiation route of
C2C12 cells into white adipocytes.
2. Investigating the in vitro combined effect of EPA and DHA on the differentiation route of
C2C12 cells into brown adipocytes.
3. Investigating the in vitro individual roles of EPA and DHA in enhancing white or brown
adipoctytes differentiation from C2C12 cells.
4. Investigating the in vivo effect of maternal diet enriched with EPA and DHA on offspring’s
skeletal muscle tissue development, intramuscular fat accumulation in offspring, expression
level of genes regulating insulin resistance and muscle protein synthesis, lipid metabolism
regulation in liver, brown adipose tissue development and activity, and potential browning
of white adipose tissue.
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1-2: Review of literature
Skeletal muscle, the biggest organ in the body compromising around 40% of its total mass,
is critical for achieving daily activities and strongly linked to body health and survival. Human
body contains more than 600 skeletal muscles, all are composed of the same structure manifested
mainly by joining clusters of multinucleated tubular cells known as myofibers or myocytes that,
in turn, are built up from bundles of myofibrils (Abmayr & Pavlath, 2012). Myosin, actin, and
titin, the corner stone of myofibrils, contribute to more than (~55-60%) of skeletal muscle total
proteins. The minimum contractile unit, sarcomere is consisting of myosin, actin, titin, and
components of Z-bands (Henderson et al., 2017; Sweeney & Hammers, 2018). These proteins are
arranged in thick and thin filaments giving the stripping like appearance of skeletal muscle and
known to be involved in regulating muscle contractile properties and related body movements.
Unlike other organs, muscle tissue infrastructure can be easily compromised in response to
external stimuli such as mechanical load, hormones, nutrients, and other systemic or cell signals
exhibiting a great flexibility and adaptability to surrounding environmental conditions. However,
the effect of exogenous factors associated changing the co-exciting balanced muscle proteins
levels may alter individual myofibers size but not number. Myofibers hypertrophy or/ and atrophy
resulting from interaction of external stimuli is by far reflected on whole muscle volume and mass
(Brooks, 2003; Brooks and Myburgh, 2014). Carrying out many physiological functions inside the
body such as respiration, vision, and mastication depends greatly on the mechanical power
conferred by skeletal muscle. Additionally, skeletal muscle supports the occurrence of many other
daily activities including individuals’ physical strength, endurance, and performance. Also,
skeletal muscle tissue is one of the key players in orchestrating body metabolism. Further, other
tissues use amino acids released from their reservoirs in skeletal muscles into the circulatory blood
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in synthesizing their biologically effective proteins or in maintaining blood glucose level during
prolonged starvation by converting launched amino acids into glucose in process known as
gluconeogenesis (Carbone et al., 2019). Moreover, skeletal muscle is the main organ involved in
glucose disposal inside the body because of its high sensitivity to insulin hormone that stimulates
glucose uptake and storage in muscle tissue to be used later in synthesizing glycogen. Insulin is
critical in maintaining the integrity of muscle tissue by stimulating muscle protein synthesis and
preventing their degradation (O'Neill et al., 2016).
1.2.1. Muscle myogenesis and regeneration
Myoblasts, progenitors of muscle tissue, are induced to recruit and fuse to form
multinucleated myofibers that are the building block of skeletal muscle in process known as
myogenesis (Chal, J., & Pourquié, 2017). Two important time points during which the potential
commitment of myoblasts into mature multinucleated myofibers is influenced, including prenatal
fetal development stage and post-maturation exposure to energy modulators. Prenatally, myoblasts
are predominately originated from myogenic progenitor cells (MPCs) expressing the transcription
factors paired box 7 (Pax7) and paired box 3 (Pax3) (Charge and Rudnicki, 2004; Bentzinger, and
Wang, 2012; Cisternas et al., 2014; Fan and Rozo 2012). Multinucleated myotubes are formed
from fusion of myoblasts after being exposed to some physiological and morphological changes
such as elongation, proliferation and maturation. Four myogenic regulatory transcriptional factors
are responsible for orchestrating the myognesis process including MyoD1, Myf5, MyoG, and
MRF4 (Charge and Rudnicki, 2004; Bentzinger and Wang, 2012; Fan and Rozo, 2012). The
process of regenerating injured muscle tissue in adults is controlled mainly by another type of
precursor cells known as satellite cells that arise from MPCs during the postnatal stage and localize
between sarcolemma and basal lamina of muscle fiber. Satellite cells are Pax7+ positive and
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quiescent at steady states. Although being quiescent, these cells are able to switch, after muscle
injury, into active myoblasts remarkably characterized by over-expression of two transcription
factors that are Pax7 and MyoD1, the latter of which enhances myoblasts proliferation (Fan and
Rozo 2012; Yin et al., 2013). However, some of satellite cells re-enter the latent state after being
activated and reside between myofibers to replenish muscle reservoir of regenerating satellite cells.
Activated cells restore their quiescent state through down-regulation the expression of MyoD1.
The last step in myogenesis process is manifested by the terminal differentiation of recently
activated myoblasts into new isolated multinucleated myofibers or by the expansion of already
existing myotubes. In this context, the process of repairing damaged fibers is mediated via
enhancing the recruitment and fusion of lately differentiated myoblasts. Myoblasts terminal
differentiation into mature multinucleated myofibers requires an inhibition of Pax7 expression and
up-regulation the transcripts of MyoG and MRF4 (J. Chal and Pourquie, 2017) (Figure 1-1).
Prenatal impairment of myogenesis process is strongly linked to increasing the mortality rate of
fetus; whereas, muscle atrophy or myopathy are the main sequels of losing the potential capacity
of regenerating damaged fibers in adults (Amack and Mahadevan, 2004). Overly, the vast majority
of muscle disorders and related mass loss takes place at the molecular level and can be attributed
to changing the expression of transcription factors implicated in regulating the myogenesis process
(Buckingham and Rigby, 2014; Bernardini, 2013). Thus, it seems to be of great importance to
identify the factors that may compromise the myogenesis process and interact with the normal
differentiation of myoblasts into mature myotubes. Factors known as RNA-binding proteins
(RBPs) and noncoding (nc) RNAs have been recently discovered to be involved posttranscriptionally in regulating the myogenesis process in parallel to the well-known roles of MRFs
(Apponi et al., 2011; Panda et., 2014; Panda et al., 2016; Lee et al., 2015; Hagan et al., 2017).
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Figure 1-1: Myogenic Program of Satellite Cells (Bhullar et al., 2016).
1.2.2. Factors affecting myoblast trans-differentiation
The process of cell reprogramming into another lineage exhibiting different genetic and
morphological characteristics is called cell trans-differentiation (Eguchi and Kodama, 1993).
Many examples have been accordingly emerged describing the potential expansion of certain
cellular phenotype using another cell line whereby this technique can be used as a therapeutic
option to repair damaged or aged tissues. The potential conversion of bone marrow stem cells into
neural stem cells is an example of the trans-differentiation process (Darabi et al., 2013). Also, the
basic unit of the nervous system, neuron, can be derived from striated muscle cells (Schultz and
Lucas, 2006). Moreover, myoblasts, progenitors of skeletal muscle cells, have a great capacity to
switch into osteocytes or adipocytes (Liu et al., 2016; Fux et al., 2004). Finally, it has been recently
revealed that mature white adipocytes participating in the rebirth of temporally died hair follicles
during wound repair are mainly originated from myofibroblasts (Plikus et al., 2017).
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Correspondingly, there is a critical need to determine the molecular mechanisms of triggering
myoblast trans-differentiation into adipocytes as it may influence the integrity of the muscular
tissue. The reciprocal conversion of adipocytes and myoblasts is mostly common as they descend
from the same progenitor embryonic adult stem cells. Reprograming skeletal muscle precursor
cells into adipocytes can be prompted under the influence of two major factors, including
adipogenic activators such as drugs or cytokines and pathophysiological conditions. Many in vivo
and in vitro evidences have stressed that muscle progenitors may lose their ability to develop into
myotubes and switch into adipocytes capable of synthesizing and storing fat once exposed to one
of these factors (Asakura et al., 2001; Teboul et al., 1995; Yeow et al., 2001; Daniel et al., 2017;
Hu et al., 1995). However, myoblasts conversion into fat cells is expected to occur only early
during the myogenesis process but not during the terminal differentiation stage or after the
formation of fully mature multinucleated myotubes (Teboul et al., 1995). On the other hand,
myocytes can be generated from stem cells that are predominantly and regularly differentiated into
adipocytes (Sakuma et al., 2009). According to Frasch, 2016 and Li et al., 2015, switching of cells
between two different lineages is a process with great complexity, requiring massive genotypic
and phenotypic modifications. Many molecular mechanisms are independently activated to
regulate the trans-differentiation of myoblasts to fat cells. It has been clarified that mitogenactivated protein kinase (MAPK) signaling pathway seem to be a target for many cytokines and
drugs to commit myoblast reprogramming into adipocytes (Qi et al., 2016; Yeow et al., 2001). The
protein kinase, MAPK, numerously expressed in wide range of cells, is implicated in regulating
many cellular activities, including proliferation, differentiation, energy balance, and apoptosis
once activated by exogenous ligands. There are three kinases belong to the MAPK family that are
extracellular signal-regulated kinases (ERK), c-Jun amino-terminal kinases (JNK), and p38
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MAPK (p38) (Pearson et al., 2001, Han et al., 2017). Based on the type of exogenous input
received, activation of ERK, JNK, and p38 MAPK can variously regulate white adipocytes
differentiation and adipogenesis associated lipid storage and expenditure (Tanabe et al., 2004;
Xing et al., 2010). It was stressed that ERK1/2 activation considerably stimulates myoblasts
conversion into adipocytes; whereas, JNK is considered only a weak activator of adipocytes
derivation from myoblasts. In contrast, Activation of p38 by far suppressed myoblasts
reprograming into adipocytes (Qi et al., 2017). Another pathway known to be implicated in
myoblasts trans-differentiation into adipocytes is through heading off myotubes formation by
inhibiting myogenesis regulating genes and activating the rout of adipocytes formation by
enhancing the expression of genes serve as key regulators of adipogenesis process such as PPARs.
Two main PPAR ligands including thiazolidinedione and LCFA, particularly EPA and DHA, are
considered as strong inducers of the potential conversion of myoblasts into adipocytes through
their inhibitory effect on genes regulating myogenesis (Grygiel-Górniak, 2014; Subi et al., 2018).
The third molecular mechanism underlying the potential conversion of myoblasts into adipocytes
is inhibition of β-catenin production and related Wnt/b-catenin cell signaling suppression, a core
regulatory pathway of myotube formation, followed by promoting the expression of PPARγ2, key
regulator of adipogenesis. It was emphasized that EPA may have such dual function as a potent
activator of PPARγ2 and main inhibitory factor of Wnt/b-catenin signaling pathway (Luo et al.,
2015).
1.2.3. Regulation of adipocyte formation
Replenishment of regularly died adipocytes is a critical process to prevent the exhaustion
of body lipid reservoirs. Annually, the total number of adipocytes diminishes around 10% in
human, whereas, only 0.6% of adipocytes deposit is exhausted daily in mice (Spalding et al., 2008;
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Rigamonti et al., 2011). The successive steps for the adipogenesis process can be categorized into
two stages including the commitment stage and the terminal differentiation stage (Rosen and
Spiegelman, 2014). Once exposed to adipogenic stimuli, mesenchymal stem cells undergo
phenotypic and genotypic changes resulting in their conversion into pre-adipocytes that are
adipose tissue precursors lacking the capacity to differentiate into other lineages under the
influence of any stimuli. During the terminal differentiation stage, Preadipocytes are differentiated
into mature adipocytes capable of synthesizing and storing fatty acids (Rosen and Spiegelman,
2014). The adipogenesis process is generally regulated by enhancing the expression of PPARγ that
is considered the key regulator whose expression is indispensable and sufficient to committ
preadipocytes into mature fat cells. In this context, Agarwal and Garg, 2002 reported a close
association between degeneration of adipose tissue and mutations in gene coding PPARγ in
human. Mature adipocytes can also be generated from non-adipogenic precursors such as
myoblasts and fibroblasts by stimulating the ectopic expression of PPARγ (Tontonoz et al., 1994,
Hu et al., 1995). Adipogenesis regulation requires the interaction of another group of transcription
factors to drive the terminal differentiation of mature adipocytes. Three members of C/EBP family,
including C/EBPβ, C/EBP δ, and C/EBPα have been identified to play an important role in
orchestrating the adipogenesis process: Among them C/EBPβ and δ stimulate the expression of
PPARγ and C/EBPα at the early stage of the process. In turn, PPARγ and C/EBPα work in one
accord to promote the terminal differentiation of adipocytes by enhancing the expression of
terminal differentiation regulating genes (Wu, Z., et al., 1999; Tang and Lane, 2012). It was
reported that brown adipocytes isolated from double knocked C/EBPβ-/- and C/EBPδ-/- mice failed
to form lipid droplets. Also, these mice exhibited low levels of epididymal WAT (Gustafson et al.,
2015). However, the expression levels of PPARγ and C/EBPα did not change indicating that these
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genes might be regulated by another transcription factors than C/EBPβ and C/EBP δ (Rosen and
MacDougald, 2006). It has been recently discovered the participation of BMP4 and Zfp423 in
adipogenesis regulation. BMP4 is a transcription factor already produced and released from fully
mature adipocytes and work on motivating adjacent undifferentiated adipose-derived stem cells to
convert into mature adipocytes (Gupta et al., 2010). On the other hand, Zfp423 is adipogenic
transcription factor stimulating the generation of adipocytes from fibroblasts through activating
SMAD signal resulting in propagating the effect of BMP4 on uncommitted cells (Gupta et al.,
2010). It has to be clarified that most of the studies investigating the adipogenesis process have
been conducted using 3T3-L1 preadipocytes during the terminal differentiation phase while little
is known about the process at commitment stage as the available information is still scant. Many
other transcription factors are implicated positively or negatively in regulating the adipogenesis
process. Early B-cell factor (EBF) family, subdivided into 3 members including EBF1, EBF2, and
EBF3, was identified to be involved in regulating the adipogenesis process during the early stage.
Also, up-regulation the expression of these three members was demonstrated to enhance the transdifferentiation of fibroblasts into adipocytes (Akerblad et al., 2002, Jimenez, 2007). However,
EBF2 has been recently identified as a key gene of BAT development (Wang et al., 2014;
Rajakumari et al., 2013; Shapira et al., 2017). Transcription factor 4 (Atf4) Activation is a wellknown promotor of adipogenesis in human MSCs (hMSCs) (Cohen et al., 2015). Yu et al., 2014
reported a positive correlation between knocking down Atf4 gene and impairing the adipogenesis
process. Also, it was demonstrated that the expression level of Atf4 is considerably higher during
the terminal differentiation stage than the commitment stage. A positive effect for nuclear factor I
(NFI) family including NFIA and NFIB on adipogenesis was initially reported by (Waki et al.,
2011). The expression levels of the basal genes regulating adipogenesis, PPARγ, C/EBPα, and
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FABP4, were up-regulated in parallel with increasing the expression of NFIA. Moreover, it was
reported that complete blunting of NFIA or NFIB impairs the occurrence of the adipogenesis
process indicating a critical role for NFI family in promoting the adipogenesis process. However,
recent genomic study stressed that the members of NFI family were only identified as a part of
BAT chromatin regions suggesting that these genes are involved in promoting the development of
brown adipogenesis (Hiraike et al., 2017). Finally, in vitro overexpression of Early growth
response protein 2 (Krox20), Kruppel Like Factor 4 (KLF4), and glucocorticoid receptor were
initially suggested as critical players in promoting adipogenesis (Rosen and MacDougald, 2006;
Chen et al., 2005; Birsoy et al., 2008). However, it was revealed, in vivo study, that the
adipogenesis process and up-regulation the expression of master genes regulating it, including
PPAR, C/EBP, and FABP4 could be prompted independent of the expression of Krox20, KLF4,
and glucocorticoid receptor (Chen et al., 2005; Birsoy et al., 2008).
1.2.4. Classification and chemical structure of fatty acids
Fatty acids have an influence on many important physiological activities inside the body
as they are known to be the main energy suppliers, an essential components of cell membrane, raw
materials for synthesizing other biologically active lipids, and effective participants in tuning many
cell signaling pathways (Mozaffarian and Wu 2011; Calder, 2014). Fatty acids are hydrocabonic
compounds with two chemically active ends, one end is terminated with a carboxylic group;
whereas, a methyl group occupies the other terminus. Fatty acids can be classified into two groups
including saturated fatty acids voided from double bonds along their molecules and unsaturated
fatty acids containing either one double bond known as monounsaturated fatty acids (MUFA) or
more than one double bond such as polyunsaturated fatty acids (PUFAs). Human diet is mainly
composed of saturated fatty acids. Polyunsaturated fatty acids PUFAs can be sub-divided into two
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types based on the position of the double bond, including n-3 PUFAs, containing their first double
bond on the third carbon atom if counting is started from the methyl terminus, and those having
their first double bond on the sixth carbon atom, named as N-6 PUFAs. Some of PUFAs, known
as essential FAs, cannot be synthesized inside the body such as linoleic acid (LA – n-6), the
shortest member of N-6 PUFAs family, and α-linoleic acid (ALA – n-3), the shortest member of
n-3 PUFAs. Like essential amino acids, these fatty acids should be compensated from diet
especially canola, flaxseed, walnuts and leafy green vegetables that are well known sources of
such PUFAs (Simopoulos 2002). The ratio of n-6 to n-3 in human daily diet was estimated to be
15/1(Simopoulos, 2002). Two important enzymes known as fatty acid elongase and delta-5 and 6
desaturases catalyze the desaturation -insertion of additional double bonds and elongation insertion of two carbon atoms of LA and ALA respectively in the liver. Arachidonic acid (AA) is
the end product of metabolizing LA; whereas, ALA can be elongated into eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA). EPA and DHA are available in high percentage in
seafood, including salmon, herring, mackerel, seaweed and algae (Abedi and Sahari 2014). Given
the potential use of both n-6 and n-3 FAs to the same set of enzymes and the higher consumption
of n-6s in comparison to n-3 FAs (15 times higher), arachidonic acid (AA) production from LA is
the most predominant reaction when compared to the conversion of ALA into EPA and DHA
underpinning the low level of EPA and DHA in the body (Calder, 2011). Another reason can be
linked to decreasing the level of EPA and DHA inside the body is the utilization of large amount
of the consumed ALA in ATP production via process known as β-oxidation (Vermunt et al., 2000;
Burdge and Wootton, 2002; Burdge, 2006). N-3s and n-6s take part in many physiological actions
such as modulating the physical and chemical structure of cell membrane (Herbst et al., 2014;
McGlory et al., 2014), changing the profile of genes regulating FA metabolism (Muhlhausler et
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al., 2010), and synthesizing eicosanoids (Zulyniak et al., 2013) and lipid peroxidized molecules
(Catalá, 2009). However, they exhibit an antagonistic behavior in their response to inflammation
where n-6 FAs promote pro-inflammatory cytokines production (Egan and Kuehl, 1980). N-3 FAs,
on the other hand, are inversely correlated with pro-inflammatory cytokine synthesis and release
(Kuda, 2017). Accordingly, n-6 FAs associated up-regulation of pro-inflammatory markers can be
strongly tied to many metabolic disorders such as insulin resistance, dyslipidemia, and
hypertension.
1.2.5. Omega-3 fatty acids’ modes of action
It was demonstrated that most of the biological effects of EPA and DHA can be carried out
through two mechanisms, including incorporation into the cellular membranes followed by
changing the physical and biochemical characteristics of these membranes and modifying genes
profile of target tissues or organs. In comparison to other fatty acids, EPA and DHA have great
affinity to be embodied into the phospholipid portion of cell membrane that is considered the main
reason behind their physiological roles (Kaur et al., 2013). N-3s mechanisms of action can be
briefly explained in (Figure1-2).
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Figure 1-2: Mechanisms of action for omega-3 fatty acids. Adapted from Mozaffarian and Wu
(2011).
1.2.5.1. EPA and DHA content in cell membrane and Function
EPA and DHA representation in cellular membranes accounts for only small portion when
compared to other fatty acids, but the level can be increased upon increasing their content in diet.
It has been mentioned that many physiological activities such as cognitive function, energy
metabolism, inflammation and cardiovascular functions may be improved once the amount of EPA
and DHA increased in cellular membranes (De Caterina, 2011; Mozaffarian and Wu, 2011). Many
studies have reported a positive correlation between increasing n-3s/n-6 FAs ratio in cell
membrane from one side and improving cell function from the other side. Adjusting the ratio of n3s/n-6-associated enhancement of cell function can be attributed to changing membrane
phospholipids composition and related alteration in physical properties such as fluidity,
permeability, thickness and structure (Spector and Yorek 1985; McIntosh and Simon 2006;
Williams et al. 2012; Shaikh et al., 2015). Liu et al., 1994, Hulbert and Else, 1999 and Shaikh et
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al., 2015 have reported a strong association between altering the profile of fatty acids comprising
the membrane phospholipids after n-3s incorporation and modifying the activities of some
enzymes regulating the movement of substrates and ions across the membrane (Liu et al., 1994;
Hulbert and Else 1999; Shaikh et al., 2015) and perturbing lipid rafts formation (Wassall and
Stillwell 2008; Turk and Chapkin, 2013). Also, the process of phospholipid translocation, known
as flip flop, has been reported to be improved by N-3s supplementation leading to synthesizing
uniform lipid bilayer membrane (Chorner et al., 2016). Another mechanism through which n-3s
may exert their effect was underlined by their important role in controlling the production of
eicosanoids and oxygenated metabolites, well-known modulators of inflammation, energy
metabolism, and redox status. Phospholipase A2 enhances N-3s release from sn-2 position on
phospholipids molecules followed by modulating the action of many cell signaling pathways and
changing the expression of many genes involved in production of eicosanoids and oxygenated
metabolites.
1.2.5.2. The effect of EPA and DHA on gene expression
Omega−3 FAs modulate the expression levels of two transcription factors that are nuclear
factor kappa B (NFκB) (Allam-Ndoul et al., 2016) and peroxisome proliferator-activated receptors
(PPARs) (Deckelbaum et al., 2006; Muralikumar et al., 2017) in order to exert their effect on
inflammation and energy homeostasis. NF-κB is composed of three subunits and presents in the
cytosol in its inactive form (Ghosh and Karin 2002). IκB kinase, the enzyme responsible for NFκB
inhibition, is inactivated by phosphorylation and released from NF-κB in response to inflammation
(Peterson et al., 2011). After being separated from its inhibiter, NF-κB is induced to switch to its
active form and leave the cytosol toward the nucleus where it binds the promoter region and
stimulate the expression of clusters of genes that might influence many inflammatory
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processes such as, cell adhesion, migration, proliferation, extracellular matrix remodeling, and cell
survival processes (Peterson et al., 2011). The anti-inflammatory effect of N-3s having been
reported by series of studies might be induced through blocking NF-κB pathway via three various
mechanisms including 1) gene activation especially PPAR-γ (Korbecki et al., 2019), 2)
inactivation of toll like receptor 4 signaling cascade, implicated in propagation of inflammatory
responses (Hwang et al., 2016), 3) activation of G-protein coupled receptor 120 pathway to
enhance the anti-inflammatory response (Oh et al., 2010; Calder, 2015). It has been reported that
lipid metabolism and glucose homeostasis can be considerably modulated through regulating the
expression of family of transcription factors known as PPARs (Chen and Yang, 2014, Li and Liu,
2018). This family is mainly composed of three subtypes given the designations of PPARα,
PPARγ, and PPARβ/δ that are variously distributed in body tissues and diversely affect body
metabolism. PPARα, a stimulator of fatty acid breaks down, is predominately expressed in liver,
muscle, kidney and heart that excessively use fatty acids as enrgy source (Botta et al., 2018). On
the other hand, PPARβ that is mainly expressed in different tissues including skeletal muscle,
adipocytes, macrophages, lungs, brain, and skin promotes FA oxidation and uncoupling respiration
associated heat production (Lima et al., 2019). Finally, PPARγ, the key transcription factor
regulating adipogenesis and lipid deposition, is predominately expressed in adipose tissue
(Ahmadian et al. 2013). N-3 FAs are well known PPARs activators, and a close association has
been recently discovered between N-3 FAs supplementation and increasing the expression levels
of many genes regulating energy expenditure in muscle tissue including (FAT/CD36) (Hao et al.,
2020), uncoupling protein-3 (UCP-3) (Yoshino et al. 2016) and carnitine palmitoyltransferase I
(CPT1) (Cetrullo et al., 2020).
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1.2.6. Health benefits of omega-3
An array of Physiological benefits in various tissues mainly skeletal muscle, heart, liver,
brain and cardiovascular system have been highlighted to be considerably improved in response
to the consumption of n-3 FAs, particularly EPA and DHA (Mozaffarian and Wu 2011). One of
the main beneficial effects of n-3 FAs on body health that has been addressed frequently by
accumulative reports is their anti-inflammatory properties. EPA and DHA associated decreasing
the blood levels of TGs and C-reactive protein can be the reason behind their antagonistic
responses to inflammation (Li et al., 2014; Balk and Lichtenstein 2017). It has been reported that
n-3 FAs retain a robust efficiency in improving cardiovascular system function through reducing
the incidence of hypertension (Cottin et al., 2011) and minimizing the chance of heart stoke
occurance by reducing blood flow resistance (Mozaffarian and Wu, 2011). Moreover, promoting
muscle proteins synthesis and orchestrating energy metabolism can be intensively tied to the
consumption of n-3 FAs enriched diet (Smith et al., 2011b, Herbst et al., 2014). Additionally,
Buckley and Howe 2009 reported that n-3 FAs exhibit an anti-obesogenic effect. However, the
beneficial effect of n-3 FAs on many tissues have not been detected by other studies especially in
human (Rauch et al., 2010; Bosch et al., 2012; Kwak et al., 2012). In context of their effect on
insulin resistance and cardiovascular risk, Lalia and Lanza, 2016; Balk and Lichtenstein, 2017
have recently stressed only a negligible role for n-3 fatty acids in improving these parameters.
Absence of the consensus can be linked to many limitations such as the size of the samples, time
of exposure, the age of volunteers participating in the experiments, and post-treatment follow up.
1.2.7. Obesity: background and relation to dietary habit
There is a considerable increase in the number of obese individuals over the world where
many reports have recently talked about three times elevation in the rate of incidence during the
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period from 1975 to 2016. Adults aged more than 18 years old contributed to the biggest ratio of
the total number of overweight individuals who, based on their body mass index (BMI), were,
then, sub-divided into two groups, 39% of them showed BMI of greater than or equal to 25 kg/m2
while those with BMI greater than or equal to 30 kg/m2 represented only 13%. In 2016, the number
of obese children aged less than 5 years old was 41 million; whereas, 340 million person aged 519 years old were identified to be obese (Di Cesare et.al, 2019). Moreover, by 2030, half of the
population worldwide are expected to be recorded with obesity (Bae et al., 2015). Many health
problems such as cardiovascular diseases, type 2 diabetes, and some cancers can always be the
consequences of obesity. It was demonstrated that the risk of death significantly reduced in obese
men whose BMI was in the range of 23.5 - 24.9 kg/m2 and women with BMI of 22.0 - 23.4 kg/m2
(Bae et al., 2014). Otherwise, the mortality rate can be mounted by 30% when the BMI is equal or
above 25 kg/m2 (Feingold et al., 1992). Two adipose tissue compartments play a critical role in
regulating energy balance and associated Obesity development inside our bodies, including white
and brown adipose tissue. Whether increasing white adipocytes size and number is extremely
linked to propagating fat deposition mediated obesity incidince (Camp et al., 2002), brown adipose
tissue expansion stimulates energy dissipation-induced weight loss (Nedergaard et al., 2007).
Accordingly, individuals increasingly prone to develop obesity are those with diminished BAT
mass and activity (Rogero and Calder, et al., 2018). The co-existing representation of white and
brown adipocytes in the body and related obesity development can considerably affected by dietary
pattern. Diet enriched with fat and/or sugar is prevalently implicated in expanding white adipose
tissue mass and subsequent weight gain (Vandevijvere et al., 2015). Thus, there is an urgent need
to intensify the effort to determine the factors relevant to expanding white or brown adipose tissue.
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1.2.8. Energy regulation
1.2.8.1. White, Brown, and Beige Adipocytes: morphological and functional characteristics
Two main classes of adipose tissues defined as white adipose tissue (WAT) and brown
adipose tissue (BAT) can be discriminated based on their function and morphological
characteristics. Energy dissipation in the form of heat resulting from oxidation of consumed dietary
substrates is the main function of BAT. Heat production is prompted by uncoupling of protons,
extracted from substrates’ breacking down and passed through electron transport chain, into heat
via group of carrier proteins, the most important one among them is UCP1. In contrast, white
adipose tissue (WAT) works on lipid storage and deposition. In addition to their role in energy
homeostasis, brown and white adipocytes may affect energy balance inside the body by clusters
of adipokines released from these tissues and work on other organs in endocrine fashion (Cypess
et al., 2009). Another type of adipose tissue that has been recently discovered named as beige fat
tissue. In terms of morphology and function, beige adipocytes exhibit a great similarity to brown
adipocytes as they are highly enriched with mitochondria and multinodular lipid droplets and retain
a massive capacity to dissipate energy as a heat. However, they are originated from different cell
lineage that BAT arise from. Beige are clusters of cells infiltrated within white adipocytes they are
derived from (Hocking et al., 2013; Loyd and Obici, 2014). Genetically, the master genes of brown
adipocytes mainly UCP1 and genes regulating non-shivering thermogenesis are slightly expressed
in beige adipocytes at the basal steady state. However, stimulus such as cold exposure can induce
the expression of these genes to hit their highest levels (Wang and Wahl, 2014). The morphological
differences between white and brown tissue is manifested by the size and number of lipid droplets
where white adipocytes possess a single big droplet occupying the majority of the cytoplasm while
other organelles are localized very close to the cell membrane (Barneda et al., 2013). Constantly,
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brown adipocytes are highly enriched with mitochondria responsible for burning fatty acids and
contain large number of small multiocular lipid droplets (Cannon and Nedergaard, 2004). During
fetal development, the middle germ layer, mesoderm, gives rise to brown and white fat where the
process is mediated via intracellular and perfectly tuned independent pathways. The ancestor
precursor cells called multipotent stem cells have the capacity to evolve either into fat cells creating
lineages or muscle cells generating lineages resulting in the formation of white adipocytes, brown
adipocytes, or myocytes. Both classical brown adipocytes and myocytes arise from the same
clusters of adult progenitor cells called myogenic factor 5 positive cells (Myf5+). White and beige
adipocytes, on the other hand, are descended from adipogenic precursors known as Myf5− cells
(Petrovic et al., 2010; Seale et al., 2011). Gene profile of beige fat cells exhibits a significant
dissimilarity to both WAT and BAT although they share a similar embryonic originality with white
adipocytes and exert the same metabolic function of brown adipocytes. Several genes expressed
by beige fat cells including (adiponectin, adipocyte protein 2 gene, and adipsin) and (Ucp1, Cidea,
Pgc-1α) contribute to a significant part of the genomic profile of WAT and BAT respectively.
However, other genes encoding the synthesis of some integral proteins and immunity modulators
are predominantly expressed by beige fat cells such as T-box1 (Tbx1), solute carrier family 27
member 1 (Slc27a1), transmembrane protein 26 (TMEM26), CD40 and CD137 (Wu et al., 2012).
1.2.8.2. Association of intramuscular lipid accumulation and insulin resistance development
The postprandial carrying of food-derived components to targeted tissues to be utilized in
one of two ways including oxidation or deposition is a complex process motivated by insulin
hormone. The cascade of regulatory pathways enhanced by insulin to maintain body metabolism
are all driven via insulin receptor activation (Saltiel & Kahn, 2001, Taniguchi et al., 2006, and
Humphrey et al., 2013). Two main tissues considered to be essential in orchestrating lipid
hemostasis and glucose uptake and disposal include muscle and liver tissue. These organs are the
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most predominant targets of insulin signal. Insulin resistance is a process of losing the response of
tissues (liver and muscle) to insulin signal at the physiological normal doses. The incidence of
insulin resistance may be linked to many pathophysiological conditions such as excessive
production of free radicals, profound accumulation of pro-inflammatory mediators, ER stress, and
impairing mitochondrial function (Donath & Shoelson, 2011, Gregor & Hotamisligil, 2011,
Tiganis 2011, Kim et al., 2015, Montgomery & Turner, 2015, Rocha et al., 2016). Ectopic
infiltration of fat in places other than its regular reservoirs represented by adipose tissue is also
implicated in developing insulin resistance (Chavez & Summers, 2012, Turner et al., 2013,
Bellini et al., 2015). Factors relevant to lifestyle and others associated to cellular molecular
mechanisms are involved in increasing the risk of insulin resistance. High fat diet and sedentary
lifestyle are mainly implicated in ectopic accumulation of fat. Obesity associated impairing
adipose tissue function are commonly tied to insulin resistance. As a compensatory response,
adipocytes exhibit atypical increase in size and number in attempt to accommodate the excessive
increase in amassed lipid that has been demonstrated to be a main reason for inducing insulin
resistance. According to Johannsen et al., 2014, McLaughlin et al., 2014, and Kim et al., 2015,
adipose tissue isolated from patients desensitize to insulin is profoundly enriched with small and
large adipocytes, the first are more numerous while the later are fewer but larger than those in
healthy individuals. The adipogenesis process is a critical to generate functional adipocytes
capable to store excess lipid and prevent its infiltration in non-adipose tissues like skeletal muscle.
Surprisingly, the findings of Yang et al., 2004, McLaughlin et al., 2007 and McLaughlin et al.,
2014 have indicated that adipogenesis is compromised in patients with insulin resistance, and the
response to insulin signal was restored once the adipogenesis process is enhanced. It is to be
included that ectopic expansion of adipose tissue is positively correlated with insulin resistance
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development. Three major molecular mechanisms responsible for devloping insulin resistance
including: excessive consumption of high calorie diets and related energy imbalance, impairment
of fat break down, and overwhelming fat synthesis over catabolism. Intramuscular lipid is
frequently stored in the form of triglyceride. A close association has been identified between
increasing triglyceride infiltration within muscle fibers as a result of impairing some pathways
regulating lipid utilization and the prevalence of insulin resistance (Pan et al., 1997, Manco et al.,
2000). However, series of recent studies in human and rodents have explained that triglyceride
accumulation in liver and muscle might not be always followed by impairing the response to
insulin signal in such tissues (Amaro et al., 2010, Visser et al., 2011, Gemmink et al., 2016, Ter
Horst et al., 2017). Further, Bergman et al. 2018 claimed that utilizing free fatty acids in
synthesizing triglyceride might help prevent intramuscular accumulation of lipotoxic metabolites
and related insulin resistance development. Insulin resistance can be enhanced by intramuscular
and hepatic accumulation of ceramide, (Longato et al., 2012; Xia et al., 2015; Luukkonen et al.,
2016; Campana et al., 2018; Perreault et al., 2018) and diacylglycerol (DAG) (Erion & Shulman,
2010; Samuel & Shulman, 2012) as well. Finally, mitochondrial disorder also was highlighted to
be linked to insulin resistance (Montgomery and Turner, 2015). Reducing adipocytes
mitochondrial function can be correlated with suppressing adiponectin secretion resulting in
impairing glycolysis and β-oxidation processes followed by insulin desensitization in common
insulin responding tissues (Wang et al., 2013a). Moreover, a positive association was revealed
between increasing the incidence of insulin resistance and suppressing the efficiency of
mitochondrial enzymes and β-oxidation (Kelley and Mandarino, 2000; Kim et al., 2000).
Individuals with IR exhibited decreased mitochondrial size (Kim et al., 2000) and impaired the
capability to substrate oxidation and related ATP production (Petersen, 2003).
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1.2.9. Intramuscular lipid accumulation and muscle protein degradation
Bringing the rate of protein synthesis vs degradation to its equilibrium state is indispensable
to maintain muscle size and strength. The process of synthesizing new muscle proteins is fueled
by daily consumed food particularly that enriched with protein. The utilization of food-derived
elements in muscles proteinogenic process can be orchestrated at different prospects including:
investment of amino acids released from digested protein, the anabolic role of postprandial insulin,
and intracellular molecular mechanisms (Gorissen et al., 2015). It has been stressed that muscle
mass is by far reduced as a result of intramuscular infiltration of lipid. The findings of accumulative
recent studies have revealed that young healthy individuals infused with lipid for seven hours
exhibited a great resistance to insulin signals and significant decrease in synthesizing muscle
proteins from their precursor, amino acids. Diacylglycerols (DAGs) and ceramides, the most
deleterious lipid metabolites produced as a result of excessive intramuscular accumulation of fat,
are known to be implicated in promoting insulin resistance (Conte et al., 2015; Aquilano et al.,
2016; Cho and Kang, 2015; Szendroedi et al., 2014; Boon et al., 2013) and muscle atrophy (Tardif
et al., 2014; Rivas et al., 2016; de Larichaudy et al., 2012). Tardif et al., 2014 and Bryner et al.,
2012, have found that the expression levels of muscle atrophy triggering factors were up-regulated
when C2C12 and L6 myotubes were exposed to palmitate supplementation. Ceramide
accumulation after palmitate treatment enhances muscle atrophy by up-regulation the expression
of atrogin‐1/MAFbx that leads to increasing the level of FoxO3 and eIF2α phosphorylation,
involved in degradation of muscle protein. In line with that, muscle protein synthesis could be
restored by enhancing mammalian target of rapamycin (mTOR) pathway that prevents ceramide
accumulation -induced activation of proteolysis stimulating cascades (de Larichaudy et al., 2012).
However, the hypothesis suggesting a positive correlation between intramyocellular lipid

25

accumulation and muscle protein degradation was rejected by Turpin et al., 2009. They claimed
that ob/ob mice fed high fat diet or those infused with lipid did not exhibit symptoms of muscle
atrophy or apoptosis; while, Turpin et al., 2006 reported that increasing ceramides level promots
muscle tissue death indicating that only some lipid intermediates are implicated in losing muscle
mass. Another aspect of muscle atrophy can be attributed to impairing mitochondrial function. It
has been shown that mitochondrial dysfunction-induced muscle loss in elderly might be caused by
increasing the level of reactive oxygen species (ROS), suppressing the activity of enzyme
regulating electron transport chain, elevating the rate of apoptotic mitochondria (Cooper, 1992),
down-regulation the expression of genes controlling mitochondrial biogenesis (Chabi et al., 2008),
mitochondrial malformation (Leduc‐Gaudet et al., 2015), and inhibiting the process of
mitochondrial β-oxidation ( Blaak et al., 1999 ; Toth and Tchernof, 2000). Consistently, always
et al., 2017 has recently reported a strong association between impairing mitochondrial function
and induction of muscular and neuronal tissue death.
1.2.10. Effect of n-3 LCPUFAs on energy handling and fatty acid composition
A positive correlation between n-3 LCPUFAs supplementation, particularly EPA and
DHA, and up-regulation the expression of BAT signature genes and thermogenesis regulating
genes has been frequently stressed. However, consensus on these findings is still missing. For
instance, Oudart et al., 1997 reported a notable improvement in the thermogenic capacity of iBAT
in rats fed marine n-3 LCPUFAs. In line with this study, the findings of Takahashi and Ide, 2000
study exhibited a significant increase in UCP1 expression, the master gene of BAT, in response to
n-3 LCPUFA treatment in rats. Further, it has been demonstrated, in series of studies, that genes
regulating lipid oxidation and thermogenic activity in iBAT could be considerably stimulated at
the transcription and protein level in mice administrated fish oil (Kim et al., 2015; Kim et al., 2016;
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Bargut et al., 2016, Pahlavani et al., 2017). However, Flachs et al., 2011 and Villarroya et al., 2014
have found non-significant difference in the expression level of UCP1 between control and n-3
LCPUFA treated group indicating no role for n-3 LCPUFA in enhancing the thermogenic capacity.
To determine whether the induction of genes regulating BAT thermogenic capacity in response to
fish oil treatment was accompanied by increasing non-shivering respiration, mice were exposed to
cold environment, 8CΟ, for 45 minutes (Kim et al., 2016) and thermoneutral temperature, 23CΟ
(Kim et al., 2015). The results of these two experiments approved an essential role for n-3
LCPUFA in stimulating uncoupling respiration manifested by increasing the rate of oxygen
consumption and heat production. Moreover, the beneficial role of EPA on BAT function was
assessed in vitro experiment in which EPA treated group exhibited an increase in mitochondrial
main parameters, encompassing mitochondrial biogenesis, glycolytic capacity (Pahlavani et al.,
2017), basal respiration, uncoupling efficiency, and maximal respiration (Kim et al., 2016). EPA
and DHA showed dissimilarity in their effect on brown adipogenesis and mitochondrial
biogenesis. EPA has been identified to be effective in stimulating the role of BAT in energy
dissipation (Kim et al., 2016, Zhao and Chen et al., 2014; Quesada-Lopez et al., 2016); while,
DHA exhibited non-significant change in the transcript and protein levels of genes orchestrating
BAT development and those responsible for regulating mitochondrial biogenesis (Zhao and Chen
et al., 2014). Correspondingly, Zhao and Chen et al., 2014; Quesada-Lopez et al., 2016, and
Fleckenstein-Elsen et al., 2016 have revealed that EPA but not DHA intake was effective in
promoting the trans-differentiation of white adipocytes into beige adipocytes that are involved in
energy expenditure as heat. Lorente-Cebrian et al., 2009 and Abdul-Rahman et al., 2016 reported
that EPA consumption-induced stimulation of brown and beige activity might be mediated through
AMP-activated kinase (AMPK) activation. Consensus on the potential effect of EPA and DHA on
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the metabolic characteristics and fate of white adipocytes is still unavailable. It has been found that
fish oil administration promotes trans-differentiation of epididymal WAT (eWAT) into brown-like
adipocytes through increasing gene expression and protein level of UCP1. Also, Maeda et al., 2016
reported a beneficial role for concurrent treatment of fish oil with fucoxanthin, carotenoid
antioxidant, in browning of WAT and enhancing thermogenic capacity. The findings of these
studies were emphasized by Okada et al., 2011 as well. However, no effect for fish oil treatment
on browning of eWAT has been observed in other experiments (Pahlavani et al., 2017; Flachs et
al., 2005). Additionally, the data gained from many investigations describing the effect of fish oil
on genes regulating β-oxidation and oxidative phosphorylation in eWAT exhibited an obvious
inconsistency (Pahlavani et al., 2017; Flachs et al., 2011; Villarroya et al., 2014; Bhaskaran et al.,
2017). On the other hand, the effect of fish oil compounds on reprogramming inguinal WAT
(iWAT) into brown - like adipocytes has been serially investigated. The expression levels of BAT
signature genes, including UCP1, PRDM16, TB1, PGC1α, CIDEA, ADRB3, CD137, and CPT1β
were found to be up-regulated significantly in fish oil treated group when compared to control.
Further, browning of iWAT manifested by increasing the number of multilocular lipid droplets
was promoted in mice fed 36 – 71 g n-3 LCPUFA per kg feed (Bargut et al., 2016). In contrast,
Pahlavani et al., 2017 asserted that mice exposed to the same dose (36 g EPA per kg feed) showed
no changes in the expression levels of BAT regulating genes in iWAT. Given that the acceptable
daily intake of n-3 LCPUFA in human is roughly 14 – 28 g/d, the doses have been used by (Bargut
et al., 2016; Pahlavani et al., 2017) are by far higher than the recommended dose (Welch et al.,
2010). Therefore, the potential induction of iWAT browning can be only promoted by excessive
consumption of high doses of n-3 LCPUFA.
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2.1. Astract
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) modulate cellular
metabolic functions and gene expression. This study investigated the impacts of EPA and DHA
on gene expression and morphological changes during white adipogenic inducement in C2C12
myoblasts. Cells were cultured and treated with diﬀerentiation medium with and without 50 μM
EPA and DHA. Cells treated with fatty acids had noticeable lipid droplets, but no formation of
myotubes compared to control group cells. The expression levels of key genes relevant to white
adipogenesis and inﬂammation were signiﬁcantly higher (P < 0.05) in cells treated with fatty
acids. Genes associated with myogenesis and mitochondrial biosynthesis and function had lower
(P < 0.05) expression with fatty acids supplementation. Moreover, fatty acid treatment reduced
(P < 0.05) oxygen consumption rate in the diﬀerentiated cells. This suggested blocking myotube
formation through supplementation with EPA and DHA droves myoblasts to enter the quiescent
state and enabled adipogenic trans-diﬀerentiation of the myoblasts. Data also suggested that
overdosage of EPA and DHA during gestation may drive fetal myogenic proginetor cell
diﬀerentiation to the fate of adipogenesis and have a long-term eﬀect on childhood obesity.
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2.2. Introdction
Growing bodies of evidences indicate that an increase in consumption of n-3
polyunsaturated fatty acids (PUFAs) is strongly linked to a decrease in risk factors for a variety of
diseases (Seo et al. 2005). As well, n-3 PUFAs have been shown to play promising roles in
improving many biological processes including cognition, learning, and visual development.
Moreover, the immune-inﬂammatory response, pregnancy outcomes, neurologic degeneration
prevention, cardiovascular diseases, and cancer treatment have been reverlead to be improved in
response to n-3 PUFAs intake (Seo et al. 2005). Eicosapentaenoic acid (EPA, 20:5, n-3) and
docosahexaenoic acid (DHA, 20:6, n-3) are two such n-3 PUFAs used for their beneﬁcial eﬀects
on growth and development (Greenberg et al. 2008; Swanson et al. 2012; Janovska et al. 2013). A
recent series of trials have found that sheep fed a high energy diet to induce maternal obesity
negatively aﬀected the development of muscular system in the fetus and oﬀspring (Huang et al.
2010a; Huang et al. 2010b; Huang et al. 2012) ; whereas, intramuscular fat tissue was elevated in
the fetus at mid and late gestation (Zhu et al. 2006; Zhu et al. 2008). Due to its metabolic
importance, fetal skeletal muscle is considered one of the target organs of lipid accumulation
induced by a high energy maternal diet (Ong and Muhlhausler 2011; Kabaran and Besler 2015;
Hsueh et al. 2018). Proper nutrient uptake and storage is essential for maintaining skeletal muscle
mass and integrity. Coordination of muscle protein synthesis and proteolysis during normal
physiological processes involves the cross communication of multiple signal pathways. Imbalance
of pathway networking can induce pathological conditions such as muscle mass atrophy, muscle
aging, cancer, heart disease, and obesity (Le et al. 2014; Wagatsuma et al. 2016; Lipina and Hundal
2017). EPA and DHA supplementation can modulate the expression of key regulatory genes
related to myogenesis, adipogenesis, mitochondrial, and peroxisomal biosynthesis in C2C12
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myoblasts during their normal diﬀerentiation into myocytes (Hsueh et al. 2018). Inhibiting
myotube formation, upregulating adipogenic-related gene expression, promoting peroxisomal
biogenesis, and suppressing mitochondrial activity were the primary outcomes of fatty acids
treatment (FA) leading to decreased energy expenditure and ROS production to block myogenesis.
This indicated that over dosage of n-3 PUFAs in the maternal diet may inﬂuence fetal muscle
development along with long-term eﬀects on the development of metabolic diseases such as
obesity and diabetes in adult oﬀspring. However, the role of EPA and DHA in driving commitment
of C2C12 cells into adipocytes lineage is not yet clear. Additionally, the role of concurrent
treatment with EPA and DHA in determining the identity of derived adipocytes is lacking. Limited
studies have addressed the molecular mechanisms behind their eﬀect on regulating the metabolic
function of brown and white adipocytes. Understanding the role of EPA and DHA in the
commitment of C2C12 cells into a speciﬁc adipocyte phenotype would allow a better
understanding of the development of obesity in an early life stage. This study investigated the
eﬀect of combined EPA and DHA treatment on the induction of C2C12 myoblast cells into white
adipocytes to explain the unusual accumulation of intramuscular fat depots and related insulin
resistance involved in many metabolic disorders. In vitro models were used to mimic in vivo
processes and isolate the desired experimental parameters. The hypothesis was that treatment with
EPA and DHA would alter key pathways related to adipogenesis and mitochondrial biosynthesis
in the diﬀerentiation of C2C12 cells.
2.3. Materials and methods
2.3.1. Cell culture and diﬀerentiation
Reagents were obtained from Sigma -Aldrich unless otherwise specified. C2C12 cell
culture was conducted as described previously (Klemm et al. 2001; Kim and Chen 2004; Yada et
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al. 2006; Yamanouchi et al. 2007). Briefly, C2C12 myoblasts were cultured in Dulbecco's
modified Eagle's medium (DMEM) 89% with 10% fetal bovine serum and 1% penicillinstreptomycin at 37°C under a 5% CO2 atmosphere. When cell confluency reached >90%, cells
were subdivided into two 6-well plates consisting of a control group (CON) and a fatty acid
treatment group (FA) with an initial density of 1.9 x 104 cells per well. Both groups were induced
to differentiate into white adipocytes. Cells were first incubated with induction differentiation
media number 1, composed of insulin (1 µg/ml), dexamethasone (0.1 µg/ml at 0.25uM),
troglitazone (10 µM), and isobutylmethylxanthine (0.125 mM) dissolved in DMSO, for 6 days.
Cells were then switched to diﬀerentiation media 2, containing only insulin (1 µg/ml) dissolved in
ethanol for the next four days. 50 μM EPA and 50 μM DHA were added to induction media 1 and
2 in the FA group.
2.3.2. Oil Red O staining
Cells were rinsed three times in PBS, fixed with 10% paraformaldehyde (Sigma-Aldrich),
incubated for 30 min at room temperature, and again washed in PBS. Cells were then stained with
filtered Oil Red O working solution (Sigma-Aldrich) (0.5% Oil Red O dissolved in 100%
isopropanol) and incubated for 30 min at room temperature (Konieczny and Emerson Jr 1984).
Morphological changes and intracellular lipid droplet accumulation were observed under the
microscope. Fat droplets were identified by their bright red color. Fully differentiated cells
displayed adipocyte-like shape with significant deposition of lipid droplets in their cytoplasm and
lacked the development of multinucleated myotubes. Images were photographically produced
using a Nikon DS-Fi3 digital camera mounted on a Nikon Eclipse TS 2R light microscope. For
quantitive measurement of Oil red O, the stain was extracted by adding 1 ml of 100% (v/v)
isopropyl alcohol with gentle rocking for 15 minutes. 80% of the extract volume was used to
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measure and read at 520 nm using microplate reader (Gene 5 Bio Tek Spectrometer) .100%
isopropanol was used to reduce background signal (Cheung et al. 2015).
2.3.3. Real-time PCR
Total RNA was isolated from cells with TRIzol reagent and purified using Zymo-Spin™
IIICG Column. Measurement of RNA concentration was performed using Nanodrop.
OD260nm/OD280nm was examined to assess the quality of the extracted RNA. The cDNA was
obtained using 5 Χ iScript cDNA synthesis kit (Bio-Rad, Richmond, CA) following the
manufacturer’s protocol. Real-time PCR was carried out using CFX Connect Real-Time PCR
Detection System (Bio-Rad, Richmond, CA), and relative quantification of RNA expression was
conducted in 15µL of reaction medium composed of 7.5 µL SYBR Green Supermix (Bio-Rad,
Richmond, CA), 3µL (100 ng) cDNA, 1.5 µL forward and reverse primers (10 µM each) (Table
1), and 3 µL DNase/RNase free water. PCR reaction conditions were set as follows: 3 min at 95°C,
10s at 95°C, and 60s at 60°C for 40 cycles. A melting curve evaluated product purity. Relative
expression levels were normalized to 18s gene and expressed in arbitrary unit (Huang et al. 2010a).
2.3.4. Oxygen consumption rate (OCR)
Orion Star A213 Dissolved Oxygen Meter (Thermo Scientific, Waltham, MA, USA) was
used to measure the OCR (Zou et al. 2018). The dissolved oxygen was measured by RDO optical
probe. On assessment day, cells were refreshed with a non-buffered pH 7.4 basal medium
composed of 2% BSA (Sigma-Aldrich), 1.1 mM sodium pyruvate (Sigma-Aldrich), and 25 mM
glucose (Sigma-Aldrich) in PBS. Oxygen concentration (g/ml) was measured before and after 15
min incubation in cell culture incubator. The difference between the two reads represented the
amount of oxygen consumed in units of time. Each sample was measured in triplicate and
normalized by the total cell count.
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2.3.5. Western blot assay
Cells were scraped from the wells using PBS (1 ml/well). Lysis buffer (T-PER),
supplemented with protease and phosphatase cocktail inhibitors at 1:100 ratio, was used to extract
total protein. Protein concentration was determined using BCA protein assay kit (Thermo
Scientific). Samples were separated on Mini-PROTEAN precast gels (Bio-Rad), then transferred
onto Trans-Blot® Turbo™ Mini PVDF Transfer Packs (Bio-Rad). Non-specific antibodies were
excluded by blocking the membrane with 5% BSA as blocking solution. Immuno-staining with
primary antibodies GAPDH (1:1000, Cusobio), myogenic differentiation 1 (MyoD) (1:25000,
Cusobio), MyoG (1:25000, Cusobio), and PGC1α (1:1000, Abcam) was performed by incubation
with the antibody of interest overnight. Blots then were incubated with the specific IgG-HRPconjugated secondary antibody for 1 hour with gentle rocking. The bands were visualized using
ECL immunoblotting clarity system (Bio-Rad) and detected on ChemiDocTM Touch imaging
system (Bio-Rad). The bands representing the levels of different proteins were quantified using
Image Lab Software. Band density was normalized according to the Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) content.
2.3.6. Statistical analysis
All data from assays used to compare CON and FA groups were assessed for signiﬁcance
by the unpaired Student’s t-test with the assumption of equal variances, and arithmetic means ±
SEM are reported. P< 0.05 was considered statistically signiﬁcant.
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2.4. Results
2.4.1. EPA and DHA supplementation augmented trans- diﬀerentiation of C2C12 into white
adipocyte-like phenotype through up-regulation of key adipogenic markers
Peroxisome proliferator-activated receptor gamma (PPARγ), adipocyte protein 2 (aP2),
CCAAT/enhancer binding protein-alpha (C/EBPα), and bone morphogenetic protein 4 (BMP4)
are the most well-known master regulators of white adipogenesis. These genes were tested for
up-regulation in C2C12 cells subjected to EPA and DHA treatments. The FA group exhibited a
signiﬁcant increase in basal levels of mRNA of aP2, C/EBPα, PPARγ, and BMP4 (274 ± 62.3%,
P = 0.0017; 159 ± 25.3%, P = 0.0009; 85.2 ± 10.6%, P = 0.00002; and 82.9 ± 25.9%, P= 0.0073,
respectively). The CON group did no display an increase in the expression level of these genes
even upon treatment with media containing white adipogenesis-inducing agents (Figure 1).
2.4.2. Concomitant treatment with EPA and DHA reduced mitochondrial function and
biosynthesis
The eﬀect of EPA and DHA on mitochondrial function and biosynthesis was investigated
by studying the expression of transcription factor A mitochondrial (TFAM), PPARγ co-activator
1 (PGC1α), cytochrome c oxidase subunit 7α1 (COX7α1), and the ratio of mitochondrial DNA
(mtDNA) to nuclear DNA (nDNA) as markers essential to assess the thermogenic capacity of
adipocytes. TFAM, mtDNA/nDNA, and COX7α1 were substantially down-regulated in FA treated
group (23.3 ± 8.45%, P = 0.0389; 57.1 ± 3.98%, P = 0.0335; and 67.1 ± 6.74%, P = 0.0004,
respectively), indicating that EPA and DHA concurrent supplementation inhibited mitochondrial
function and biosynthesis (Figure 2).
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2.4.3. EPA and DHA inhibited multinucleated myotube formation
MyoD1 and myogenic factor 5 (Myf5) genes were significantly down-regulated in the FA
group in comparison with CON group (38.5 ± 6.49%, P = 0.0028; and 45.6 ±5.79%, P = 0.037,
respectively), while the expressein level of paired box 7 (Pax7) tended to be highly increased in
the FA group (40.7 ± 15.1%, P = 0.0569) (Figure 3).
2.4.4. EPA and DHA promoted fat droplet accumulation
The FA group showed higher accumulation of lipid droplets compared with the CON group
(Figure 4(A). Quantitative measurement of Oil Red O staining showed a signiﬁcant increase in the
amount of stain extracted from the FA group compared to CON (24.2 ± 3.41%, P = 0.0001) (Figure
4(B)). These results suggested that EPA and DHA induced the trans-diﬀerentiation of myoblasts
into white adipocytes-like cells.
2.4.5. EPA and DHA aﬀected the metabolism of C2C12 myoblasts
The FA group showed a signiﬁcant decrease in oxygen consumption rate when compared
to the CON group (61.9 ± 4.95%, P= 0.0016) (Figure 5). This decline is consistent with the
decreased expression observed in mitochondrial biosynthesis related genes. The FA group showed
an increase in the expression of genes driving adipogenesis and suppressing mitochondria induced
thermogenesis, which may be responsible for the dramatic reduction in the maximal respiratory
capacity. The data indicated that EPA and DHA supplementation negatively aﬀected
mitochondrial activity.
2.4.6. Morphological changes in C2C12 myoblasts
It was previously shown that inhibition of myotube formation would induce myocyte transdiﬀerentiation into other lineages (Singh, 2007). In this experiment, morphological changes during
myoblast diﬀerentiation were detected by Oil Red O staining (Figure 6). RT–PCR and Oil Red O
staining results conﬁrmed the trans-diﬀerentiation of C2C12 cells into white adipocytes-like cell,
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indicated by the absence of multinucleated myotubes and the presence of clusters of rounded cells
containing lipid droplets in the FA group compared to the CON group.
2.4.7. Pro-inﬂammatory eﬀect of EPA and DHA treatment
A study suggested that inﬂammation in adipose tissue boosts systemic inﬂammation, which
is highly related to insulin resistance in obese individuals (Ajuwon and Spurlock 2005). The
potential capacity of EPA and DHA to modulate inﬂammation in C2C12 cells trans-diﬀerentiated
into adipocytes were tested. EPA and DHA treated group exhibited a dramatic increase in
interleukin 6 (IL-6) gene expression (74.0 ± 28.6%, P= 0.0214), but not tumor necrosis factor α
(TNFα) (P = 0.3080) (Figure 7).
2.4.8. Eﬀect of EPA and DHA treatment on genes involved in peroxisome biogenesis and
function
ATP binding cassette subfamily D member 3 (70 kDa peroxisomal membrane protein,
PMP70) was signiﬁcantly up-regulated (47.8 ± 9.64%, P= 0.0018) in the FA group (Figure 8).
However, peroxisomal biogenesis factor 2 (PEX2) and PEX19, speciﬁcally associated with the
biogenesis process, were not signiﬁcantly aﬀected (P = 0.0728 and P = 0.4698).
2.5. Discussion
Long-chain PUFAs play an essential role in fetus and neonatal development (Jensen 1999;
Duttaroy 2009; Kabaran and Besler 2015). Studies indicate insuﬃcient maternal n-3 PUFAs
supplement results in greater childhood body and abdominal fat mass of the oﬀspring (Vidakovic
et al. 2016). However, few studies have focused on the eﬀects of excessive n-3 fatty acids on
muscle growth and development (Church et al. 2008; Hsueh et al. 2018). In previous research with
n-3 PUFAs supplementation in C2C12 cell cultures, toxicity of EPA and DHA on C2C12 cells
was found with concentrations above 50 μM in the growth medium. The myogenic feature of
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C2C12 cells was inhibited while adipogenic potential was promoted by 50 μM EPA and DHA
treatment (Lee et al. 2013; Hsueh et al. 2018). Previous research also found trans-diﬀerentiation
of C2C12 myoblasts accompanied changing myoblast morphology. Excessive accumulation of
lipid droplets in the cytoplasm was induced by thiazolidinediones, a potent PPARγ activator
adipogenic agent (Singh, 2007). Regarding arrested formation of multinucleated myotubes and
adipocyte creation, our data suggested that adipocyte derivation and blunting the formation of
multinucleated myotubes could be attributed to increased expression of C/EBPα and PPAR-γ and
decreased expression of genes regulating myogenesis process and myosin heavy chain. Consistent
with a previous study using a chick model (Shang et al., 2014), increased expression of
adipogenesis-related genes, including PPARγ and aP2, was associated with cytoplasmic lipid
droplet accumulation and adipocyte diﬀerentiation induced by fatty acid treatment. Further,
increased expression of the master regulator of adipocyte diﬀerentiation, PPARγ, and adipocytespeciﬁc genes C/EBPα and aP2 in FA group enhanced cytoplasmic lipid droplet accumulation and
changed cell morphology from ﬁbroblast-like into polygon (Matsubara et al., 2008). This
demonstrated that myoblasts have a great capacity to trans-diﬀerentiation into white dipocyteslike phenotype through up-regulation of transcription factors PPARγ and C/EBPα.
Transcription factor Pax7 is a myogenesis related gene that plays a vital role in guiding the
lineage speciﬁcation of myocytes. Pax7 is highly expressed during the proliferation phase, but
rapidly down-regulated during diﬀerentiation. It has been shown that inhibiting myotube formation
in C2C12 cells is closely associated with up-regulation of Pax7 (Xia et al., 1996). A study
demonstrated myoblast diﬀerentiation and myotube formation were induced only when the
expression of Pax7 was inhibited by MyoD1, mediated by the expression of miR-206 and 486,
which target the Pax7 gene 3′-untranslated region (Dey et al., 2011). Factors inhibiting the
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expression of these micro RNAs can block myotube formation through assisting Pax7 protein
synthesis. Preventing myotube formation with thiazolidinediones could drive myoblast
development into another lineage. Accordingly, this study suggested that EPA and DHA mediated
increased expression of Pax7 may be implicated in C2C12 cells trans-diﬀerentiation into
adipocytes. On the other hand, Pax7 up-regulation may be a compensatory attempt to counter
adipogenicity and regenerate the impaired myogenic capacity of C2C12 cells. Our data suggested
that high fatty acid treatment down-regulated the expression of genes involved in mitochondrial
function and biosynthesis, including TFAM, COX7α1, and mtDNA/nDNA ratio. TFAM is a
transcription factor critical for mitochondrial replication encoded in the nucleus (Fisher and
Clayton 1988). It has been shown that mitochondrial function and subsequent cell growth and
morphology can be compromised by TFAM gene knockdown, followed by reducing mtDNA copy
number and expression (Jeng et al., 2008). Consistent with previous studies, impaired TFAM
expression negatively aﬀected the mtDNA/nDNA (mitochondrial DNA per nuclear DNA copy
number) ratio and mitochondrial respiratory chain eﬃciency (Wang et al., 2001; Woo et al., 2012;
Xie et al., 2016; Lan et al., 2017). Decreased mitochondrial biosynthesis was shown by the
mtDNA/ nDNA ratio (Phillips et al., 2014; Hsueh et al., 2018).The transcription of mitochondrial
genes regulating lipid metabolism is well-orchestrated by PPARγ, through regulation of PGC1α
expression, which maintains the normal physiological and the functional status of mitochondria
(Vega et al., 2000; Puigserver and Spiegel- man 2003). Mitochondrial gene expression can also be
regulated by the expression of TFAM. An example of the importance of TFAM and COX7α1 in
promoting mitochondrial biosynthesis and maintaining its structure is evident in a study in which
the positive eﬀects of linoleic acid on cell viability after streptozotocin damage occurred through
maintaining the mitochondrial structure and increased biosynthesis induced by up-regulation of
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TFAM, COX7α1, and PGC1 (Jeng et al., 2009). Accordingly, our data suggested there was no
defect in the PPARγ- PGC1 pathway. Reduction in mitochondrial biosynthesis, function, and,
subsequently, decreased oxygen consumption rate was attributed to the disruption of PGC1-NRFTFAM cascade. To further test the proadipogenic eﬀects of n-3 PUFAs on mitochondrial
metabolism, we calculated the metabolic rates by measuring the oxygen consumption rate. Our
data suggested that EPA and DHA reduced the metabolic capacity of trans-diﬀerentiated C2C12
cells. In addition to the adverse eﬀect of down-regulation of TFAM and COX7α1, the decreased
oxygen consumption rate was linked to up-regulation of adipogenic markers. The oxygen
consumption rates were consistent with those obtained from qPCR. This suggested a diminished
oxygen consumption rate in the FA group was attributed to the enhanced expression of PPARγ
and its target gene aP2 along with the increased expression of C/EBPα. Correspondingly, it was
reported that reducing expression of PPARγ and its target genes in liver and adipose tissue is
accompanied by increased AMP/ATP ratio (den Besten et al., 2015). Therefore, stimulating
oxidative metabolism through activation of AMP-activated protein kinase (AMPK) pathway plays
an essential role in shifting lipid synthesis to fatty acids oxidation to reduce adipogenesis in mice.
Moreover, induced activation of AMPK was blocked by adding rosiglitazone, well-known PPARγ
agonist (McGarry et al., 1983; den Besten et al., 2015). The induction of adipogenic markers,
including PPARγ, ap2, and C/EBPα, are strongly linked with suppression fatty acid oxidation,
stimulation of lipogenesis, and triglyceride deposition (den Besten et al., 2015). BMP4, a white
adipogenesis speciﬁc marker, was highly expressed in FA group as compared to CON group,
which may account for the acquisition of white adipocytes-like phenotype and impairment of the
thermogenic capacity. Other studies have demonstrated that BMP4 promoted the shift of
adipocytes from brown to white during the terminal diﬀerentiation phase due to suppression of
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lipolysis via regulation of hormone- sensitive lipase expression. BMP4 stimulated the expression
of adipogenic markers such as PPARγ and ap2, leading to enhanced lipid storage. Further, BMP4
blunted not only cAMP-induced lipolysis, but also lipolysis stimulated by isoproterenol, forskolin,
and isobutyl- methylxanthine and suppressed the acute rise in the OCR promoted by cAMP
(Modica et al., 2016).
The FA group exhibited a signiﬁcant increase in the expression of the pro-inﬂammatory
cytokine IL-6 but not TNFα. Our ﬁndings consistent with results reported that freshly isolated
human adipocytes could secrete profound amounts of IL-6 in the supernatants aspirated from the
culture medium. It has been shown that IL-6, secreted mainly from adipose tissue in humans,
contributes to 15–35% of the total circulating level cytokines (Fried et al., 1998). TNFα, on the
other hand, is scantly produced by human fat cells (Fried et al. 1998; Ekin et al. 2003). As a
transcriptional factor, C/EBPα plays a pivotal role in regulation and expression of IL-6 promoter
(Vanden Berghe et al. 2000). Consistently, increased expression of C/EBPα gene in this study was
implicated in promoting IL-6 expression. Because adipocytes are a signiﬁcant source of proinﬂammatory cytokines, and a promotor of IL-6 receptor and IL-6 expression in obese patients
(Maachi et al., 2004; Sindhu et al., 2015), it was expected that TNFα expression increases as well.
However, it was demonstrated that IL-6 has the potential to inversely aﬀect the expression and
production of TNFα in skeletal muscle (Pedersen et al., 2003).
Adipocytes are inﬁltrated with a considerable number of peroxisomes, appearing as small
organelles adjacently localized to lipid droplets in adipocytes (Schrader et al., 2013). Their
numbers are dramatically increased during adipocyte diﬀerentiation, reﬂecting their involvement
in lipid metabolism (Novikoﬀ and Novikoﬀ 1982). Various aspects of peroxisomal biogenesis,
including their assembly, division, and inheritance, are orchestrated by speciﬁc proteins called
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peroxins, which are encoded by PEX genes, such as PEX2 and PEX19 (Dimi- trov et al. 2013;
Lodhi and Semenkovich 2014). It was reported that n-3 PUFAs promote peroxisome synthesis and
bioactivity resulting in increased FA beta-oxidation (Willumsen et al. 1993; Neschen et al. 2002;
Hirabara et al. 2013; Romanatto et al. 2014). Moreover, PMP70 is unnecessary for biogenesis and
proliferation but required for the normal function of peroxisomes (Imanaka et al. 1999). Consistent
with these results, this study showed that with increased expression of PMP70 in EPA and DHA
treated group (47%) but not PEX2 or PEX19, PUFAs aﬀected peroxisomal function, exhibited by
increased fatty acid transport into peroxisome lumens, without aﬀecting the biogenesis process.
Data suggested up-regulation of PMP70 as a compensatory mechanism prompted by EPA and
DHA associated lipid droplet accumulation.
2.6. Conclusions
This study suggested that concomitant treatment with EPA and DHA inhibits myotube
formation by targeting myogenesis signature genes such as Myf5, MyoD1, MyoG, and PAX7,
while also promoting the white adipocyte-like phenotype, as indicated by up-regulation of white
adipose tissue-selective genes such as BMP4, C/EBPα, and IL-6. This study also indicated that
combined supplementation of EPA and DHA is correlated with mitochondrial dysfunction,
attributed to a reduction in expression of TFAM, COX7α1, and PGC1α genes regulating
mitochondrial biosynthesis and function. Lipid droplet accumulation was associated with reduced
oxygen consumption rate. EPA and DHA supplementation were able to further promote lipid
storage over induction diﬀerentiation media alone, attributed to the higher number of adipocytes
formed. Finally, this study demonstrated that white adipocyte-like subsets could arise from
myogenic precursors expressing Myf5, previously thought to give rise only to skeletal muscle and
brown adipocytes. These observations suggested that excessive maternal exposure to EPA and
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DHA may potentially be involved in obesity and negatively aﬀect muscle tissue development,
mass, and quality in oﬀspring.
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Table 2-1. Primer sequences for real-time PCR
Primers

Forward sequence

Reverse sequence

MyoD

TCTGGAGCCCTCCTGGCACC

CGGGAAGGGGGAGAGTGGGG

Myf-5

CCTGTCTGGTCCCGAAAGAAC

GACGTGATCCGATCCACAATG

Pax7

CTCAGTGAGTTCGATTAGCCG

AGACGGTTCCCTTTGTCGC

aP2

CGACAGGAAGGTGAAGAGCATC
ATA
C/EBPα GCAAGCCAGGACTAGGAGAT

CATAAACTCTTGTGGAAGTCACGC
CT
AATACTAGTACTGCCGGGCC

PPARγ

GATGTCTCACAATGCCATCAG

TCAGCAGACTCTGGGTTCAG

BMP-4

GCCCTGCAGTCCTTCGCTGG

CTGACGTGCTGGCCCTGGTG

TFAM

GCTTGGAAAACCAAAAAGAC

CCCAAGACTTCATTTCATT

PGC1α

TCCTCTGACCCCAGAGTCAC

CTTGGTTGGCTTTATGAGGAGG

COX7a
1
mtDNA

CAGCGTCATGGTCAGTCTGT

AGAAAACCGTGTGGCAGAGA

CGATAAACCCCGCTCTACCT

AGCCCATTTCTTCCCATTTC

nDNA

CTCAGCAATCAGCCGTCCAATTCC
TA
CAGGGCCTTATTCAGTTCA

PMP70

CCTTGGGTCCTTGGCTTCGTTCC
T
TGAAGGAACCACTTAGAAATTA
CAGA
CAGAGTGAGATGTGTTAGGAGA
TG
AAGAATGGCGATGGCAAGACT

Il-6

GCTGGTGACAACCACGGCCT

AGCCTCCGACTTGTGAAGTGGT

TNFα

TGGGACAGTGACCTGGACTGT

TTCGGAAAGCCCATTTGAGT

18S

GTAACCCGTTGAACCCCATT

CCATCCAATCGGTAGTAGCG

PEX2
PEX19
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GTGCCAAGGAGACGAAGAC
TGTGAAACGGTAAAGAGGGTGAT

Figure 2.1: Gene expression analysis by RT-qPCR of adipogenic genes in C2C12 10 days after
induction of white adipogenesis by a diﬀerentiation induction medium (DIM) in the absence
(CON) or presence of 50 µM EPA and 50 µM DHA (FA). EPA and DHA were chronically
present in the DIM (10 days). Data are expressed as mean + SEM. The relative expressions were
calculated in arbitrary units. *P < 0.05; n = 6.
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Figure 2.2: (A) Gene expression analysis by RT-qPCR of gene regulating mitochondrial function
and biosynthesis in C2C12 10 days after induction of white adipogenesis by a diﬀerentiation
induction medium (DIM) in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA).
EPA and DHA were chronically present in the DIM (10 days). Data are expressed as mean + SEM.
Relative expressions were calculated in arbitrary units. *P < 0.05; n = 6. (B) Protein level
measurement by western blot of the spliced form of PGC1α and GAPDH from C2C12 cell culture
10 days after induction of white adipogenesis in the absence (CON) or presence of 50 µM EPA
and 50 µM DHA (FA). 10% precast 10-well polyacrylamide gel (Bio-Rad) was used, n = 4.
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Figure 2.3: (A) Gene expression analysis by RT-qPCR of myogenesis regulating genes in C2C12
after induction of white adipogenesis by a diﬀerentiation induction medium (DIM) in the absence
(CON) or presence of 50 µM EPA and 50 µM DHA (FA). EPA and DHA were chronically present
in the DIM (10 days). Data are expressed as mean + SEM. The relative expressions were calculated
in arbitrary units. * P < 0.05; & P < 0.1; n = 6. (B) Protein level measurement by western blot of
MyoD, MyoG, and GAPDH from C2C12 after induction of white adipogenesis in the absence
(CON) or presence of 50 µM EPA and 50 µM DHA (FA). 10% precast 10-well polyacrylamide
gel (Bio-Rad) was used, n = 4.
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Figure 2.4: Representative images of Oil Red O staining of C2C12 myoblasts after adipogenic
diﬀerentiation. (A) Treatment with EPA and DHA (FA) showed excessive accumulation of
distributed lipid clusters. Lipid droplets are indicated with black arrows. (B) Quantitative
assessment of Oil Red O staining in FA and CON. Signiﬁcant diﬀerence between the two groups
was calculated in arbitrary units. * P< 0.05; n = 6. Data were normalized by the total number of
cells counted using a hemocytometer in each group.
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Figure 2.5: Relative oxygen consumption rate in C2C12 cells 10 days after induction of white
adipogenesis by a diﬀerentiation induction medium (DIM) in the absence (CON) or presence of
50 µM EPA and 50 µM DHA (FA). EPA and DHA were chronically present in the DIM (10
days). Data are expressed as mean + SEM. The relative oxygen consumption rate was measured
for 15 min and calculated in arbitrary units. * P < 0.05; n = 6.
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Figure 2.6: Morphological changes of C2C12 myoblasts under EPA and DHA treatment (FA).
Arrows refer to multinucleated tubes in the control group (CON (black arrows). The FA group
displays the large, round lipid droplet characteristic of white adipocytes with large amounts of
cytoplasm and a single nucleus.

Figure 2.7: Gene expression analysis by RT-qPCR of gene-regulating cytokines production in
C2C12 10 days after induction of white adipogenesis by a diﬀerentiation induction medium (DIM)
in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA). EPA and DHA were
chronically present in the DIM (10 days). Data are expressed as mean + SEM. The relative
expressions were calculated in arbitrary units. * P < 0.05; n = 6.
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Figure 2.8: Gene expression analysis by RT-qPCR of gene-regulating peroxisomes function and
biogenesis in C2C12 cells 10 days after induction of white adipogenesis by a diﬀerentiation
induction medium (DIM) in the absence (CON) or presence of 50 µM EPA and 50 µM DHA
(FA). EPA and DHA were chronically present in the DIM (10 days). Data expressed as mean +
SEM. The relative expressions were calculated in arbitrary units. * P< 0.05; n = 6.
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3.1. Abstract
Maternal dietary supplementation of n-3 polyunsaturated fatty acids (n-3 PUFAs),
especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are considered to play
a positive role in fetal neuro system development. However, maternal n-3 PUFAs may induce
molecular reprograming of uncommitted fetal myoblasts into adipocyte phenotype, in turn,
affecting lipid metabolism and energy expenditure of the offspring. The objective of this in vitro
study was to investigate the combined effects of EPA and DHA on C2C12 cells undergoing brown
adipogenic differentiation. C2C12 myoblasts were cultured to confluency and then treated with
brown adipogenic differentiation medium with and without 50µM EPA and 50µM DHA. After
differentiation, mRNA and protein samples were collected. Gene expression and protein levels
were analyzed by real-time PCR and western blot. General Proteomics analysis was conducted
using mass spectrometric evaluation. The effect of EPA and DHA on cellular oxygen consumption
was measured using a Seahorse XFP Analyzer. Cells treated with n-3 PUFAs had significantly
less (P<0.05) expression of the brown adipocyte marker genes PGC1α, DIO2, and UCP3.
Expression of mitochondrial biogenesis related genes TFAM, PGC1α, and PGC1β were
significantly down-regulated (P<0.05) by n-3 PUFAs treatment. Expression of mitochondrial
electron transportation chain (ETC) regulated genes were significantly inhibited (P<0.05) by n-3
PUFAs, including ATP5J2, COX7a1, and COX8b. Mass spectrometric and western blot
evaluation showed protein levels of enzymes which regulate the ETC and Krebs cycle, including
ATP synthase α and β (F1F0 complex), citrate synthase, succinate CO-A ligase, succinate
dehydrogenase (complex II), ubiquinol-cytochrome c reductase complex subunits (complex III),
aconitate hydratase, cytochrome c, and pyruvate carboxylase were all decreased in the n-3 PUFAs
group (P<0.05). Genomic and proteomic changes were accompanied by mitochondrial
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dysfunction, represented by significantly reduced oxygen consumption rate, ATP production, and
proton leak (P<0.05). This study suggested that EPA and DHA may alter the BAT fate of
myoblasts by inhibiting mitochondrial biogenesis and activity and induce white-like adipogenesis,
shifting the metabolism from lipid oxidation to synthesis.
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3.2. Introduction
Worldwide obesity prevalence is increasing, particularly in the United States (Shin et
al., 2018). Obesity is associated with the increased incidence of clinically important metabolic
diseases such as type 2 diabetes, fatty liver, chronic inflammatory, and cardiovascular diseases.
Excessive caloric storage exceeding body need is commonly followed by hormonal disturbance,
profound secretion of pro-inflammatory cytokines, and energy imbalance (Kalupahana et al.,
2011). Lipid biology and energy balance inside the body are controlled by clusters of genes and
transcription factors that can be variably modulated in response to the type of fatty acids
composing the diet (Hammad & Jones, 2017). Two tissues including white adipose tissue (WAT)
and brown adipose tissue (BAT) play critical roles in energy regulation, storage, and expenditure.
The ability of brown adipocytes in countering obesity and subsequent type 2 diabetes in
humans has been demonstrated using advanced imaging techniques (Poher et al, 015). Brown
adipose tissue helps moderate energy balance inside the body through non-shivering
thermogenesis that maintains basal body temperature and mitigates obesity through heat
production, attributed to the expression of uncoupling protein 1 gene (UCP-1). UCP1 regulates
mitochondrial uncoupling respiration in response to stimuli such as catecholamines and cold
exposure (Chechi et al., 2014; Harms& Seale, 2013; Stier et al., 2014). However, other
important mechanisms may exert a profound impact on the thermogenic function of BAT
and relevant overall body energy expenditure independent of any induction of UCP1 leading
to promoting substrates oxidation and preventing lipid accumulation. An example of such
methods are pharmacological activation of AMPK induced fat oxidation (Gaidhu et al., 2011),
suppressing adipocytes re-esterification capacity (Gaidhu et al., 2011), and enhancing
cytochrome oxidase activity in UCP1-ablated mice upon cold stimulus (Meyer et al., 2010). It
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was reported that mitochondrial dysfunction induced impairing oxidative capacity in brown
adipocytes even without any change in UCP1 level is strongly linked to diet-induced obesity
(Feldmann, 2009).
The proportion of brown adipose tissue to total body lipids dramatically decreases with
obesity and ageing (Harms& Seale, 2013; Pfeifer, A., & Hoffmann, 2015). Therefore, finding
effective ways to increase the mass of brown adipose tissue is highly desirable. Reprogramming
stem cells into functional brown adipocytes may be considered as a valuable therapeutic option
if they are propagated ex-vivo, then returned via implant to the same obese individuals they
obtained from without possible immunogenic rejection. This method exhibited a great
effectiveness against obesity upon being used in mice exposed to high fat diet (Liu et al., 2013).
Two important subsets of progenitor cells can originate from mesenchymal stem cells
during the prenatal stages of embryonic life including myogenic progenitor cells and those giving
rise to adipocytes or fibroblasts (Du et al., 2013). Muscle ﬁbers and satellite cells arise from fetal
myogenic precursors (Joe et al., 2010; Uezumi et al 2010); whereas, adipogenic-ﬁbrogenic
progenitors constitute the pool of stromal-vascular cells consisting of adipocytes, ﬁbroblasts,
and resident progenitor cells surrounding mature skeletal muscle fibers (Hausman et al., 2002;
Hausman & Poulos, 2004; Uezumi et al., 2011). It has been suggested that factors such as
nutrition and drugs interact with the normal differentiation of mesenchymal cells-derived
myoblasts into muscle fibers, enabling their differentiation into adipocytes, leading to increased
intramuscular deposition of fat (Vettor et al., 2009) that can be associated with insulin resistance
( Boettcher et al., 2009; Goodpaster et al., 2000), muscle weakness (Baum et al., 2016) and muscle
stiffness in elderly (Beavers et al., 2013; Marcus et al, 2012; Murphy et al., 2014). Exogenous
factors such as a maternal diet enriched with EPA and DHA, recommended during pregnancy,
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may trigger myoblast reprograming into certain adipocyte phenotype, since their ligand PPARγ ,
the key regulator of adipogenesis, is ectopically expressed in myoblasts and fibroblast (Tontonoz
et al., 1994; Hu et al., 1994) , leading to substituting muscle tissue with adipose tissue and
associated myopathy.
The positive impacts of long chain polyunsaturated fatty acids, particularly
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on human health in reducing
the incidence of cancer, Alzheimer’s disease, chronic inflammatory disorders, and
cardiovascular diseases have been intensively studied (Bucher et al., 2000; Chapkin et al., 2008;
Carrié et al., 2009). Although the potential anti-obesogenic and anti-inflammatory roles of n-3
PUFAs and monounsaturated fatty acids (MUFA) were stressed using animal models (MartínezFernández et al., 2015), the results are still controversial in humans (Buckley & Howe, 2009).
Trans-differentiation of neonatal myoblasts into brown adipocytes can be induced by
promoting the expression of PRDM16, the key transcription factor regulating brown adipogenesis
(Seale et al., 2008). However, it has been recently discovered that MYF5+ progenitors can also be
committed into white-like adipocytes (Sanchez-Gurmaches, J., & Guertin, 2014). Although
concurrent supplementation of EPA and DHA positively corroborating the route of differentiation
of C2C12 into white-like adipocytes was stressed in our previous study (Ghnaimawi et al., 2019),
evidence of myoblast trans-differentiation into brown adipocytes is lacking. Therefore, the
objective of this study was to test the potential effects of combined EPA and DHA treatment on
C2C12 myoblasts undergoing differentiation into brown adipocytes.
Given that the incorporation of n-3 PUFAs into the mitochondrial membrane induced
alteration in its lipid complex and related changes in mitochondrial function , and the association
of adipocytes mitochondrial dysfunction with obesity (Noer et al., 2006; Berdasco et al., 2012),
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we hypothesized that combined treatment with EPA/DHA may impair the acquisition of functional
brown phenotype independent of UCP1 via inducing metabolic changes in the function of
mitochondria shifting C2C12 towards an adipogenic phenotype exhibiting the features of white
adipocytes, leading to negatively affecting surrounding muscle tissue and accumulation of
intramuscular fat.
Considering the importance of preclinical models such as in vitro cell lines as useful tools
helping in predicting clinical response and identifying the mechanisms of action of different drugs
especially with the insufficiency of clinical samples, C2C12 cells were used in this experiment as
a representative model of progenitor myoblasts as they have been extensively used to better
understanding of the cellular and molecular mechanisms of muscle differentiation, murine and
vertebrate myogenesis, muscle regeneration, myofiber atrophy, and hypertrophy processes
occurring during muscle disease and ageing (Goljanek-Whysall et al., 2012; Cornelison, 2008;
Georgantas et al., 20014; Sharples et al., 2010; Yaffe & Saxel, 1977; Hidestrand et al., 2008;
Teboul et al., 1995).
3.3. Materials and methods
3.3.1. Cell culture and induction of C2C12 differentiation
C2C12 cells were initially cultured in growth medium composed of Dulbecco's modified
Eagle's medium (DMEM) 89% supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin (Sigma-Aldrich) at 37 °C in a 5% CO2 atmosphere. Upon reaching 90% confluence,
the cells were plated into 6-wells plates at an initial density of 1.9 × 104 cell per well and subdivided
into two groups including control group (CON) and EPA/DHA treated group (FA). cells were
allowed to differentiate into brown adiposity by incubation with differentiation medium (1)
composed of insulin 5µg/ml, dexamethasone 1µg/ml, rosiglitazone 5µg/ml, indomethacin 125 nM,
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T3 1nM, and isobutylmethylxanthine (IBMX) (Sigma-Aldrich) 0.1 mM for 3 days. Then, the cells
were introduced to differentiation medium 2, which contained insulin (5µg/ml), rosiglitazone
5µg/ml, and T3 1nM for four days (Zhou et al., 2014). A total of 7 days was sufficient to induce the
trans-differentiation of myoblasts into brown adipocytes, confirmed by lipid droplet formation and
morphological changes. The effect of n-3 poly unsaturated fatty acids on the acquisition of brown
adipocytes phenotype was tested by adding 50μM EPA and 50μM DHA (Sigma-Aldrich) to
differentiation media 1 and 2 in FA treated group only. In line with that, multiple concentrations of
combined EPA and DHA were used to determine the recommended dose and toxicity profile of the
investigated compounds (data of early stage cell culture trial is not included). We found that with
the use of 50µM each, considerable increase in the percentage of Oil Red O positive cells was
observed indicating the occurrence of trans-differentiation process. Since a significant number of
cells were dead in 75 µM and 100 µM EPA and DHA containg medium, 50 µM concentration was;
thus, chosen as the most effective dose for subsequent experiments.
3.3.2. Oil Red O staining and quantitative measurement
Medium was aspirated off and cells rinsed three times with PBS. Cells were fixed with
neutral buffered paraformaldehyde (Sigma-Aldrich) 10% for 30 minutes at room temperature,
followed by 3 times wash with PBS. Lipid droplets were stained with Oil Red O (Sigma-Aldrich)
(Konieczny, S. F., & Emerson, 1984). Stoke solution was prepared by dissolving 0.5g Oil Red O in
100 ml absolute isopropanol. The working solution was prepared by mixing six parts of stoke
solution with four parts of ultra-pure water and kept at room temperature for 10 minutes after being
filtered using 0.2μm filter. Cells were incubated with Oil Red O working solution for 30 minutes at
room temperature. Morphological changes and intracellular lipid droplets were identified by their

88

bright red color under the microscope. Nikon DS-Fi3 digital camera mounted on a Nikon Eclipse
TS 2R light microscope was used to take images from different sections.
Oil red O was extracted by 1 ml 100% (v/v) isopropyl alcohol after gentle rocking for 15
minutes. The extract was transported into 1.5 micro-centrifuge tubes, and absorbance was measured
at 520 nm using microplate reader (Gene 5 Bio Tek Spectrometer). 100% isopropanol was used to
control the background signal (Cheung, et al., 2015).
3.3.3. Real-time PCR
Total RNA was isolated and purified using Zymo-Spin™ IIICG kit. RNA concentration was
then measured by Nanodrop, and quality of extracted RNA was evaluated by considering
OD260nm/OD280nm ratio. cDNA was synthesized using 5 Χ iScript cDNA synthesis kit (Bio-Rad,
Richmond, CA) by following the manufacturer’s instructions. Real-time PCR was then performed
using CFX Connect Real-Time PCR Detection System (Bio-Rad, Richmond, CA). The total volume
of PCR reaction was 15µL composed of 7.5 µL SYBR Green Supermix (Bio-Rad, Richmond, CA),
3µL (100 ng) cDNA, 1.5 µL forward and reverse primers (10 µM each), and 3 µL DNase/RNase
free water. Primer pairs used are shown in (Table 1). PCR reaction conditions were set as follows:
3 min at 95°C, 10 s at 95°C, and 60 s at 60°C for 39 cycles. Product purity was evaluated based on
the melting curve value . 18s gene was used as a housekeeping gene, and the expression levels of
interested genes were normalized to those of 18s.
3.3.4. Oxygen consumption rate (OCR)
Key parameters of mitochondrial function were evaluated by directly measuring Oxygen
consumption rate (OCR) in differentiated cells using Seahorse XFP (Seahorse Bioscience,
www.seahorsebio.com) and Agilent Seahorse XFP Cell Mito Stress Test (following the kit
instructions). The sequential injection of the following three chemicals, including oligomycin to
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inhibit ATP synthase , the uncoupler carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone
(FCCP) that collapses the proton gradient and affect mitochondrial membrane potential, and finally
the mixture of rotenone (complex 1 inhibitor) and antimycin-A (complex ІІІ inhibitor) to switch
off mitochondrial respiration and allowed non-mitochondrial respiration to be measured, was used
to assess cells’ typical bio-energetic profile (all from Seahorse Bioscience). Cells were seeded in
customized seahorse 8-well miniplate at initial density of 10× 10^3 cell per well and induced to
differentiate into brown adipocyte, as was described above. One day before the assay, the cartridge
was hydrated using Seahorse Calibrant (Seahorse Bioscience) and incubated overnight in non CO2
incubator at 37c. At the measurement day, cells were incubated, for 1 hour, with XF base medium
(Seahorse Bioscience) supplemented with 10 mM glucose, 10mM pyruvate, and 2 mM glutamine
at 37CΟ in a non-CO2 incubator. The pH of the medium was adjusted to 7.4 using NAOH 1M.
During the assay, oligomycin, FCCP, and rotenone/ antimycin-A were injected in order and at
final concentrations of 1μM, 3 μM, and 1 μM, respectively. Oxygen consumption rate (OCR) and
other parameters were calculated using the Seahorse XF Cell Mito Stress Test Report Generator.
The data were normalized by protein concentration, measured in each individual well (CalderonDominguez et al., 2016).
3.3.5. Western blot analysis
C2C12s were cultured and differentiated in 6-well plates, as was previously described. Cells
were gently scraped from the wells using PBS (1 ml/well). Lysis buffer (T-PER) supplemented with
protease and phosphatase cocktail inhibitors at a ratio of 1:100 was used to extract total protein.
Protein concentration was determined using a BCA protein assay kit (Thermo Scientific). Samples
were run on Mini-PROTEAN precast gels (Bio-Rad) and then transferred onto Trans-Blot® Turbo™
Mini PVDF Transfer Packs (Bio-Rad). The blots were incubated with 5% dry skim milk as blocking
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solution for 1 hour. The following primary antibodies were used UCP1 (1/1,000; Abcam),
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1/1,000; Cusabio), UQCRC1 (complex
III) (1/1,000; Invitrogen), SDHA (complex II) (1/1,000; Invitrogen), Tfam (1/1,000Cusabio), Myo
D (1/1,000; abcam), Myo G (1/1,000; abcam), MRF4 (1/1,000 Cusabio) PGC1α ( (1/1,000 Cusabio)
, and PRDM16 (1/1,000; abcam). Immuno-staining with primary antibodies was performed by
incubation with target antibodies overnight. After several washes, blots then were incubated with
specific IgG-HRP-conjugated secondary antibody for 1 hour with gentle rocking. Bands were
visualized using ECL immune blotting clarity system (Bio-Rad) and detected on ChemiDocTM
Touch imagining system (Bio-Rad). Band density was normalized according to the Glyceraldehyde3-phosphate dehydrogenase (GAPDH) content. The bands representing the levels of different
Proteins were quantified using Image Lab Software (Bio-Rad) (Herrero et al., 2005).
3.3.6. Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) proteomic
study
Proteins samples were extracted and quantified as previously described. Samples were then
reduced with 25 mM dithiothreitol (MP Biomedicals, OH) for 1 h at 60°C and alkylated with 40
mM iodoacetamide (MP Biomedicals, OH) for 1 h in a dark room at room temperature. After the
reduction and alkylation, samples were each passed through 3 kDa molecular weight cut off filter
(Nanosep, Pall corporation) to remove iodoacetamide and unnecessary salts and digested with
trypsin (Promega, Madison, WI) at 37°C for 48 h. The digests were centrifuged at 21,000 g for 10
min at 4°C and the supernatant were dried using Centrivap concentrator and desalted with C18
Spin Columns (Pierce, IL, USA) per manufacturer’s protocol. The eluted peptides were dried and
suspended in 0.1% FA for LC-MS/MS. The digested samples were analyzed using an Agilent 1200
series capillary C18-RP-HPLC coupled to a Bruker Amazon-SL quadrupole ion trap mass

91

spectrometer capable of performing data-dependent acquisition. Tryptic peptides were separated
by reverse-phase liquid chromatography (RP-HPLC) using a Zorbax SB C18 column, (150 x
0.3mm, 3.5 µm particle size, 300 Å pore size, Agilent Technologies), with a solvent flow rate of
4 µL/min, and a gradient of 5 to 40 % consisting of 0.1% FA (solvent A) and ACN (solvent B) for
300 min. There were four biological replicates per group and two technical replicates per sample.
Bruker data analysis 4.0 software was used to pick peaks from the LC-MS/MS chromatogram
using a default setting as recommended by the manufacturer to create ProteinAnalysisResults.xml
file which was then used for MASCOT database search. The parent ion- and fragment ion mass
tolerances were set at 0.6 Da with cysteine carbamidomethylation and methionine oxidation as
fixed and variable modifications in MASCOT search. Mascot search was carried out against mouse
proteins in UniProt database to identify the proteins in the cell extracts. The peptides from all
proteins were identified with 95% confidence and reported based on <5% false discovery rate
using at least 2 peptides with one unique peptide from a protein. MASCOT.dat files were then
exported into Scaffold proteome software version 4.8 (http://www.proteomesoftware.com) to
identify differentially expressed proteins (Rath et al., 2019). The quantitative differences were
calculated on the basis of 95% confidence limit. The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019) partner
repository with the dataset identifier PXD016929 and 10.6019/PXD016929.
3.3.7. Statistical analyses
All data used to compare control and FA treated groups were assessed for significance by
the unpaired Student t-test and expressed as the mean ± SEM. P<0.05 was considered statistically
significant.
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3.4. Results
3.4.1. EPA and DHA supplementation trigger C2C12 differentiation to adipocyte lineage
To confirm changing C2C12 cells genetic profile and losing their myogenic ability, we
investigated the combined effect of EPA and DHA on the relative expression of genes regulating
the terminal differentiation of myoblast into mature multinucleated myotubes. We found that the
expression level of genes regulating myogenesis including Myf5, MyoD1, MyoG, and MRF4
(Myf6) was significantly down-regulated in EPA/DHA treated group in comparison with control
group (35 ± 4.5%, P = 0.02; 89 ± 2.3%, P =0.00001; 61 ± 4.4%, P = 0.02; and 92 ± 0.71%, P =
0.0019, respectively) (Figure 1A). The Western blot bands and quantification showed that MyoD1,
MRF4 were lower in the FA group compared to the CON group (P < 0.05), while MyoG was
tended to be lower in the FA group (P < 0.1) (Figure 1B).
3.4.2. Effect of EPA and DHA supplementation on BAT specific genes
Non-significant differences in expression levels of some of browning markers including
uncoupling protein 1 (UCP1, master thermogenic protein) cell-death-inducting DFFA-like
effector A (CIDEA), PR domain containing 16 (PRDM16), and peroxisome proliferatoractivated receptor alpha (α) (P = 0.22, 0.25, 0.49, and 0.448, respectively) were observed
between the two different groups (Figure 2). Specific markers for BAT, including peroxisome
proliferator-activated receptor-gamma coactivator-1 alpha (PGC1α), uncoupling protein 3
(UCP3), and Type II iodothyronine deiodinase (Dio2) showed significantly decreased levels in
EPA and DHA treated group in comparison with control group (82 ± 1.2%, P = 0.00002; 84 ±
14.6%, P = 0.0028; and 68 ± 5.4%, P = 0.0002, respectively).
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3.4.3. Effect of EPA and DHA in combination on mitochondrial biogenesis
The expression levels of PGC1-α, PGC1-β, and TFAM were significantly reduced in group
exposed to concurrent treatment with EPA and DHA (82 ± 1.2%, P = 0.00002; 52 ± 7.2%, P =
0.022; and 42% ± 5.5, P = 0.047, respectively); while, Errα showed non-significant difference
between groups (55% lower in FA group, P = 0.065) (Figure 3).
3.4.4. Effect of concurrent treatment of EPA and DHA on genes regulating ETC work
Expression levels of COX7α1, COX8β, and ATP5j2 were by far down-regulated in EPA
and DHA treated group when compared to control group (88 ± 0.9%, P = 0.0025; 88 ± 1.1%, P
= 0.0032; and 47 ± 4.6%, P = 0.015, respectively); whereas, the mRNA expression of COX5β,
and ATPase4a were non-significant although it was lower in group of treatment (46% and 35%
respectively, P = 0.1) (Figure 4).
3.4.5. Effect of combined EPA and DHA on lipid accumulation and morphology changes
Our findings revealed obvious morphological changes and notable increase in size and
number of lipid droplets in FA treated group. Lipid accumulation in FA treated group was
confirmed by quantitative measurement of oil red which exhibited a dramatic increase in EPA
and DHA treated group when compared to control group (200 ± 27.3%, P = 0.00001) (Figure 5).
3.4.6. Effect of EPA and DHA on proteins involved in regulating Krebs cycle and electron
transport chain
In order to explain the effect of EPA and DHA treatment on the global proteome of C2C12
cells undergoing differentiation into brown adipocytes, we identified and quantified the expression
of total proteins using LC-MS/MS. Then, we compared the differential expressed proteins between
CON and FA treated group and analyzed their functions. Finally, western blot analysis was
performed to validate the variation of brown adipocytes signature proteins. After comparing
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differential protein levels between the two groups, functional analysis indicated a negative impact
of combined treatment with EPA and DHA on some proteins regulating Krebs cycles and electron
transport chain. Our results exhibited a massive decrease in ATP synthase α (48±2.9%, P =0.003),
aconitate hydratase (58 ± 5.8%, P = 0.001), ATP synthase β (F1F0 complex) (46 ± 6.3%, P=
0.002), citrate synthase (73 ± 7.1%, P = 0.0002), cytochrome c (87± 13.8%, P = 0.0122), Succinate
dehydrogenase (complex II) (88 ± 7.3%, P = 0.002), Pyruvate carboxylase (95± 5.4%, P = 0.017),
and succinate CO-A ligase (66 ± 20%, P = 0.013) (Figure 6A). The Western blot bands and
quantification showed that TFAM, Complex II, and Complex III were lower in the FA group
compared to the CON group (P < 0.05) (Figure 6B).
3.4.7. EPA and DHA supplemented in-combination reduced mitochondrial respiration
and ATP production
Data revealed significant decrease in mitochondrial parameters, including basal
respiration (45 ± 8.7%, P = 0.005), non-mitochondrial respiration (31 ± 0.6%, P = 0.0009),
maximal respiration (54 ± 0.9%, P = 0.0002), proton leak (51 ± 14.6%, P = 0.013), ATP
production (33 ± 1.9%, P = 0.006), and spare respiratory capacity in FA treated group (55%
± 0.6%, P = 0.0002) (Figure 7).
3.5. Discussion
This study investigated the effect of concurrent supplementation of EPA and DHA
at 50 μM respectively in vitro on C2C12 myoblast cells undergoing differentiation into
brown adipocytes. According to previous studies, EPA and DHA were found to be toxic
to C2C12 cell culture with concentration above 50μM (Ghnaimawi et al., 2019; Hsueh et al.,
2018; Lee et al., 2018). We found that the EPA and DHA supplementation resulted in UCP1independent impairment of mitochondrial oxidative capacity followed by increasing lipid
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accumulation. This effect may correlate positively with adiposity and lipid toxicity. Consensus
on the beneficial effects of EPA and DHA are still lacking, with conflicting research
outcomes. EPA and DHA mediated weight loss and up-regulation of brown adipocyte-specific
genes is still controversial. For instance, Saraswathi et al., 2007 reported that mice fed diets
enriched with EPA and DHA exhibited significant change in lipid composition to the favor of
increasing perigonadal fat mass, compared to control group (Saraswathi et al., 2007).
Moreover, offspring born from dams fed maternal diet high in DHA throughout the period of
gestation and lactation showed increased total and subcutaneous fat mass when adjusted to total
body weight at 6 weeks of age. Furthermore, n-3 PUFAs consumption has been recently linked
to increased body fat composition in adult mice with genetically induced diabetes (Todoric et
al., 2006). However, the Nurses’ Health Study reported an opposite result and indicated that
the 79,839 women consumed large amount of fish and n-3 PUFAs to improve their resistance
against stroke exhibited a great propensity to develop obesity (Iso et al., 2006).
It has been recently reported that BAT specific genes were up-regulated upon
exposure to EPA treatment while the expression levels of WAT specific genes were
inhibited (Zhao, M., & Chen et al., 2017). Many studies have reported EPA-associated
increased expression of UCP1 mRNA and protein levels in mice fed high fat or high
sucrose diets enriched with omega-3 (Oudart et al., 1997; Mori et al., 1999; Takahashi, Y., &
Ide 2000). However, it was reported that no change in UCP1 expression was induced by a
high fat diet although excessive fat deposition was prevented by n-3 fatty acids (Kus et al.,
2011). The same study claimed that BAT exhibited excessive accumulation of lipid when
histologically analyzed and omega-3 intervention was ineffective. Many studies have
revealed no significant increase in levels of UCP1 and FGF21(Fibroblast growth factor 21) in
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BAT although the dose of n-3 PUFAs requisite for exerting an anti-obesity effect was increased
3-fold (Kuda et al., 2018). It is clear from the contrasting evidences that the effect of EPA and
DHA on regulating the expression of BAT specific genes still need to be investigated
thoroughly. Consistent with these results, our finding showed no change in expression of
UCP1 or BAT related genes including PPARα, PRDM16, or CIDEA. However, we found
that EPA and DHA supplementation may impair the function of BAT and reduce its
thermogenic capacity in many aspects including: down- regulation of genes associated
with mitochondrial biogenesis, decreasing mitochondrial respiratory capacity and OXPHOS
activity, reducing ATP production which is requisite for fueling fatty acid cycling (TAG/FA
cycle) mediated energy expenditure, and inhibiting proton leak. These changes in
mitochondrial function were concurrent with increased lipid droplets size and number.
Together, EPA and DHA supplementation can compromise energy expenditure and
dissipation in brown adipocyte independent of UCP1, which may be positively correlated
with intramuscular lipid accumulation and obesity. Induction of UCP1 expression in BAT
may not be sufficient to build up robust resistance against fat depositon and obesity in
instance of mitochondrial dysfunction. Consistent with our observations, many studies
have reported that accumulation of body fat and obesity can be induced by mitochondrial
dysfunction-related impaired energy expenditure independent of UCP1. Excessive lipid
deposition can be prevented by activating different pathways such as AMPK in rats (Gaidhu
et al., 2011). Pharmacological activation of AMPK associated increased FA oxidation,
TAG/FA cycle activation, and mitochondrial biogenesis independent of UCP-1 induction in
white adipocytes can prevent excessive caloric deposition. UCP1-ablated mice exposed to mild
cold stress but not thermos-neutral temperature kept their ability to overcome obesity
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(Anunciado-Koza et al., 2008; Kozak, 2010). It has been stressed that cytochrome c oxidase
activation- induced stimulation of TAG/FA cycle and increased energy expenditure is the core
mechanism supporting resistance to obesity in case of complete absence of UCP1 (Meyer et
al., 2010). Correspondingly, decreased production of cytochrome c oxidase in our experiment
may be associated with the increased lipid accumulation during concurrent treatment with EPA
and DHA. Reduced expression of OXPHOS subunits and mitochondrial biogenesis
observed in our study can be closely associated with the significant decrease in ATP
production/oxygen consumption ratio. These critical changes in mitochondrial function
may be followed by an excessive production of ROS, the primary contributor to many
pathological disorders such as mutations, aging, and insulin resistance. The effect of
omega-3 supplementation on mitochondrial changes gained in our study is in great
consistency with (Yamaoka et al., 1988) who found that mitochondrial respiration in either
heart or skeletal muscle was compromised upon exposure to omega-3 supplementation.
However, (Khairallah et al., 2012; Lanza et al., 2013) found no effect after treatment with
omega-3. Given that mitochondrial membrane lipid composition can be changed by
incorporation of EPA and DHA upon omega-3 supplementation, we suggest that the
reduced mitochondrial function and the decreased OXPHOS reported in our study may be
closely linked to these structural changes. Consistently, reduced mitochondrial oxygen
consumption related to fish oil intake was illustrated in an experiment in which the
efficiency of dietary fish oil in restoring impaired mechanical force and contractility of
cardiac muscle during an experimental model of myocardial ischemia - reperfusion was
evaluated. Fish oil treatment was judged as beneficial as it could prevent the oxidative
damage of the heart through lowering the rate of oxygen consumed by mitochondria isolated
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from ischemic hearts (Pepe et al., 2002). The decrease in mitochondrial respiratory rate can be
attributed to n-3 PUFAs induced physical and biochemical changes in membrane phospholipids
(Pepe et al., 1999). Similar observations were gained from healthy humans fed fish oil during
cycling exercise and subjected to fixed workload (Peoples et al., 2008). Moreover, our results
are comparable to the study reported diet rich in n-3 PUFAs but low in linoleic acid reduced
the maximal respiration of cardiac mitochondria isolated from rats (Yamaoka et al., 1988).
Decreasing the activity of electron transport chain activity by n-3 PUFAs supplementation and
cardiac tetralinoleoyl cardiolipin (L4CL) depletion were identified as the main causes behind
that reduction. Dietary n-3 PUFAs induced alteration in skeletal muscle membrane fatty acid
composition has been investigated in skeletal muscle as well, and the results showed great
similarity with those reported from cardiac mitochondria (Peoples et al., 2008; Peoples et al.,
2010; Hoy et al., 2009).
A study on cardiac mitochondria found that the enzymatic activities of OXPHOS
subunits including complexes I, IV, V, and I+III were compromised upon exposure to omega3 treatment (Sullivan et al., 2008). Remodeling of mitochondrial phospholipid acyl chains
caused by frequent exposure to polyunsaturated fatty acids has been identified to be associated
with many pathological disorders including diabetic cardiomyopathies (He et al., 2014), aging,
obesity, and Barth Syndrome (Shi, 2010; Gonzalvez et al., 2013). For instance, complexes I,
III, IV, V, and the mobile electron carrier cytochrome c regulating oxidative phosphorylation
are turned inactive once loosed their binding to phospholipid CL (Paradies et al., 2002; Iverson
& Orrenius, 2004; Arnarez et al., 2013; Planas-Iglesias et al., 2015). DHA is considered as one
of the prominent players in remodeling mitochondrial phospholipidome (Sparagna, G. C., &
Lesnefsky, 2009; He et al., 2014). Paradoxically, DHA that is well-known cardioprotective
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agent has been strongly linked to various cardiovascular diseases in human and animal subjects
(Endo et al., 2016; Madingou et al., 2016). Another aspect of reducing the thermogenic
capacity of BAT by EPA and DHA treatment in this report represented by down regulation
the expression of some BAT specific thermogenic genes such as UCP3, PGC1α, and Dio2.
UCP3 is highly expressed in brown adipocytes and skeletal muscle cells (Ricquier et al.,
2000). Endogenous or exogenous activation of UCP3 and UCP2 by environmental factors
sparkles a thermogenic capacity in these genes although they are not responsible for
thermogenesis (Brand, M. D., & Esteves, 2005). It has been recently discovered a close
association between UCP3 ablation and fat accumulation in mice exposed to high-fat diet
reflecting a protective role for this gene against obesity (Costford et al., 2008).
The effect of EPA and DHA on PGC1α expression in our study corresponded with other
studies in which fish and krill oil were used as sources of marine n-3 fatty acids. They found
that the expression levels of PGC1α and Slc25a12 were dramatically reduced upon exposure
to n-3 fatty acids (Burri et al., 2011; Liu et al., 2013; Rundblad et al., 2018). It indicates that
there is a negative correlation between the higher level of n-3 fatty acids and the expression
level of some genes regulating mitochondrial biogenesis and thermogenic capacity, or at least
the relationship is dose dependent. Type II iodothyronine deiodinase (Dio2) is another
marker of brown adipocytes that was significantly down-regulated in our experiment.
Protein coded by this gene is a critical enzyme catalyzing the conversion of inactive thyroid
hormone, prohormone thyroxin (T4), into its active form triiodothyronine (T3) that is
essential to stimulate the thermogenic capacity of the cell. Many stimulators such as cold
exposure, insulin, glucagon, and norepinephrine enhance the expression of Dio2; whereas,
its activation is exerted by dependent protein kinase (PKA) (Bianco et al., 2002). Another
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study exhibted an adverse relationship between EPA and DHA supplementation and Dio2
expression level (Mehus & Picklo, 2017). They found that there is an increase (38%) in
Dio2 expression level in the cerebral cortex of mice fed corn oil where the concentration of
n-3 PUFAs is low in comparison to mice fed soybean oil with ad libitum intake.
The notable increase in lipid droplet size and number seen in our experiment is
consistent with other studies. Research suggested that EPA and DHA can stimulate the
terminal differentiation of 3T3 cells into mature adipocytes, accompanied by excessive
accumulation of lipid droplets, where the adipogenic effect of DHA was more potent than
EPA (Murali et al., 2014). Incorporation of EPA and DHA in membrane phospholipids was
considered the main cause behind lipid storage. Correspondingly, accumulation of neutral lipid
after EPA and DHA supplementation was reported by Wójcik et al. (2014) as well. However,
Prostek et al. (2014) reported that 3T3-L1 adipocytes incubated with EPA and DHA did not
exhibit any change in terms of triacylglycerol accumulation along the differentiation process.
EPA mediated lipid droplets accumulation was reported by Zhao & Chen, (2014) who
revealed that increasing calories storage as a result of incubating fully differentiated inguinal
WAT adipocytes with EPA for 24 h was closely associated with enhancing triglyceride
synthesis and reducing lipolysis. This finding agrees with two other studies (Hartweg et al.,
2009; Lorente-Cebrián et al., 2012).
Although the process of insulin induced sugar disposal was promoted, it has been
recently discovered that intravenous co-injection of omega-3 PUFAs with lipid led to an
excessive increase in the amount of lipid accumulated within myocytes, reached to 50%
more than te control group instead of being broken down by β-oxidation. Lipid
accumulation was attributed to the possible incorporation of supplemented omega-3 in
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membrane phospholipids (Stephens et al., 2014). Moreover, skeletal muscle myotubes
isolated from healthy individuals and from those with T2D exhibited accumulation of lipid
upon treatment with EPA where the effect was more potent in T2D patients. They found
that EPA intervention was positively correlated with TAG synthesis (Wensaas et al., 2009).
However, EPA and DHA supplementation associated increase TAG synthesis (particularly in
muscle tissue) may be beneficial as it may improve insulin sensitivity by preventing the
accumulation of lipid intermediaries such as ceramides and diacyle glycerol and related
deleterious effect on insulin signaling pathways. Given the various reasons mentioned above
describing the potential role of EPA and DHA in stimulating lipid accumulation, we can
add that the obvious increase in lipid droplets size and number observed in our study can
be strongly linked to reducing the expression level of genes regulating mitochondrial
biogenesis and thermogenic capacity like TFAM, PGC1α, ERRα, PGC1β, UCP-3, and
DIO2 and other proteins orchestrating mitochondrial oxidative phosphorylation.
3.6. Conclusion
This study illustrated that although EPA and DHA concomitant treatment had no effect
on the terminal differentiation of C2C12 into brown adipocytes, both mitochondrial oxidative
phosphorylation and energy expenditure were strongly affected. We identified an inhibition at
the level of mitochondrial function and biogenesis that can be attributed to down regulation the
expression of genes regulating cellular respiration such as those encoding proteins regulating
ETC, PGC1α, PGC1 β, and TFAM. General Proteomic assessment exhibited reduction in the
level of some proteins regulating Krebs cycle and ETC like aconitate hydratase, citrate
synthase, succinate dehydrogenase (complex II), cytochrome c oxidase (complex IV), pyruvate
carboxylase, and succinate CO-A ligase. The expression level of genes associated with BAT
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thermogenic capacity PGC1α, UCP-3 and DIO2 was significantly suppressed. Consistent with
the observed mitochondrial dysfunction, we found that FA treated group exhibited a significant
decrease in maximal oxygen consumption rate, ATP production, and proton leak that may
impair the uncoupling of proton chemical gradients into heat production. EPA and DHA
supplementation associated mitochondrial dysfunction in C2C12 tans-differentiated into brown
adipocytes was independent of UCP1 production and was not directly connected to the
thermogenic uncoupling mechanism. Two sites of action are thus targeted through the
inhibitory effect of EPA and DHA on mitochondrial function in brown adipocytes including
oxidative phosphorylation and mitochondrial density.
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Table 3-1: Primer sequences for real-time PCR
Primers

Forward sequence

Reverse sequence

Myf-5

CCTGTCTGGTCCCGAAAGAAC

GACGTGATCCGATCCACAATG

MyoD

TCTGGAGCCCTCCTGGCACC

CGGGAAGGGGGAGAGTGGGG

MyoG

GCAATGCACTGGAGTTCG

ACGATGGACGTAAGGGAGTG

MRF4

GTGGACCCCTACAGCTACAAACC

TGGAAGAAAGGCGCTGAAGAC

UCP1

TCTCTGCCAGGACAGTACCC

AGAAGCCACAAACCCTTTGA

UCP3

GACCACGGCCTTCTACAAA

TCAAAACGGAGATTCCCGCA

PRDM16

AAGGAGGCCGACTTTGGATG

TTTGATGCAGCTCTCCTGGG

PPARα

AGTTCGGGAACAAGACGTTG

CAGTGGGGAGAGAGGACAGA

DIO2

CAGTGTGGTGCACGTCTCCAATC

TGAACCAAAGTTGACCACCAG

CIDEA

TGCTCTTCTGTATCGCCCAGT

GCCGTGTTAAGGAATCTGCTG

TFAM

GCTTGGAAAACCAAAAAGAC

CCCAAGACTTCATTTCATT

PGC1α

TCCTCTGACCCCAGAGTCAC

CTTGGTTGGCTTTATGAGGAGG

PGC1β

TGGCTCTGATTACTGTGCCTG

TCCTGGGGACTTAGAAGCCA

ERRα

GGTGTGGCATCCTGTGAGGC

AGGCACTTGGTGAAGCGGCA

ATP5j2

GCGGCCTCTGACTTCACTTAA

AACTTGGCAGCTGTGTCGAT

ATPase4a

CTCGGGTGTGGAAAACGAGA

AAGAAGACCATGGCCCGAAG

COX7a1

CAGCGTCATGGTCAGTCTGT

AGAAAACCGTGTGGCAGAGA

COX8b

GAACCATGAAGCCAACGACT

GCGAAGTTCACAGTGGTTCC

COX5b

GCTGCATCTGTGAAGAGGACAAC CAGCTTGTAATGGGTTCCACAGT

18S

GTAACCCGTTGAACCCCATT

113

CCATCCAATCGGTAGTAGCG

Figure 3.1: A) Gene expression analysis by RT-qPCR of myogenesis regulating genes in C2C12
cells 7 days after induction of brown adipogenesis by a differentiation induction medium (DIM)
in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA). EPA and DHA were
chronically added in the DIM of FA treated group (7 days). The relative expressions were
calculated in arbitrary units *P < 0.05; n=6. B) Protein level measurement by western blot of
myogenesis regulating genes in C2C12 and GAPDH as housekeeping gene n=4.
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Figure 3.2: Gene expression analysis by RT-qPCR of brown adipocytes marker genes in C2C12
cells 7 days after induction of brown adipogenesis by a differentiation induction medium (DIM)
in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA). EPA and DHA were
chronically added in the DIM of FA treated group (7 days). Data are expressed as mean + SE. The
relative expressions were calculated in arbitrary units. *P < 0.05; n=6.
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Figure 3.3: Gene expression analysis by RT-qPCR of mitochondrial biogenesis regulating genes
in C2C12 7 days after induction of brown adipogenesis by a differentiation induction medium
(DIM) in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA). EPA and DHA
were chronically added in the DIM of FA treated group (7 days). Data are expressed as mean +
SE. The relative expressions were calculated in arbitrary units. *P < 0.05; n=6.
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Figure 3.4: Gene expression analysis by RT-qPCR of genes regulating electron transport chain (
ETC) function in C2C12 7 days after induction of brown adipogenesis by a differentiation
induction medium (DIM) in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA).
EPA and DHA were chronically added in the DIM of FA treated group (7 days). Data are expressed
as mean + SE. The relative expressions were calculated in arbitrary units. *P < 0.05; n=6.
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Figure 3.5: Representative images of Oil Red O staining of C2C12 myoblasts after adipogenic
differentiation. A) Treatment with EPA and DHA (FA) showed an increase in number of
distributed lipid clusters. B) Quantitative assessment of Oil Red O staining in FA and CON.
Signiﬁcant differences between the two groups are at the indicated time points. * P < 0.05; n=6.
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Figure 3.6: A) Protein level measurement by mass spectrophotometry of proteins regulating
Krebs cycle and electron transport chain (oxidative phosphorylation) in C2C12 7 days after
induction of brown adipogenesis in the absence (CON) or presence of 50 µM EPA and 50 µM
DHA (FA). EPA and DHA were chronically present in the DIM (7 days). Data are expressed as
mean + SE. The relative expressions were calculated in arbitrary units. *P < 0.05; n=4. B) Protein
level measurement by western blot of brown adipocytes signature proteins and GAPDH as
housekeeping gene from C2C12 7 days after induction of brown adipogenesis in the absence
(CON) or presence of 50 µM EPA and 50 µM DHA (FA) n=4.
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Figure 3.7: Typical bio-energetic profile of C2C12 cells 7 days after induction of brown
adipogenesis in the absence (CON) or presence of 50 µM EPA and 50 µM DHA (FA). (A) Basal
and stimulated mitochondrial OCR in cultured C2C12 cells. OCR traces are expressed as pmol O2
per min in C2C12 cells and normalized to protein concentration. Vertical dashed lines indicate the
times of addition of oligomycin (2 µM), FCCP (0.7 µM), and antimycin A (1 µM). (B) Total
oxygen consumption (reserve capacity) is significantly lower in FA group. Data show the changes
of basal respiration, maximal respiration, ATP production, and proton leak in FA group compared
with CON group. The relative changes were measured in pmol per min. (C) Relative changes in
basal respiration, maximal respiration, non-mitochondrial respiration, ATP production, spare
respiratory capacity, and proton leak calculated in arbitrary units. *P < 0.05; n=3.
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4.1. Abstract
Muscle derived stem cells (MDSCs) and myoblast play an important role in myotubes
regeneration when muscle tissue is injured. However, these cells can be induced to differentiate
into adipocytes once exposed to PPARγ activator like EPA and DHA that are highly suggested
during pregnancy. The objective of this study aims at determining the identity of transdifferentiated cells by exploring the effect of isolated EPA and DHA on C2C12 undergoing
differentiation into brown and white adipocytes. Confluent cultured cells were treated with white
and brown induction differentiation medium (WIDM and BIDM respectively) with and without
50µM EPA and 50µM DHA separately. DHA but not EPA committed C2C12 cells reprograming
into white like adipocyte phenotype by down-regulation the expression of genes involved in
regulating the differentiation of myoblasts into myotubes such as MyoD1, MyoG, and MRF4 and
up-regulation the expression of white adipogenesis specific markers including Pparγ, C/EBPα,
C/EBP𝛽, AP2, BMP4, FAT, Zfp423, and Il-6 (P<0.05). Moreover, cells treated with WIDM and
DHA exhibited decrease in mitochondrial biogenesis through suppressing the level of PGC1α,
TFAM, and mDNA/nDNA (P<0.05). Also, DHA promoted the expression of lipolysis regulating
genes but had no effect on genes regulating β-oxidation referring to its implication in lipid reesterification. Furthermore, DHA impaired C2C12 cells browning through reducing the
thermogenic capacity and mitochondrial biogenesis of derived cells independent of UCP1 by
significantly suppressing the expression levels of COX7α1, COX8β, PGC1α, Dio2, and UCP3
genes (P<0.05). Accordingly, DHA treated groups showed an increased accumulation of lipid
droplets and suppressed mitochondrial maximal respiration and spare capacity. EPA, on the other
hand, reduced myogenesis regulating genes including MyoD1, MyoG, and MRF4 (P<0.05), but
no significant differences were observed in the expression of adipogenesis key genes such as
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PPARγ, C/EBPα, C/EBPβ, and AP2 (P>0.05) . Likewise, EPA suppressed the expression of WAT
signature genes BMP4 and Zfp423 (P<0.05) indicating that EPA and DHA have an independent
role on white adipogeneis. EPA and WIDM treatment suppressed the expression levels of Tfam
and PGC1α, but no significant differences were observed in PGC1a protein level and
mDNA/nDNA ratio. Although, COX7α1, COX8β, UCP3, and PGC1α transcripts were reduced
in EPA and BIDM treated group, no significant changes in mitochondrial function were observed.
Unlike DHA treatment, EPA supplementation has no effect on the differential rout of C2C12 cells
into brown adipocytes. It is to be included that EPA and DHA may similarly affect muscle tissue
development and regeneration, but DHA is a potent adipogenic and lipogenic factor that can
change the metabolic profile of the body by increasing intramuscular fat.
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4.2. Introduction
The skeletal tissue making up the majority of body mass is marked by its responsibility on
body movement and metabolism regulation. Muscle tissue generated prenatally during fetal
development increases in size and develops into mature muscle fibers during postnatal stage
(Buckingham, 2001). Prenatally, somite-derived myoblasts, the progenitors of muscle tissue, leave
the cell cycle after proliferation to form myotubes in a process known as myogenesis (Sabourin &
Rudnicki 2000). Progenitor cells, including muscle derived stem cells (MDSCs) and myoblasts
play an important role in regenerating myotubes when muscle tissue suffers from damaging
injuries. The cells responsible for the repairing process are non-differentiated and quiescent during
the steady state. When muscle subjects to a certain damage, the regenerating cells gain a massive
capacity of rapid proliferation and switch into the active form to form new myofibers (Lukjanenko
et al., 2013).However, these cells can also be induced to differentiate into other lineages such as
adipocytes, osteocytes, and chondrocytes in response to external stimuli such as maternal nutrition
(Yang et al., 2013).
Harper & Pethick, 2004 emphasized that Intramuscular Fat (IMF) can be originated from
mesodermal derived multipotent stem cells, which are a regular sources of fat deposits, and from
myoblasts and fibroblasts upon exposure to adipogenic factors. Hence, there is an urgent necessity
to identify stimuli, capable of committing myoblast into adipocytes lineage, and discover the
molecular mechanisms orchestrating the trans-differentiation process. Such studies may help find
out more about the origin of intramuscular fat whether it is only simple ectopic extension of other
fat locations or by-product of possible trans-differentiation of myoblast into adipocytes.
Health benefits of long chain (n-3) polyunsaturated fatty acids (PUFAs) supplements,
particularly eicosapentaenoic acid (EPA) (20:5n3) and docosahexaenoic acid (DHA), have been a
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frequently addressed topic (Calder, 2012; Mozaffarian & Wu, 2012; Calder, 2013; Liu et al.,
2013). Several studies have attested that EPA and DHA have an important role in blunting muscle
atrophy, orchestrating lipid metabolism, enhancing protein synthesis, and improving insulin
resistance in skeletal muscle ( Kamolrat & Gray, 2013; Capel et al., 2015; Tachtsis et al., 2018). It
was stressed that 30 µM DHA is sufficient to counteract the effect of palmitate induced insulin
resistance in C2C12 myotubes (Capel et al., 2015). Furthermore, Kamolrat & Gray, 2013 found
that muscle protein synthesis can be considerably improved after exposing to 50 µM EPA.
However, the effect of EPA and DHA on the myogenesis process and the possibility of
reprograming myoblasts into another lineage is still controversial. Consequently, further
investigations are required to determine the association between the usage of EPA and DHA and
myoblast fate (Tachtsis et al., 2018).
N-3-PUFA

supplementations,

particularly

eicosapentaenoic

acid

(EPA)

and

docosahexaenoic acid (DHA), are highly recommended during pregnancy because of their
neuronal development along with retinal and immune functions improvements (Swanson et al.,
2012). However, long-term exposure to n-3 PUFAs carries the risk of growth deficiencies that
might be linked to nutritional toxicity (Church et al., 2008). Considering the potential impact of
maternal nutrition on myoblast proliferation and differentiation during fetal development (Reed et
al., 2014), we hypothesize that EPA and DHA supplementation may induce myoblast transdifferentiation into adipocyte lineage while compromising fetal skeletal muscle development and
influencing its insulin sensitivity and energy balance.
It has been highlighted that the adipogenesis process can be induced in non-adipogenic
cells, such as fibroblasts and myoblasts, by enforcing the ectopic expression of PPARγ, the key
gene in regulating the adipogenesis process (Tontonoz et al., 1994; Hu, 1995). Anticipating the
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potential activation of PPARs by n-3 polyunsaturated fatty acids, well known PPARs’ ligands
(Luo et al., 2009), there is a great chance that the maternal diet enriched with EPA and DHA may
induce myoblasts trans-differentiation into adipocytes. As reported by Luo et al., 2009, n-3 PUFA
enriched diet is positively correlated with increasing the accumulation of intramuscular fat where
the adipogenic effect was attributed to over-expression of adipogenesis signature genes. Further,
EPA has been recently identified to have a well-established role in converting myoblasts cells into
the adipogenic lineage (Luo et al., 2015). However, the identity of the adipocyte derived from
myoblasts is still need to be uncovered. Therefore, the objective of this study was to explore the
effect of EPA and DHA on myoblasts undergoing differentiation into brown and white adipocytes
in an in vitro model. In our previous studies we found that the combined supplementation of EPA
and DHA in culture medium induced C2C12 reprograming into white adipocyte-like phenotype
(Ghnaimawi et al., 2019, Ghnaimawi et al. 2020). Our primary focus here was to determine the
participation level of each one of these n-3 polyunsaturated fatty acids in the adipogenesis process.
Accordingly, the investigation was carried out to find the independent roles of EPA and DHA on
the potential whitening or browning of C2C12 myoblast.
4.3. Materials and methods
4.3.1. Cell culture and differentiation
C2C12 cell culture was conducted as previously described by Klemm et al., 2001. Briefly,
the cells were cultured in a growth medium composed of Dulbecco's modified Eagle's medium
(DMEM) 89% supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin
(Sigma-Aldrich) at 37 °C in a humfied atmosphere of 5% CO2. Then, confluent cells were treated
with a white (WIDM) and browning differentiation induction medium (BDIM) in the absence
(CON) or presence of isolated doses of 50µM EPA and DHA for 10 and 7 days respectively. White
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adipogenesis induction medium 1 (WDIM 1) was composed of 0.125 mM IBMX, 0.3 µM
dexamethasone, 1µg/ml insulin for the first 6 days. Thereafter, the cells were switched into WDIM
2 composed only of 1µg/ml insulin for 4 days (Yamanouchi et al., 2007). On the other hand,
browning differentiation induction medium (BDIM 1) was composed of 0.1 mM IBMX, 125 nM
indomethacin, 1 µM dexamethasone, 5µg/ml insulin, 1 nM T3 and 5 µM rosiglitazone. After 3
days the cells were exposed to BDIM 2 composed of 5µg/ml insulin, 1 nM T3 and 5 µM
rosiglitazone (Zhou et al., 2014). All the reagents composing WDIM and BDIM are from (SigmaAldrich, St. Louis, Missouri United States).
4.3.2. Oil Red O staining
At the last day of differentiation in both experiments, the medium was aspirated off and the
cells were rinsed three times in phosphate buffer solution (PBS). Cells were fixed with 10% neutral
buffered paraformaldehyde (Sigma-Aldrich, St. Louis, Missouri United States) for 30 minutes at
room temperature followed by 3 washes with PBS. Lipid droplets were stained with Oil Red O
(Sigma-Aldrich, St. Louis, Missouri United States) (Konieczny & Emerson1984). A 0.5g of Oil
Red O was dissolved in 100 ml absolute isopropanol to prepare stoke solution. Six parts of stoke
solution was mixed with four parts of distilled water to make working solution and then filtered
using 0.2μm filter. Cells were maintained in Oil Red O working solution for 30 minutes at room
temperature 25°C. Morphological changes were observed under the microscope and intracellular
lipid droplets were identified in the cytoplasm by their bright red color. Nikon DS-Fi3 digital camera
mounted on a Nikon Eclipse TS 2R light microscope (Konan, Minato-ku, Tokyo, Japan) was used
for imaging and the results were analyzed using image J software. Finally, Oil Red O was extracted
by 1 ml 100% (v/v) isopropyl alcohol to quantitatively measure the density of the stain in different
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groups at 520 nm using microplate reader ((Gene 5 Bio Tek Spectrometer, BioTek, northern
Vermont, USA). Isopropanol was used as a blank (Cheung et al., 2015).
4.3.3. Real-time PCR
Total RNA was extracted from the cells using Rneasy mini Kit (QIAGEN, Germany). The
cDNA was synthesized using Χ iScript kit (Bio-Rad, Richmond, California) by following the
manufacturer’s protocol. Real-time PCR was performed using CFX Connect Real-Time PCR
Detection System (Bio-Rad, Richmond, California). Primers (Table 1) used were designed in
accordance with NCBI database and Primer Quest (IDT. com). The data was normalized to the
reference gene 18s and the relative expression levels were measured in arbitray unit (Huang et al.,
2010).
4.3.4. Oxygen consumption rate (OCR)
Mitochondrial function was evaluated to assess typical bio-energetic profile of cells by
directly measuring Oxygen consumption rate (OCR) in differentiated groups using Seahorse XFP
(Seahorse Bioscience, www.seahorsebio.com) and Agilent Seahorse XFP Cell Mito Stress Test.
Cells were seeded in customized Seahorse 8-well miniplate at initial density of 10× 10^3 cell/ well
and induced to differentiate into brown, as was described above. One day before the assay,
cartridge hydration was conducted in 200µ calibrant per well (Seahorse Bioscience) and incubated
overnight in non CO2 incubator at 37 C. On the day of assessment, cells were incubated for 1 hour
with completed assay medium (PH 7.4) consisted of basal medium supplemented with 10 mM
glucose, 10mM pyruvate, and 2 mM glutamine at 37 °C in a non-CO2 incubator. During the assay,
the following chemicals, including oligomycin, FCCP, and rotenone/ antimycin-A were orderly
injected at final concentrations of 2μM, 0.7 μM, and 1 μM respectively (all from Seahorse
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Bioscience). The Seahorse XF Cell Mito Stress Test Report Generator was used to analyze the
data. The results were normalized to protein concentration (Calderon-Dominguez et al, 2016).
4.3.5. Western blot assay
Cells were isolated using PBS (1 ml/well), and protein, then, was extracted by lysis buffer,
T-PER, (Sigma-Aldrich, St. Louis, Missouri United States) mixed with protease and phosphatase
cocktail inhibiter at ratio of 100:1. Protein concentration was measured using Pierce™ BCA
Protein Assay Kit (Sigma-Aldrich, St. Louis, Missouri United States) following the
manufacturer’s instructions. Samples were separated on Mini-PROTEAN precast gels (Bio-Rad)
and transferred onto Trans-Blot ® Turbo™ Mini PVDF Transfer Packs (Bio-Rad). Immunostaining was conducted by overnight incubation with primary antibodies [GAPDH (1:1000,
Cusobio), myogenic differentiation 1 (MyoD1) (1:25000, Cusobio), MyoG (1:25000, Cusobio),
UCP1 (1/1,000; Abcam), UQCRC1 (complex III) (1/1,000; Invitrogen), SDHA (complex II)
(1/1,000; Invitrogen), PRDM16 (1/1,000; Santa Cruz).and PGC1α (1:1000, Abcam) , C/EBPβ
(1:1000, Cusobio), PPARγ (1:1000, Cell Signaling), Bmp4(1:1000, Cusobio), Myogenic factor 6
(MRF4) (1:1000, Cusobio) ] . The membrane was then incubated with HPR conjugated secondary
antibody for 1 hour after 3 times washing with TBST buffer. The bands were visualized using ECL
immunoblotting clarity system (Bio-Rad, California, USA) and detected on ChemiDoc TM Touch
imaging system (Bio-Rad). Band density was normalized according to the glyceraldehyde-3phosphate dehydrogenase (GAPDH) content and analyzed using Image Lab software (Bio-Rad)
(Herrero et al., 2005).
4.3.6. Statistical analysis
Student’s t-test and One-way ANOVA were used to analyze the data. Data are expressed
as mean ± SEM. P<0.05 value was considered statistically significant.
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4.4. Results
4.4. 1. Effect of EPA and DHA separately on C2C12 induced to white adipocytes
4.4.1.1. Both EPA and DHA suppressed the expression of genes regulating the differentiation
of C2C12 in to mature myotubes
Myotubes formation was dramatically suppressed in this experiment when C2C12 exposed
to EPA and DHA separately. Both EPA and EPA induced down- regulation the expression levels
of MyoD1, MyoG, and MRF4 but not MyF5 indicating that the myogenesis process was
compromised at the terminal differentiation stage. DHA treated group exhibited considerable
decrease in the expression levels of MyoD1, MyoG, and MRF4 (74 ± 3.9% P=0.03, 57 ± 21.7%
P=0.007, and 97 ± 0.36% P=0.0001, respectively). On the other hand, the expression levels of
MyoD1, MyoG, and MRF4 were significantly down-regulated in EPA treated group compared to
control group (49 ±9.1% P= 0.01, 89± 4.5% P= 0.0001, and 93 ±0.63% P=0.0001 respectively)
(Figure 1).
4.4.1.2. DHA but not EPA induced trans-differentiation of C2C12 into white adipocyte-like
phenotype through up-regulation of WAT specific markers
We investigated the effect of isolated EPA and DHA on the expression level of genes wellknown to be involved in the regulation of white adipogenesis such as PPARγ, C/EBPα, C/EBPβ,
AP2, FAT, Bmp4, and Zfp423. Our findings showed increased the expression levels of PPARγ,
C/EBPα, C/EBPβ, AP2, FAT, Bmp4, and Zfp423 in DHA treated group in comparison to control
group (150 ± 9.5% P= 0.011, 100 ± 25% P=0.002, 41± 12.1% P= 0.013, 628 ± 87.9% P=0.0001,
249 ± 45.8% P= 0.034, 48 ± 9.3% P=0.003, and 84± 29.2% P=0.01, respectively). On the other
hand, EPA treated group exhibited non-significant change in the expression levels of basal
adipogenesis key genes: PPARγ, C/EBPα, C/EBPβ, AP2, and FAT (P > 0.05). However, EPA
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dramatically reduced the expression of WAT regulating transcriptional factors including Bmp4
and Zfp234 (745 ±32.6% P=0.00007 and 67 ± 2.9% P= 0.0001, respectively), compared to control
(Figure 2).
4.4.1.3. DHA reduced the expression of genes regulating mitochondrial biogenesis and
mtDNA replication
To investigate the effect of EPA and DHA on expression of genes known to serve as
stimulators of mitochondrial biogenesis and mtDNA copy number, the expression levels of PGC1α,
Cox7α1, and Tfam in C2C12 muscle cells undergoing white adipogenesis differentiation were
measured by real-time quantitative PCR and the ratio of mtDNA to nuclear DNA (nDNA) was
determined. The results showed that mRNA levels of PGC1α, Tfam, and Cox7α1 were significantly
reduced in DHA treated group (62 ± 3.8% P= 0.005, 47 ±2.5% P=0.044, and 84 ± 0.9% P= 0.007
respectively) and EPA treated group (30 ±10.6% P=0.034, 70 ±4.7% P=0.014, and 94 ± 0.8% P=
0.0001 respectively). However, at protein level, the result of PGC1α was consistent in DHA treated
group (significantly lower); whereas, non-significant difference was observed between control and
EPA treated group. In line with that, the mtDNA/nDNA ratio decreased (65 ± 6.6% P=0.014) in the
group treated with 50 μM DHA; however, there was no significant difference for mtDNA copy
number in group treated with 50 μM EPA (P= 0.088) (Figure 4).
4.4.1.4. The individual effect of EPA and DHA supplementation on lipolysis and βoxidation regulating genes
Our data exhibited an increase in basal lipolytic activity in DHA treated group but not in
EPA treated group when compared to control. The mRNA levels of ATGL, HSL, and MGL were
significantly increased in DHA treated group (56 ± 13.6% P= 0.0011, 121 ± 32.1% P=0.0024, and
225 ± 84.7% P=0.013 respectively); whereas, non-significant variations were observed in the
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values of mRNA expression of ATGL, HSL, and MGL genes between EPA and control treated
groups (P=0.351, 0.342, and 0.375 respectively). On the other hand, no significant changes
between DHA and control groups were observed in the expression levels of genes regulating fatty
acids uptake and β-oxidation such as Cpt1α, Lcad, Mcad, Acadvl, and Slc25a5 ( P=0.055, 0.099,
0.28, 0.37, and 0.306 respectively). EPA treatment, in contrast, induced down-regulation the
expression levels of Lcad, Mcad, Slc25a5 (44 ± 0.4% P=0.004, 70 ± 4% P= 0.00001, 49 ± 3.2%
P= 0.0007 respectively), but not the expressions of Acadvl and Cpt1α (P=0.33 and 0.42
respectively). (Figure 4)
4.4.1.5. Effect of EPA and DHA supplementation on lipid droplets formation and
morphological changes
Our findings revealed noticeable morphological changes in DHA and EPA treated
groups. The absence of multinucleated myofibers and formation of rounded cells was
observed in both EPA and DHA treated groups. However, formation of large monocular
bright red lipid droplets was indicated only in DHA treated group. Lipid accumulation in the
different groups was confirmed by quantitative measurements of oil red which exhibited a
dramatic increase in DHA treated group in comparison to control and EPA treated groups ( 76%
P = 0.008) (Figure 5). These results were consistent with those obtained from PCR and western
blot implied that C2C12 loss their myogenic capacity once exposed to EPA and/or DHA
treatment. However, only DHA has the capability of committing C2C12 trans-differentiation into
white-like adipocytes trapping triglyceride in the form of large lipid droplets.
4.4.1.6. Effect of DHA and EPA on pro-inflammatory cytokines formation
Given the profound effect of pro-inflammatory cytokines produced from adipose tissue
on systemic inﬂammation and related insulin resistance in case of obesity, the potential capacity
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of EPA and DHA in modulating inﬂammation in C2C12 cells trans-differentiated into white
adipocytes were tested in this study. Both EPA and DHA treated groups exhibited a dramatic
increase in interleukin 6 (IL-6) gene expression (225± 34% P= 0.001 and 48 ±11% P=0.04
respectively), but not tumor necrosis factor α (TNFα) (P= 0.21 and 0.42 respectively) (Figure 6).
4.4. 2. Effect of EPA and DHA separately on C2C12 induced to brown adipocytes
4.4. 2.1. Effect of EPA and DHA supplementation on BAT specific genes
The results exhibited non-significant differences in expression levels of some of brown
adipocytes specific markers including uncoupling protein 1 (UCP1) cell death-inducing
DFFA-like effector A (CIDEA), and PR domain containing 16 (PRDM16) in DHA (P =0.28,
0.36, and 0.29 respectively) and EPA treated group (P =0.20, 0.21, and 0.065 respectively).
However, genes involved in regulating BAT thermogenic capacity such as peroxisome
proliferator-activated receptor gamma coactivator-1 alpha (PGC1α), uncoupling protein 3
(UCP3), and Type II iodothyronine deiodinase (Dio2) showed significant decline in both EPA
(68± 10.0% P=0.0013 , 93 ± 2.0% P=0.00001, and 61 ±2.7% P= 0.00004, respectively) and DHA
treated groups (55± 10.9% P= 0.0074 , 39 ± 4.3% P= 0.0004 , 51 ± 4.3% P= 0.010 respectively)
in comparison to control groups. On the other hand, there was no significant difference in PGC1α
protein level in EPA treated group, compared to control group (Figure 7). It was apparent
that DHA treated group impaired the course of C2C12 cells differentiation into brown
adipocytes independent of changing UCP1 level.
4.4.2.2. Effect of single treatment with EPA and DHA on genes regulating mitochondrial
biogenesis
The metabolic characteristics of mitochondria in muscle cells and BAT exhibit a great
similarity. These two tissue types are highly enriched with mitochondria which are
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responsible for orchestrating the oxidative capacity through the activities of fatty acids’
oxidation enzymes and respiratory chain components. Thus, reduced mitochondrial density
and function may impair the thermogenic capacity of cells. Our findings reveals that the
expression levels of PGC1α were significantly reduced in groups exposed to treatment with EPA
and DHA (68± 10.0% P=0.0013 and 55± 10.9% P= 0.0074 respectively); while, Errα and PGC1β
showed non-significant difference between control groups and those treated with DHA (P=0.11
and 0.30 respectively) or EPA (P=0.2 and 0.19 respectively). On the proteomic level, PGC1α was
significantly reduced in DHA treated group only. (Figure 8).
4.4.2.3. Effect of isolated treatment with EPA and DHA on genes regulating ETC work
Co-factors produced from TCA and β-oxidation are directed to the electron transport chain
(ETC) to be used in uncoupling respiration to produce heat which is the main function of brown
adipocytes. Thus, we aimed to investigate the effect of EPA and DHA supplementation on the
master genes encoding proteins involved in regulating electron transport chain work. We found
that the expression levels of COX7α1, COX8β were by far down-regulated in EPA (61± 6.3% P=
0.0007and 92 ± 2.6% P= 0.0001, respectively) and DHA treated groups (68 ± 7.2% P= 0.001 and
87± 2.4% P= 0.0001, respectively), compared to control groups, whereas, the transcripts of
COX5β, and ATP5jα were non-significantly different between groups treated with EPA (P= 0.1
and 0.45, respectively) or DHA (P= 0.23 and 0.35respectively) . Also, non-significant changes
were observed in protein levels of complex II and complex III in both groups exposed to EPA and
DHA treatment upon comparison to control groups. (Figure 9).
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4.4.2.4. Effect of EPA and DHA supplementation on lipid accumulation and
morphological changes
Our findings showed notable losses of multinucleated myotubes and changing the
morphology of the cells into rounded cells filled with lipid droplets (Figure 10). Also, the
results exhibited an increase in lipid droplets size and number in DHA treated groups,
compared to other groups (SF1, ST1). This results were consistent with the results obtained
from the quantitative measurement of oil red which exhibited a dramatic increase in DHA
treated group in comparsion to EPA and control groups (200 ±27.3% P= 0.00001(Figure 10).
4.4.2.5. DHA but not EPA reduced mitochondrial respiration and spare capacity
Data revealed significant decrease in mitochondrial maximal respiration and spare
capacity in DHA treated group (56± 3.0% P= 0001 and 51 ± 4.1% P= 0.0005 respectively). On
the other hand, non-significant differences were shown between control and EPA treated
group (P=0.16 and P=0.11 respectively). Taken together, DHA associated-reduced
mitochondrial metabolic efficiency may be attributed to decreasing the mitochondrial content
resulted from suppressing PGC1α protein level (Figure11).
4.5. Discussion
In addition to its contribution to more than 40% of body mass, skeletal muscle is considered
a major site of glucose disposal because of its enrichment with insulin receptor. In this sense, it
was reported that roughly 80% of circulating plasma glucose is exhausted to fuel daily muscular
activities (Watt, 2009). A positive correlation has been revealed between intramuscular lipid
infiltration and lipotoxicity and related insulin resistance in humans as muscle tissue is not as
efficient as adipose tissue in lipid storage (Schaffer, 2003; Lelliott, C., & Vidal-Puig, 2004).
Reprogramming of skeletal muscle precursor cells into functional adipocyte exhibiting a great
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capacity in synthesizing and deposition of fat has been reported by many in vitro and in vivo
studies to be induced only after stimulation by certain drugs and cytokines or concurrently with
pathophysiological conditions (Hu et al, 1995; Asakura et al., 2001; Teboul et al., 1995; Yeow et
al., 2001; Kopinke et al., 2015). While uncommitted myoblast and satellite cells have a great
tendency to Trans-differentiate into adipocyte during fetal early development, fully mature
myotubes do not lose their myogenic ability to the favor of another lineage under any conditions
(Teboul et al., 1995). It has been demonstrated that generation of fat cells from myogenic
precursors is a complicated process that requires changing genes profile, particularly those
regulating the myogenesis process (Yu et al., 2015). Here, we identified that both EPA and DHA
have the ability to inhibit myotubes formation in vitro. However, DHA but not EPA could
effectively induce trans-differentiation of myoblasts into white-like adipocytes that might
subsequently leads to the accumulation of intramuscular fat. In our study, DHA enhanced the transdifferentiation of myoblasts in to white -like adipocytes. The mechanism could be prompted at
many prospects including: a) inhibiting the terminal differentiation of myoblast into mature
myotubes via down-regulating the expression of myogenesis signature genes such as MyoD1 ,
MyoG, and MRF4 ; b) inducing the expression of PPARγ , C/EBPβ, C/EBPα ,Ap2, FAT, Bmp4,
and Zfp423, white adipogenesis key genes; and c) impairing the acquisition of functional brown
adipocyte phenotype through reducing the function and density of mitochondria leading to fat
accretion instead of being catabolized.
The first evidence of DHA induced C2C12 reprograming into white adipocyte-like
phenotype is the ectopic expression of adipogenesis key regulators, PPARγ, C/EBPβ, and C/EBPα,
which droves C2C12 to loss their myogenic identity and switch into the adipocytes like lineage.
Inhibition of myotubes formation can be attributed to reducing the expression of myogenesis

136

regulating genes particularly MyoD1, MyoG, and MRF4. However, it was reported that muscles
progenitors could restore their myogenic capacity once PPARγ is disconnected from its activator
indicating that the trans-differentiation process is a temporary and depends on the sustained
expression of PPARγ and C/EBPα (Hu et al., 1995). It has been demonstrated that PPARγ is the
key regulator of adipocyte formation from non-adipogenic precursors, where its expression is
sufficient and indispensable for the terminal differential of fibroblast into mature adipocytes. Also,
all adipogenic factors may lack their ability in enhancing the adipogenesis process without PPARγ
activation (Tontonoz et al., 1994; Tang et al., 2005). A comparative study was conducted to
elucidate the necessity of the ectopic expression of C/EBPα and PPARγ in committing mouse
embryonic fibroblasts (MEFs) into adipocyte lineage. They found that PPARγ ectopic expression
is sufficient to induce the trans-differentiation of C/EBPα/- MEFs into adipocytes in vitro (Wu et
al., 1999); whereas, enforcing the expression of C/EBPα in PPARγ/- MEFs was not adequate to
induce the reprogramming process (Rosen et al., 2002). These results indicated that C/EBPα is not
obligate for adipocyte differentiation while PPAR ectopic expression is indispensable for driving
non-adipogenic progenitors into adipocyte lineage. The myogenesis process is regulated by group
of important MRFs, including MyF5, MyoD, myogenin, and MyF6 (MRF4) (Pownall et al., 2002).
It has been demonstrated that Myf5+ progenitors have the potential to switch between two different
lineages including myoblasts and brown preadipocytes in response to surrounding environment.
Persistent expression of MyoD drives cells commitment toward the myogenic fate while brown
adipocytes derivation from C2C12 requires blunting the activity of MyoD (Sanchez-Gurmaches
& Guertin, 2014).These findings had a great correspondence with a previous study conducted by
Salehzada et al., 2009. It was also reported that adipogenic factors intervention-mediated inhibition
of MyoD and related trans-differentiation of myogenic precursors into adipocytes was not
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accompanied with increasing the level of UCP1, the main regulator of brown adipocytes, which
required the interaction of other factors such as Notch signaling and sympathetic innervation to be
induced (Bartness et al., 2010; Pasut et al., 2016). These observations are in agreement with our
results suggesting that white like adipocyte can arise from Myf5+ myoblasts upon their exposure
to PPARγ activators.
The second evidence is that the DHA treated group exhibted increased expression levels
of white adipocytes specific genes including FAT, Bmp4 and Zfp423. It was reported that Bmp4
promotes brown adipocytes switching into white adipocyte phenotype by down-regulation the
expression of browning specific markers and up-regulation of white adipogenesis signature genes
during the terminal differentiation stage. Also, it suppressed lipolysis and inhibited oxygen
consumption rate (OCR) followed by reducing the thermogenic capacity of cells (Modica et al.,
2016). Zfp423 was reported to exert a profound effect on adipogenesis regulation and associated
intramuscular lipid overload in beef cattle. It was attested that stromal vascular cells isolated from
beef samples were induced to Trans-differentiate into adipocytes via enforcing the expression of
Zfp423. The mechanism of Zfp423 action was mediated through down-regulation the expression
of transforming growth factor (TGF-β), well-known myogenic factor, and increase the expression
of adipogenesis key regulators, PPARγ and C/EBPα .Moreover, the study added that high
adipogenic selected clones lack their adipogenic capacity once the Zfp423 gene was knocked out
using shRNA indicating the necessity of Zfp423 expression in regulating the potential conversion
of non-adipogenic precursors into adipocyte cells with great capability to synthesize and storage
of fat (Huang et al., 2012). Moreover, it was recently demonstrated that white adipocytes are highly
enriched with Zfp423 gene, and it is essential for maintaining their phenotype. Additionally,
Zfp423 suppressed the thermogenic capacity of brown adipocytes through reducing the activity of
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Ebf2 leading to inhibiting Prdm16 activation. Moreover, reprogramming white adipocytes into
beige-like adipocytes requires inactivation of Zfp423 which is highlighted as a therapeutic option
to counter obesity (Shao et al., 2016). Contrary, we found that EPA supplementation reduced the
expression levels of these two white adipocytes specific markers (Bmp4 and Zfp423) referring to
its inverse association to the expression of transcription factors enhancing white adipose tissue
expansion. Taken together, we may conclude that DHA supplementation associated up-regulation
of whitening signature genes induced C2C12 to Trans-differentiate into white adipocyte like
phenotype; whereas , inhibiting the expression and protein level of myogenesis regulating genes
may prevent myotubes formation but not necessarily committ the trans-differentiation of
myoblasts into adipocyte lineage, which what was observed in the cells exposed to EPA treatment.
It is appear to be understood that the commitment of C2C12 cells into adipocytes is entirely
mediated by PPARγ overexpression while activating the Bmp4 -Zfp423- PPARγ pathway favors
promoting the white adipogenesis route and prevents the development of brown adipocytes
phenotype. This mode of action was asserted by (Gupta et.al, 2012).
The third evidence of C2C12 reprogramming into white like adipocytes upon DHA
exposure is down-regulation the expression of genes responsible for mitochondrial thermogenic
capacity including PGC1α, Cox71α, Cox8β, Dio2, and UCP3. In corroboration with PGC1β,
PGC1α was identified as critical elements in creating brown adipose tissue and enhancing their
function through stimulating mitochondrial biogenesis and driving UCP1 synthesis by stimulating
its promoter (Richard & Picard, 2011). Down-regulation the expression of PGC1α in C2C12
exposed to EPA and DHA observed in our experiment is consistent with other studies in which the
level of PGC1α was considerably decreased in mice treated with n-3 fatty acids alone or in
combination with dexamethasone (Fappi et al., 2019). Our results were also comparable with the
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study conducted by Martins et al. in 2017. However, our findings showed non-significant change
in UCP1 gene expression and protein level despite of inhibiting the expression of its activator
PGC1α indicating the potential regulation of UCP1 production by another molecular pathways.
Also, our results showed that EPA treatment has a massive effect on PGC1α at the transcription
level but not at the level of protein in both experiments. Furthermore, reducing the expression level
of Dio2, well known regulator of thermogenesis process, could be highlighted as another indicator
of myoblast conversion into white like adipocytes phenotype in this study. Type II iodothyronine
deiodinase (Dio2)-induced thyroxin (T4) conversion into its active form triiodothyronine (T3) is
the rate limiting step in stimulating the thermogenic capacity of the cell. Cold exposure and
norepinephrine associated increased thermogenesis can be attributed to up-regulation of Dio2
(Bianco et al., 2002). Therefore, down regulation the expression of Dio2 may reduce
thermogenesis. Consistently, according to Mehus & Picklo, 2017, a negative correlation between
EPA and DHA supplementation and Dio2 expression level was revealed in mice study. However,
unlike in DHA treated group, EPA treatment induced down regulation the expression levels of
thermogenesis regulating genes was not accompanied with mitochondrial dysfunction as no
changes were observed in maximal respiration and spare respiratory capacity. Also, the results of
oil red staining showed no change in lipid droplets size and number.
The fourth evidence of C2C212 conversion into white-like adipocytes after DHA treatment
is reducing the expression of genes regulating mitochondrial biogenesis in DHA treated group.
Given that the phenotype of adipocyte cell can be identified based on their mitochondrial content,
we investigated the effect of DHA and EPA supplementation on mitochondrial density and its
association with mitochondrial function manifested by maximal respiration and spare respiratory
capacity. Accordingly, we measured the relative expression and protein levels of mitochondrial
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biogenesis regulating key genes. While DHA reduced the gene expression and protein level of
PGC1α and Tfam, the expression of other genes involved in regulating mitochondrial biogenesis
such as PGC1β and Errα were not changed. It was reported that PGC1α, but not PGC1β is critical
for orchestrating mitochondrial thermogenic capacity. However, the biogenesis process can be
comprised by reducing the expression of either of them (Uldry et al., 2006). Additionally, It was
demonstrated that PGC1α regulates the expression of NRF1 and NRF 2 which are nuclear
transcription factors responsible for regulating the expression of mitochondrial transcription factor
A (Tfam), controlling mitochondrial DNA content inside the cells (Yu et al., 2015; Bargut et al.,
2017). DHA associated Reducing mitochondrial copy number in C2C12 during the course of
differentiation into white adipocytes reported in this paper, predicted from the decreased
mtDNA/nDNA ratio can be attributed to reducing the protein level of PGC1α and associated
decreased the expression of Tfam, followed by respiratory chain disorder and mitochondrial
dysfunction. On the other hand, the suppressing effect of EPA on PGC1α in both experiment was
only noticed on the transcription level while protein production was unchanged, compared to
control group and was concurrent with normal mitochondrial function. It is to be included that the
DHA mediated mitochondrial dysfunction observed in this study may be attributed to reducing the
density of mitochondria. Moreover, the observed reduction in mitochondrial maximal respiration
and spare respiratory capacity in group treated with DHA and BIDM can be linked to its
incorporation in the mitochondrial membrane. Correspondingly, it was stressed that DHA induced
structural changes in lipid components of the inner mitochondrial membrane isolated from mice
cardiocytes led to reducing the enzymatic activities of OXPHOS subunits including complexes I,
IV, V, and I+III. In consistent with our study, the findings exhibited suppressing the activity but
not the expression levels of OXPHOS regulating subunits (Sullivan et al., 2018). Additionally, it
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has been recently discovered that DHA is an essential factor in remodeling mitochondrial
phospholipidome (Sparagna & Lesnefsky, 2009; He & Han, 2014; Han et al., 2007 ).Given that
both EPA and DHA has the same effect on the set of genes regulating mitochondrial content and
thermogenesis but only DHA treated group exhibited insufficiency in mitochondrial work, we
think that DHA mediated suppressing mitochondrial biogenesis as a result of reducing PGC1α
protein production is the main reason behind mitochondrial dysfunction and related impairing the
acquisition of brown adipocyte like phenotype. However, the hypothesis of linking DHA
incorporation into cell membrane to the generation of brown adipocytes with less mitochondrial
content and function is still feasible as it has been mentioned that DHA is the key player in
remodeling the biochemical structure of cell membrane specially lipid rafts; whereas, EPA is
mainly implicated in orchestrating other central processes including immunity and inflammation
(Stillwell & Wassall, 2003; Calder, 2006). Another reason might be linked to reducing the function
of mitochondria in DHA treated groups is the potential excessive production of mitochondrial ROS
in MAPKs activation-dependent manner (Jeong et al., 2014). They found that using antioxidant
reversed DHA-induced mitochondrial malfunction and enabled restoring the mitochondrial
respiration rate.
The fifth evidence is that the DHA and EPA treated group exhibited an increased
expression of pro-inflammatory cytokine IL-6. It has been demonstrated that white adipocytes
isolated from obese individuals are profoundly enriched with interleukin-6 (IL-6) and its receptor
(IL-6R), and they contribute to the majority of the total circulating level of IL-6 (Maachi et al.,
2004; Sindhu et al., 2015). In line with our results, White et al., 2014 reported a positive correlation
between administration of Protectin DX, a docosahexaenoic acid (DHA) metabolite, and
increasing the secretion of IL-6 from skeletal muscle. However, they highlighted that IL-6 released
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from muscle tissue was of a great importance in tuning hepatic glucose metabolism. IL-6 is
multifunctional cytokines released from immune cells and other cells such as myocytes and
adipocytes to combat infectious agents or to correct certain metabolic disorder (Pal et al., 2014).
Muscular tissue damage stimulates the recruitment of IL-6 secreting immune cells to help repair
damaged muscle (Pedersen et al., 2001; Pedersen et al., 2000). Unlike cytokines released from
inflammatory cells, IL-6 produced from muscle cells in response to intensive exercise is only
accompanied with slight increase in acute-phase proteins, regularly and extensively up-regulated
in case of inflammation and implicated in the development of inflammation reactions (Pedersen et
al., 2000). Also, a positive correlation has been demonstrated between injecting human with
recombinant IL-6 and increasing glucose disposal (Carey et al., 2006; Febbraio et al., 2004).
However, IL-6 is secreted in profound amount from white adipose tissue especially during obesity
(Maachi et al., 2004; Sindhu et al., 2015). Given that only C2C12 cells treated with DHA are
induced to differentiate into white adipocytes-like cells, we think that the profoundly elevated
expression level of IL-6 in EPA treated group is a kind of muscle cells- derived IL-6 released as a
compensatory response to the microstructural damage of muscle elements as a consequence of
disrupting myotube formation or to maintaining the compromised homeostasis of myocytes.
The sixth evidence was the observed increased in lipid droplets size and number in DHA
treated group. It is well known that one of the main metabolic characteristics of adipocytes is
intracellular lipid storage, where white adipocyte cells are characterized by their monocular lipid
droplets while brown adipocytes are enriched with small and multillocular droplets. In this study,
we found that in both experiments there was an increase in the number and size of lipid droplets
in DHA treated group in comparison to control and EPA treated groups. Series of studies have
revealed a positive correlation between EPA and DHA supplementation and intracellular lipid
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accumulation. Murali et al., 2014 reported that EPA and DHA induced terminal differentiation of
pre-adipocytes 3T3 cells into mature adipocytes was accompanied by excessive accumulation of
lipid droplets where DHA exhibited more potency. They reported that increased lipid accumulation
was closely linked to incorporation of EPA and DHA in the cell membrane. Another study
emphasized that omega-3 PUFA associated increase in intramyocellular deposition of lipid
droplets can be attributed to TAG synthesis (Wensaas et al., 2009). Additionally, DHA related
inhibition of thermogenesis and up-regulation of WAT regulating genes such as C/EBPα, FAT,
BMP4, and ZFP423 observed in this study may be the reason behind increasing lipid droplets size
and number.
The seventh evidence is DHA induced lipid re-esterification. Our findings revealed upregulation of genes regulating basal lipolysis in group treated with combination of DHA and
WIDM. In line with that, the results exhibited an increase in lipid trapping inside the cells and
unchanging the levels of set of genes known to be involved in enhancing fatty acid uptake and
catabolism. Thus, we can conclude that free fatty acids resulted from triglyceride breakdown are
re-uptake and re-esterified by the cells again. It was reported that lipid handling through several
interconnected process such as lipolysis, glyceroneogenesis, and FA re-esterification is one of the
main features of white adipose tissue (Dragos et al., 2017). On the other hand, we found that EPA
induced suppressing of some genes regulating β-oxidation. We think lacking β-oxidation capacity
in EPA treated group may not be linked to mitochondrial insufficiency, particularly the results did
not exhibit an inhibition of mitochondrial density and bioenrgetic rate. Instead it might be a kind
of metabolic flexibility where cells can easily switch between glucose and lipid oxidation. In line
with that, the non-mitochondrial respiration was enhanced in EPA treated group when compared
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to control (SF2) indicating the preferential role of EPA in enhancing the capability of muscle cells
in substrates handling. Our results are consistent with that obtained by Hessvik et al., 2010.
4.6. Conclusion
We can conclude that C2C12 losses their myogenic capacity once exposed to EPA and
DHA treatment. DHA is adipogenic factor inducing C2C12 trans-differentiation into white-like
adipocytes by increasing the expression level of its ligand PPARγ, the master regulator of
adipogenesis process. PPARγ activation accompanied with up-regulation of whitening signature
genes like C/EBPα, C/EBPβ, AP2, BMP4, and Zfp423. Also, adipocytes derived from C2C12
treated with DHA showed decreased thermogenic capacity and reduced mitochondrial copy
number and activity. Mitochondrial dysfunction observed in DHA treated group may be attributed
to inhibition of genes and proteins known to be implicated in regulating mitochondrial biogenesis
and thermogenic capacity such as PGC1α, Dio2, UCP3, and Tfam. The results showed no change
in UCP1 level between groups indicating that the effect of DHA on thermogenesis is independent
of UCP1. Adipocytes arise from C2C12 after DHA treatment were enriched with big uniocular
lipid droplets. The obvious increase in size and number of lipid droplets in DHA treated group
might be caused by incorporation of DHA in the cellular membrane or enhancement of triglyceride
synthesis (TGA). Moreover, DHA enhances basal lipolysis and fatty acid re-esterification. EPA is
non-lipogenic factor inhibiting the myogenesis process and inversely affecting the expansion of
white adipose tissue by inhibiting the expression of Bmp4 and Zfp423, an important
transcriptional factors implicated in regulating white adipogenesis.
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Table 4.1: Primer sequences for real-time PCR
Primers

Forward sequence

Reverse sequence

UCP1

TCTCTGCCAGGACAGTACCC

AGAAGCCACAAACCCTTTGA

PRDM16

AAGGAGGCCGACTTTGGATG

TTTGATGCAGCTCTCCTGGG

UCP3

GACCACGGCCTTCTACAAA

TCAAAACGGAGATTCCCGCA

DIO2

CAGTGTGGTGCACGTCTCCAATC

TGAACCAAAGTTGACCACCAG

TFAM

GCTTGGAAAACCAAAAAGAC

CCCAAGACTTCATTTCATT

PGC1α

TCCTCTGACCCCAGAGTCAC

CTTGGTTGGCTTTATGAGGAGG

PGC1β

TGGCTCTGATTACTGTGCCTG

TCCTGGGGACTTAGAAGCCA

CIDEA

TGC TCT TCT GTA TCG CCC AGT

GCC GTG TTA AGG AAT CTG CTG

PPARγ

GATGTCTCACAATGCCATCAG

TCAGCAGACTCTGGGTTCAG

ERRα

GGTGTGGCATCCTGTGAGGC

AGGCACTTGGTGAAGCGGCA

18S

GTAACCCGTTGAACCCCATT

CCATCCAATCGGTAGTAGCG

COX7a1

CAGCGTCATGGTCAGTCTGT

AGAAAACCGTGTGGCAGAGA

COX8b

GAA CCA TGA AGC CAA CGA CT

GCG AAG TTC ACA GTG GTT CC

COX5b

GCTGCATCTGTGAAGAGGACAAC

CAGCTTGTAATGGGTTCCACAGT

ATPase 4

CTCGGGTGTGGAAAACGAGA

AAGAAGACCATGGCCCGAAG

CPT1

TATAACAGGTGGTTTGACA

CAGAGGTGCCCAATGATG

ATP5j2

GCGGCCTCTGACTTCACTTAA

AACTTGGCAGCTGTGTCGAT

Acadvl

CACTCAGGCAGTTCTGGACA

TCCCAGGGTAACGCTAACAC

Lcad

GGA CTC CGG TTC TGC TTC CA

TGC AAT CGG GTA CTC CCA CA

Mcad

CAA CAC TCG AAA GCG GCT CA

ACT TGC GGG CAG TTG CTT G

Cpt1a

CTCAGTGGGAGCGACTCTTCA

GGCCTCTGTGGTACACGACAA

Slc25a20

CCGAAACCCATCAGTCCGTTTAA

ACATAGGTGGCTGTCCAGACAA

ATGL

TTCCCCAAAGAGACGACGTG

CGGTGATGGTGCTCTTGAGT

HSL

CCCTCGGCTGTCAACTTCTT

GGTGCTAATCTCGTCTCGGG

MGL

ACTTCTCCGGCATGGTTCTG

GGGACATGTTTGGCAGGACA

MYF 5

CCTGTCTGGTCCCGAAAGAAC

GACGTGATCCGATCCACAATG

MYOD 1

TCTGGAGCCCTCCTGGCACC

CGGGAAGGGGGAGAGTGGGG

MyoG

GCAATGCACTGGAGTTCG

ACGATGGACGTAAGGGAGTG

MRF4

GTGGACCCCTACAGCTACAAACC

TGGAAGAAAGGCGCTGAAGAC
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Figure 4.1: Representative image of western blot, densitometric analysis, and quantitative RTqPCR analysis of the expression levels of myogenesis regulating genes in C2C12 cells during the
trans-differentiation into white adipocytes by a hormonal cocktail. The cells were treated with
differentiation induction medium (DIM) in the absence (CON) or presence of isolated doses of 50
µM EPA and 50 µM DHA for 10 days. All the values of RT-qPCR were normalized to the
expression levels of 18s genes and calculated in arbitrary units. Data are represented as mean ±
SEM. The significant differences were presented as *P < 0.05; n = 6. The level of GAPDH was
used as a housekeeping gene to normalize the western blots data. (A) Effect of DHA on the
expression of myogenesis regulating genes. (B) Effect of EPA on the expression of myogenesis
regulating genes.
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Figure 4.2: Representative image of western blot, densitometric analysis, and quantitative RTqPCR analysis of the expression levels of adipogenesis regulating genes in C2C12 cells during the
trans-differentiation into white adipocytes by a hormonal cocktail. The cells were treated with
differentiation induction medium (DIM) in the absence (CON) or presence of isolated doses of 50
µM EPA and 50 µM DHA for 10 days. All the values of RT-qPCR were normalized to the
expression levels of 18s genes and calculated in arbitrary units. Data are represented as mean ±
SEM. The significant differences were presented as *P < 0.05; n = 6. The level of GAPDH was
used as a housekeeping gene to normalize the western blots data. (A) Effect of DHA on the
expression of WAT specific genes (B) Effect of EPA on the expression of WAT specific genes.
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Figure 4.3: Representative image of western blot, densitometric analysis, and quantitative RTqPCR analysis of the expression levels of genes regulating mitochondrial biogenesis in C2C12
cells during the trans-differentiation into white adipocytes by a hormonal cocktail. The cells were
treated with differentiation induction medium (DIM) in the absence (CON) or presence of isolated
doses of 50 µM EPA and 50 µM DHA for 10 days. All the values of RT-qPCR were normalized
to the expression levels of 18s genes and calculated in arbitrary units. Data are represented as mean
± SEM. The significant differences were presented as *P < 0.05; n = 6. The level of GAPDH was
used as a housekeeping gene to normalize western blots data. (A) Effect of DHA on the expression
of mitochondrial biogenesis regulating genes. (B) Effect of EPA on the expression of
mitochondrial biogenesis regulating genes.
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Figure 4.4: Quantitative RT-qPCR analysis of the expression level of genes regulating basal
lipolysis and β-oxidation activity in C2C12 cells during their reprograming route into white
adipocytes by a hormonal cocktail. The cells were treated with differentiation induction medium
(DIM) in the absence (CON) or presence of isolated doses of 50 µM EPA and 50 µM DHA for 10
days. The values were normalized to the expression levels of 18s genes and calculated in arbitrary
units. (A) Effect of DHA on the expression of genes regulating basal lipolysis. (B) Effect of DHA
on the expression of genes regulating lipid uptake and β-oxidation (C) Effect of EPA on the
expression of genes regulating basal lipolysis. (D) Effect of EPA on the expression of genes
regulating lipid uptake and β-oxidation. Data are represented as mean ± SEM. The significant
differences were presented as *P < 0.05; n = 6.
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Figure 4.5: Analysis of morphological changes and lipid droplets formation by Oil Red O (ORO)staining of C2C12 cells undergoing differentiation into white adipogenesis. The cells were treated
with differentiation induction medium (DIM) in the absence (CON) or presence of isolated doses
of 50 µM EPA and 50 µM DHA for 10 days. A) Microscopic view of trans-differentiated cells
stained with ORO from different groups. B) Quantitative measurement of ORO stain extracted
from the different groups. Data is represented as mean ± SEM. The significant difference was
presented as letters difference; b means P < 0.05; n = 4.

158

Figure 4.6: Quantitative RT-qPCR analysis of the expression levels of genes encoding IL-6 and
TNFα production in C2C12 cells during their reprograming route into white adipocytes by a
hormonal cocktail. The cells were treated with differentiation induction medium (DIM) in the
absence (CON) or presence of isolated doses of 50 µM EPA and 50 µM DHA for 10 days. The
values were normalized to the expression levels of 18s genes and calculated in arbitrary units. Data
are represented as mean ± SEM. The significant differences were presented as mean ± SEM *P <
0.05; n = 4. . (A) Effect of DHA on the expression level of genes regulating IL-6 and TNFα
production. (B) Effect of EPA on the expression of genes regulating IL-6 and TNFα production.
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Figure 4.7: Representative image of western blot, densitometric analysis, and quantitative RTqPCR analysis of the expression levels of brown adipogenesis master genes in C2C12 cells during
the trans-differentiation into brown adipocytes by a hormonal cocktail. The cells were treated with
differentiation induction medium (DIM) in the absence (CON) or presence of isolated doses of 50
µM EPA and 50 µM DHA for 7 days. All the values of RT-qPCR were normalized to the
expression levels of 18s genes and calculated in arbitrary units. The level of GAPDH was used as
a housekeeping gene to normalize the Western blots data (A) Effect of DHA on the expression of
browning adipogenesis regulating genes. (B) Effect of EPA on the expression of BAT signature
genes. Data are represented as mean ± SEM. The significant differences were presented as *P <
0.05; n = 6.
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Figure 4.8: Representative image of western blot, densitometric analysis, and quantitative RTqPCR analysis of the expression levels of key genes regulating mitochondrial biogenesis in C2C12
cells during the trans-differentiation into brown adipocytes by a hormonal cocktail. The cells were
treated with differentiation induction medium (DIM) in the absence (CON) or presence of isolated
doses of 50 µM EPA and 50 µM DHA for 7 days. All the values of RT-qPCR were normalized to
the expression levels of 18s genes and calculated in arbitrary units. Data are represented as mean
± SEM. The significant differences were presented as *P < 0.05; n = 6. The level of GAPDH was
used as a housekeeping gene to normalize the Western blots data (A) Effect of DHA on the
expression of mitochondrial biogenesis regulating genes. (B) Effect of EPA on the expression of
mitochondrial biogenesis regulating genes.
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Figure 4.9: Representative image of western blot, densitometric analysis, and quantitative RTqPCR analysis of the expression levels of some electron transport chain regulating genes in C2C12
cells undergoing differentiation into brown adipocytes by a hormonal cocktail. The cells were
treated with differentiation induction medium (DIM) in the absence (CON) or presence of isolated
doses of 50 µM EPA and 50 µM DHA for 7 days. All the values of RT-qPCR were normalized to
the expression levels of 18s genes and calculated in arbitrary units. Data are represented as mean
± SEM. The significant differences were presented as *P < 0.05; n = 6. The level of GAPDH was
used as a housekeeping gene to normalize the Western blots data. (A) Effect of DHA on the
expression of ETC regulating genes. (B) Effect of EPA on the expression of ETC regulating genes.
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Figure 4.10: The effect of EPA and DHA separately on lipid accumulation in C2C12 myoblasts
after induction of brown adipogenesis. The cells were treated with differentiation induction
medium (DIM) in the absence (CON) or presence of isolated doses of 50 µM EPA and 50 µM
DHA for 7 days. (A) Representative images of ORO staining of cells from different groups
exhibiting morphological changes and lipid droplet formation (B) Quantitative measurement of
ORO staining in control and fatty treated groups. Signiﬁcant differences between the two groups
were measured in arbitrary unit and data are represented as mean ± SEM. Letters represents
significant difference where b means P < 0.05; n=4.
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Figure 4.11: The effect of EPA and DHA separately on metabolic rate of C2C12 cells undergoing
differentiation into brown adipogenesis. The cells were treated with differentiation induction
medium (DIM) in the absence (CON) or presence of isolated doses of 50 µM EPA and 50 µM
DHA for 7days. (A) The effect of DHA treatment on maximal respiration and spare respiratory
capacity. OCR traces are expressed as pmol O2 per min in C2C12 cells and normalized to protein
concentration (B). The Relative differences in maximal respiration and spare respiratory capacity
of control and DHA treated group (C) The effect of EPA supplementation on maximal respiration
and spare respiratory capacity. OCR traces are expressed as pmol O2 per min in C2C12 cells and
(D) the relative changes in maximal respiration and spare respiratory capacity was measured in
arbitrary units. Data are represented as mean ± SEM *P < 0.05; n=3 and 12 measurements.
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4.8: Supplementation

Figure 4.8.1: The effect of EPA and DHA separately on lipid droplets’ size in C2C12 myoblasts
after induction of brown adipogenesis. The cells were treated with differentiation induction
medium (DIM) in the absence (CON) or presence of isolated doses of 50 µM EPA and 50 µM
DHA for 7 days. Signiﬁcant differences among groups were measured in arbitrary unit and
presented as mean ± SEM. Different letters indicate significant differences among variously
treated groups where b = P < 0.05; n=10.
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Table 4.8.1. Size of lipid droplets

* The size was measured in nanometer. Scale bar is 100µm. The value of each sample represents
the mean of 10 measurements (10 samples per group; 10 measurements per sample). P value is <
0.001

Figure 4-8.2: (A) the effect of EPA treatment on non- mitochondrial respiration. OCR traces are
expressed as pmol O2 per min in C2C12 cells and normalized to protein concentration (B). The
Relative differences in non- mitochondrial respiration of control and EPA treated group.
Signiﬁcant differences among groups were measured in arbitrary unit and presented as mean ±
SEM. *P < 0.05; n=3; 12 measurements.
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5.1. Abstract
EPA and DHA are class of long chain fatty acids with diversity of health benefits on
offspring, underpinning the accumulative recommendations for their prenatal ingestion. Multitude
of biological processes including energy expenditure and muscle growth and metabolism have
been reported to be altered in response to EPA/ DHA treatment in adult but remain unknown in
offspring. Recent in vivo studies have emerged indicating a positive correlation of EPA/ DHA
with fetal BAT development while other in vitro trials demonstrated their implication in promoting
fetal myoblast reprograming into adipocytes. Therefore, the objective of this study was to test the
in vivo effect of maternal EPA/ DHA on fetal and offsprimg’s muscle development and energy
balance.Two groups of female C57BL/6 mice were assigned to different diets throughout the entire
period of gestation and lactation. The first group was fed EPA/ DHA enriched diet (FA); whereas,
the other was fed diet devoid of EPA/ DHA (CON). Embryos at day 13 of gestation and offspring
at age of 1 and 21day were selected for sample collection and processing. No change in birth
number and body weight was observed between groups in newborns at day1, but tendency toward
weigh loss in FA group was detected after weaning. The expression level of genes regulating
myognesis, muscle contractile proteins, muscle protein synthesis, and muscle glucose metabolism
was comparable between fetuses collected from different groups (P>0.05). However, transient
increase in the expression levels of MyoD1, MyoG, MRF4, and MHC4 was observed at day 1
post-parturition (P<0.05). Except of IGF-1 P<0.05, the expression levels of genes regulating
muscle protein synthesis and catabolism were comparable (P>0.05) between (FA) and (CON) at
two time points of offspring’s life: day 1 and 21. The significant increase in myogenesis regulating
genes, MHC4, and IGF-1 was not associated with increasing muscle mass manifested by myotubes
number, diameter, length, and number of nuclei per myotube. Persistent increase in ISR expression

168

(P<0.05) but not in GLUT-4 (P>0.05) was detected in offspring at age 1 and 21 days. An increase
in the transcripts of PPARγ an AP2 but not C/EBPα (P<0.05) were observed at day 1. The three
key regulators of basal adipogenesis were up-regulated in weaned mice (P<0.05). Up-regulation
of PPARγ, AP2, and C/EBPα levels were accompanied by increasing intramuscular fat
accumulation in day 1 and 21 samples. Considerable increase in the transcripts of genes regulating
lipid catabolism and thermogenesis in liver including Cpt1α, Ehhadh, Mcad, Lcad, Acadvl,
slc22a5, slc25a20, and Pparα (P<0.05) was noticed in FA group after 21 day of treatment; whereas,
only the transcripts of Cpt1α and Ehhadh increased in day1 neonates ‘ livers . Similarly, genes
regulating lipolysis (ATGL and HSL, MGL and LPL) were up-regulated at day 21 of treatment in
FA group (P<0.05) while EPA/ DHA maternal intake has no effect on the expression of lipogenesis
regulating genes (Fasn and Srebp1c) (P>0.05) in day 1 and 21 offspring. EPA/ DHA treatment
promoted BAT development and activity through increasing the expression of BAT signature
genes including (UCP1, Cidea, Prdm16, Pgc1α, Dio2, Zic1, Fgf21, P2rx5, and PPARα (P<0.05).
Also, maternal intake of EPA/ DHA enriched diet enhanced browning of sWAT by stimulating
the expression of beige markers such as UCP1, Shox2, Tmem26, and PAT2 and thermogenesis
regulating genes ( PPARα, PGC1α, Cox7α1,and Cox8β) (P<0.05). Taken together, maternal
ingestion of EPA/ DHA may be suggested as a therapeutic option to encounter many
pathophysiological disorders mainly childhood obesity and confer long-lasting metabolic benefits
on offspring.
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5.2. Introuction
A positive correlation has been suggested between offspring’s health and development
from one side and dietary habit and environmental conditions of mothers from the other side
(Mennitti et al., 2015, Elahi et al., 2009). The quantity and quality of diet consumed by the mothers
especially at two critical periods including pregnancy and lactation is of a great importance for
offspring’s life. The risk of producing fetuses with bad health quality can be potentiated when
pregnant mothers fail to meet the minimum requirements of essential food elements such as
vitamins, minerals, fatty acids, and amino acids during pregnancy and lactation and vice versa
(Mennitti et al., 2015). Obesity, imbalance of energy uptake and expenditure, is a threat leading
factor for both mothers and newborns. Obeseity risk in mother increases in intensity once
developed during prenatal stage of pregnancy (Schmatz et al., 2010; Marshall and Spong, 2012).
Also, the progression of fetal development hits the peak at prenatal stage, so maternal obesity is
considered a big threat at this time point (Catalano and Ehrenberg, 2006; Poston, 2012; Menting
et al., 2018). Offspring born from obese women are more likely on the risk of developing many
long and short-term pathophysiological disorders such as asthma, adult metabolic syndrome and
obesity, and impaired neuronal development (Segovia et al., 2014; Catalano and Ehrenberg, 2006).
Given the continuous increase in the overall number of obese women at reproductive age where
more than 60% of them have been identified as overweighed recently (Yang and Colditz, 2015),
an effective gestational strategies should be launched to protect offspring from multitude of
metabolic disorders urged by maternal obesity. Anticipating that dietary intervention is most likely
the less harmful approach that can be used to modulate energy balance and adiposity compared to
using pharmacological intervention and its related side effects (Santulli and Iaccarino, 2016).
Food-derived components known to be involved in enhancing energy expenditure and weight loss
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regulating pathways can be assumed as options to combat current widespread childhood obesity.
Series of studies have asserted that fatty acids are an essential components of maternal diet because
of their direct effect on the molecular machinery regulating fetal tissues development and
differentiation (Mennitti et al., 2018; Hoile et al., 2013; Kelsall et al., 2012). Polyunsaturated fatty
acids mainly long-chain derivatives (LC-PUFA) are an important partition of diet that are essential
in synthesizing the lipid bilayer of cell membrane and many biologically active compounds
orchestrating various body functions. Many studies have emphasized the disability of fetus and
infant to catalyze critical chemical reactions requisite for synthesizing these LC-PUFA. Thus, LCPUFAs or their precursors should be supplied in sufficient amount in maternal diet to compensate
insufficiency. Based on previous observations, fetal energy balance and many other cell signaling
pathways can be considerably influenced by the quality and relative proportion of the different
LC-PUFAs supplemented in maternal diet, resulting in subsequent development of certain
metabolic modifications in offspring (Mennitti et al., 2018; Kelsall et al., 2012; Ducheix et., 2013).
For instances, it has been demonstrated that increasing the ratio of n6: n3 FAs is implicated in
compromising the normal development of fetus and promoting the incidence of inflammation and
other metabolic disorders. (Segovia et al., 2014; Simopoulos, 2016; Muhlhausler et al., 2011). In
this context, increasing the consumption of n-6 UFAs enriched diet especially at the mid of
gestation has been identified as the main reason behind the born of premature offspring (Meher et
al., 2016) or offspring with high body mass index (BMI) (Vidakovic et al., 2016). On the other
hand, Omega-3 FAs are highly suggested during pregnancy particularly during the third trimester
because of their great importance in promoting placental function, growth progression, and
neuronal development (Greenberg et al., 2008; Chavan-Gautam et al., 2018). Wide range of health
threating disorders have been recently revealed to be battled by increasing diet content of fish oil
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mainly EPA and DHA. In relation to that, EPA and DHA supplementation has been approved to
reduce the risk of inflammation and hyperlipidemia (Yokoyama et al., 2007), autoimmune and
cardiovascular disease (Casula et al., 2013), diabetes (Kim et al., 2015), and high fat diet induced
obesity and insulin resistance in mice (Pahlavani et al., 2017). Moreover, the effectiveness of EPA
and DHA in stimulating the activity and underling mechanisms regulating thermogenic capacity
of brown adipocytes have been disclosed by several studies (Okla et al., 2017; Pahlavani et al.,
2017; Kim et al., 2016; Bargut et al., 2016; Zhao and Chen, 2014). Regarding its role in combating
childhood obesity, EPA and DHA intake exhibited promising results upon having been tested in
several clinical trials in human (Vidakovic et al., 2016; Donahue et al., 2011; Moon et al., 2013;
Foster et al., 2017). In accordance with these results, it is conceivable that maternal diet enriched
with EPA and DHA could promote prenatal resistance to epidemic childhood obesity. Therefore,
studying the metabolic sequels of maternal EPA and DHA intervention with fetal and postnatal
development and energy handling has become of critical need. However, despite the wellestablished physiological roles of EPA and DHA in aforementioned metabolic benefits, many
studies including our previous studies have asserted that EPA/DHA supplementation promoted
myoblast trans-differentiation into adipocytes and increased intramuscular lipid infiltration that
may lead to developing insulin resistance and muscle atrophy (Ghnaimawi et al., 2019; Hsueh et
al., 2018; Peng et al., 2012; Zhang et al., 2019, Lacham-Kaplan et al., 2020). However, all the
studies describing the role of EPA and DHA in enhancing the potential trans-differentiation of
myoblasts into adipocytes have been conducted in vitro models or on isolated cells from muscle
tissue; whereas, information about their impact on fetal and offspring’s muscle development and
metabolism in the early stages of gestation (the onset of myogenesis process) or during both
gestation and lactation is still little or completely missed. Furthermore, accumulative evidences,
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both in vivo and in vitro, have been provided to affirm the beneficial roles of EPA and DHA in
promoting the thermogenic capacity of brown adipocytes and enhancing white to brown
adipogenesis in adults (Bargut et al., 2016a; Pahlavani et al., 2017; Worsch et al., 2018, Bargut et
al., 2019; Quesada-Lopez et al., 2016, Ghandour et al., 2018), but their effects on regulating energy
balance in offspring still need to be investigated. Thus, the objective of this study is to elucidate
the effect of maternal EPA and DHA supplementation on fetal and offspring’s muscle tissue
development and potential metabolic alterations.The study aims at (1) investigating the effect of
maternal EPA and DHA enriched diet on muscle development and metabolism at three time points
including day 13 of gestation, postnatal (day 1), and post-weaning (day 21) (2) investigating the
effect of maternal EPA and DHA on adipogenesis process and intramuscular lipid accumulation
(3) investigating the effect of maternal EPA and DHA on energy handling and its relevance to
body weight and fat distribution in weaned mice by studying lipid metabolism regulation in liver,
brown adipose tissue activity and development, potential browning of sub-cutaneous fat, and the
growth of visceral fat. Anticipating their high affinity to bind and activate PPARs members,
ubiquitously expressed specially in tissues involved in energy handling, we hypothesize that EPA
and DHA can promote energy dissipation via activating BAT activity and browning of
subcutaneous fat and enhancing lipid metabolism in offspring’s liver . However, it may increase
intramuscular fat accretion through direct effect on genes regulating basal adipogenesis.
5.3. Material and methods
5.3.1. Animals
Animals’ handling and care in this study were approved by Institutional Animal Care &
Use Committee (IACUC) in University of Arkansas (Protocol # is 19057R). Forty female, 4-6
weeks old, and forty male C57BL/6J mice obtained from Jackson Laboratory were housed for two
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weeks under constant conditions of temperature and humidity for acclimatization. The mice were
exposed to unchanged cycle of 12 hours of light and darkness and had an access to food and water
ad libitum. Mice were checked daily for estrus cycle, and females identified with typical signs of
estrus were housed individually with males for breeding. Once the vaginal plug was observed,
females were separated and assigned for one of two type of diets. Animals were fed 3.05% fish oil
diet enriched with EPA and DHA (FA) (TD.190782) or control diet (CON), replacing the fish oil
with soybean oil (TD.160647, Envigo Madison, Wisconsin USA, www.envigo.com). The mice
from different groups were maintained on their respective diet throughout the periods of gestation
and lactation. Diets composition are explained in (Table 5-2). Twenty female were euthanized at
day13 of gestation and two fetuses from each mother were randomly selected for gene expression.
Due to the small size of embryos at day13 of gestation, the whole body of each fetus was collected
after removing the head. The other twenty mice were allowed to give birth. On day 1 postpartum,
pups were euthanized by CO2 inhalation after being weighted. The average number of pups per
litter was seven, and only three pups from each litter was selected randomly to be assessed for
different parameters. At this time point (day1), livers and all muscles of the thigh were sampled
after removing the skin because of the complexity of isolating fetal hand limb muscles and the
insufficiency of individual muscle for RNA and protein extraction. The number of birth and body
weights of pups were recorded where the parameters of all the pups per litter were considered in
this experiment, and the results of each litter were used for statistical analysis. On the 21st day
postpartum, the weaned mice were euthanized using CO2 inhalation and samples from vastus
lateralis muscle, gastrocnemius muscle, Subcutaneous WAT, visceral WAT, and brown adipose
tissue were dissected and frozen in liquid nitrogen for gene expression and western blots analysis.
Some of the peri-renal fat, tibialis anterior muscles, Subcutaneous WAT, and visceral WAT were
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collected and fixed in formalin 4% for histology. Twenty pups, selected randomly, one from each
litter, were used for different assessments.
5.3.2. RNA extraction and cDNA synthesis
RNA was isolated from liquid nitrogen frozen samples using the RNeasy Mini Kit (Qiagen
Ltd., UK) and Direct-zol™ RNA Miniprep Plus. Nanodrop 2000 (Thermo Scientific) was used to
measure the concentration and purity of extracted RNA where 260/280 (1.8-2.0) and 260/230 ratio
(≥2) were considered as indicators of high quality RNA. cDNA was synthesized using an iScript™
reverse transcription Supermix kit (Bio-Rad, Richmond, CA) and the reaction condition was set in
accordance with the manufacturer instructions. Gene expression was conducted using CFX
Connect Real-Time PCR Detection System (Bio-Rad, Richmond, CA). Relative gene expressions
were determined using the comparative Ct method and the data of each target gene was normalized
to 18s values in the same sample. The set of primers used in this experiment are explained in
(Table 5-1).
5.3.3. Western blot assay
Samples were prepared for protein extraction by homogenizing ~100mg of frozen tissues
with MagNA lyser green beads in lysis buffer composed of a mixture of T-PER (Sigma-Aldrich,
St. Louis, Missouri United States) and protease and phosphatase cocktail inhibiter at ratio of 100:1.
The homogenized tissue lysate was transferred into 1.5 tubes and centrifuged at 13,000 g for 20
minutes. Thereafter, the supernatant containing total proteins was gently aspirated into new
centrifuged tubes. The Pierce™ BCA Protein Assay Kit (Sigma-Aldrich, St. Louis, Missouri United
States) was used to determine the concentration of total protein by following the instructions from
manufacturer. Gel electrophoresis was performed by loading 40µg protein from all samples (control
and treatment) into the wells of Mini-PROTEAN precast gels (Bio-Rad). Then, the protein was
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transferred on the membrane using Trans-Blot ® Turbo™ Mini PVDF Transfer Packs (Bio-Rad).
The membrane was blocked for one hour in 5 % blocking solution (dry milk or/and BSA) at room
temperature with gentle shaking. After being washed three times with 1X TBST buffer, membrane
was incubated overnight with specific primary Abs including:[GAPDH (1:1000, Cell Signaling),
myogenic differentiation 1 (MyoD1) (1:1000, Abcam), MyoG (1:2000, Abcam), PGC1α (1:1000,
Cell Signaling), P-mTOR (1:1000, Cell Signaling) , P-p70s6 kinase (1:1000, Cell Signaling),
CPT1α (1:1000, cusabio), P-HSL (1:1000, Abcam),UCP1 (1:1000, Abcam), and PRDM16 (1:1000,
Abcam) ] . Then, the membrane was incubated with HPR conjugated secondary antibody diluted to
(1:5000) for 1 h at room temperature. ECL immunoblotting clarity system (Bio-Rad) was used to
visualize the bands, detected under ChemiDoc TM Touch imaging system (Bio-Rad, California,
USA). Band density was analyzed using Image Lab software (Bio-Rad, California, USA) and
normalized according to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) content (Iwase
et al., 2020).
5.3.4. Histology
The whole muscles of the thigh of new born pups (day 1) and the tibialis anterior from
weaned mice (D 21) were collected and stored in 4 % paraformaldehyde for subsequent
hematoxylin - eosin (H&E) and oil red O staining. Samples stained with hematoxylin and eosin
(H&E) were used to determine the number of nuclei per myotube, myotubes’ length, and
myotubes’ number and thickness. Further, sections stained with oil red O were used to evaluate
intramuscular lipid accumulation. Peri-renal fat pads collected from weaned mice were maintained
in 4 % paraformaldehyde and stained with hematoxylin and eosin (H&E) to be used in determining
adipocyte sizes and numbers. Subcutaneous samples were maintained in 4 % paraformaldehyde
and stained with hematoxylin and eosin (H&E) to examine the potential browning of white
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adipocytes. Eight samples were used in each group and eight sections randomly selected from each
image were used for analysis. The image analyzing software, image J (Fiji-win32), was used to
analyze all the data. Intramuscular lipid accumulation was identified as a bright red areas located
in the sarcoplasm of the fibers and/or in endomysium (between fibers). Zeiss Imager M2
microscope and digital camera (Axiocam 105 color)” was used for taking images.
5.3.5. Hematoxylin and Eosin staining
Samples were kept in 10% buffered formalin solution until time of processing. Tissue
samples were sliced into 2-3 pieces and placed in VWR brand Monosette IV cassettes (Missouri,
USA). Tissues were fixed overnight using a Lipshaw Model 2500 automated processor (Thermo
Scientific, Waltham AM). The tissue samples were rinsed in 70%, 80%, 85%, 95% (2x) and 100%
(2x) alcohol followed by two rinses in toluene and two paraffin baths. The following morning,
tissue samples were removed from the Lipshaw 2500 and embedded in liquid paraffin. After
setting up, the paraffin blocks were removed from the forms and placed in a 5FΟ freezer overnight.
Samples were removed from the freezer, one at a time, and cut into ~2nm slices using a Lipshaw
manual rotary microtome and placed on VWR Superfrost Plus microscope slides. Tissues were
placed in a Lipshaw slide dryer overnight. Paraffin was removed from the tissue samples with 2
toluene rinses followed by 100% (2x), 95% (2x) and tap water rinse before being stained with
VWR Harris Hematoxylin solution for 15 min. After rinsing, samples were dipped in an acid
alcohol solution 4 times before being rehydrated in dd H2O for 15 min. After rehydrating, they
were submerged in Harleco brand staining blueing solution for 30 seconds, followed by 2 minutes
in Eosin Y solution. Samples were then rinsed in alcohol 4 times and toluene 4 times. After the
final toluene rinse, cover slips were fixed using Thermo Scientific Xylene Substitute Mountant
and left to dry overnight (Hiroyasu et al., 2020).
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5.3.6. Oil red O staining
Oil red O staining was conducted according to (Luna, 1992). Briefly, 0.5 gm oil red O was
gradually dissolved in 100 ml absolute propylene glycol ( 100%) to prepare working solution (0.5
%). Large undissolved pieces were allowed to melt progressively by periodic stirring. The mixture
was, thereafter, heated on hot plate with gentle stirring, taking in account the gradual increase of
temperature till reaching 95CΟ as a maximum without exceeding the 100 CΟ. Before getting cold,
the solution was filtered directly with rough filter paper. Then, the leached solution was collected
in conical 50 ml tube and let stand at room temperature overnight followed by vacuum filtration
using Seitz filter with the coarse surface facing up. Muscle samples were preserved in 10%
buffered formalin prior to paraffin embedding. Paraffin samples were prepared following the same
steps outlined in H&E protocol. Paraffin embedded tissue sections were cut approximately 10 um
thick and mounted on slides. The following day, paraffin was removed from tissue samples with
2 changes xylene (2minutes each) followed by 100% ethanol (2 changes / 2minutes each ), 95%
reagent alcohol(2 changes / 2minutes each) and tap water rinse (1 time/ 1 min). The slides were
then placed in Oil Red O working solution (0.5 %,) for 24 hours. Thereafter, they were immersed
in 85% propylene glycol for 1 min with gentle agitation. Later, the slides were rinsed in distilled
water (2 changes/2minutes each), followed by incubation with Mayer’s hematoxylin for 5 minutes.
Afterwards, the slides were rinsed under tap water for 10 minutes. Finally, Shandon Xylene
Subsitute Mountant (Thermo Scientific, Waltham, MA) was used to mount coverglass.
5.3.7. Statistical analysis
All data from assays used to compare CON and EPA/ DHA treated groups were assessed
for significance by the unpaired Student’s t-test with the assumption of equal variances, and
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arithmetic means ± SEM are reported. P<0.05, 0.001, and 0.0001 was considered statistically
significant.
5.4. Results
5.4.1. Birth outcomes and tissue weights
Our results showed that the number of births and body weight of pups at day 1 were not
affected by EPA /DHA treatment (P = 0.413476 and 0.252995 respectively) (Figure 5-1).
Similarly, although it was not significantly different, EPA /DHA treated group exhibited a
tendency toward decrease body weight (9.36 ± 0.45 g) when compared to control group at weaning
(day 21) (10.48± 0.53 g) (P = 0.062). In line with that, no significant differences were detected in
the ratios of different fat depots including S-FAT, V-fat, and BAT (P=0.08897, 0.078182,
0.218379 respectively) among weaned pups coming from mothers fed control or EPA and DHA
enriched diet (Figure 5- 2).
5.4.2. Day 13 of gestation
5.4.2.1. Effect of EPA and DHA treatment on genes regulating myogenesis, muscle
contractile proteins, muscle protein synthesis, and adipogenesis
The results exhibited non-significant differences between control and EPA/DHA treated
groups in expression level of genes regulation myogenesis process including MyoD1, MyoG,
Myf5, MRF4, and β-catenin (P= 0.083881, 0.09182, 0.49113, 0.312692, and 0.494429
respectively). Also, the transcripts of genes encoding the main muscle structural proteins including
myosin heavy chain-4 (MHC4) and α-actin were comparable between control and EPA/DHA
treated groups ( P= 0.448238 and 0.201322 respectively). Moreover, non-significant differences
were observed in expression levels of genes regulating muscle protein synthesis and glucose
metabolism, including mammalian target of rapamycin (mTOR), muscle ring finger 1 (MURF1),
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insulin-like growth factor 2 (IGF-2), F-box only protein 32 (Atrogin-1), insulin-like growth factor
1 (IGF-1), Insulin receptor (INSR), and glucose transporter-4 (P= 0.26, 0.25, 0.067, 0.13, 0.23,
0.399, and 0.29 respectively). Further, no significant differences were observed in the expression
level of adipogenesis regulating genes including PPARγ, CEBPα, and AP2 between control and
EPA/DHA treated groups at this time point (P= 0.339223, 0.334623, and 0.48406 respectively)
(Figure 3).
5.4.3. Day 1 neonates
5.4.3.1. Effect of EPA and DHA treatment on genes regulating myogenesis, muscle
contractile proteins and muscle protein synthesis
The results exhibited a considerable increase in the expression level of genes regulation
myogenesis process including MyoD1, MyoG ,and MRF4 in EPA/DHA treated group when
compared to control (220 ± 81.7% P= 0.019004 , 115 ± 59.6% P= 0.044065, and 221 ± 98.5% P=
0.025263 respectively). However, no significant difference was observed in MyoG protein level
between differentially treated groups. Also, the transcript of gene encoding MHC4 but not α-actin
was significantly higher in EPA/DHA treated groups upon comparison to control group (102 ±
54.6% P= 0.050957, P= 0.427226 respectively). Additionally, our findings revealed a considerable
increase in the expression level of IGF-1 in EPA/DHA treated group when compared to control
group (126 ± 68.5% P= 0.018595). However, the results of other genes regulating protein synthesis
such as mTOR, MURF1, IGF-2, and Atrogin-1 were comparable between variously treated groups
(P= 0.276066, 0.261989, 0.193612, and 0.137308 respectively). Also, a significant increase in the
expression level of gene encoding insulin receptor (INSR) was detected in EPA/DHA treated
group in comparison to control group (65± 29.3% P= 0.037078). However, no significant
difference was observed in EPA/DHA treated groups in expression level of GLUT-4 (P
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=0.135904). The results may be an indicator of a positive correlation between EPA and DHA
supplementation and muscle insulin sensitivity (Figure 4).
5.4.3.2. Effect of EPA and DHA treatment on myotube formation
The histological analysis of muscle tissue exhibited non-significant differences in the
number of muscle fibers , diameter of fibers, length of fibers, and number of nuclei per fiber
between control and EPA/DHA treated groups in neonates aged 1 day ( P= 0.399, 0.091, 0.309691,
and 0.134535 respectively ) (Figure 5). The results were inconsistent with those obtained from
gene expression indicating that maternal EPA/DHA intake has no effect on muscle tissue mass
and growth in offspring.
5.4.3.3. Effect of EPA and DHA treatment on intramuscular fat accumulation
EPA/DHA treatment considerably enhanced the expression levels of adipogenesis
regulating genes. In this context, the expression levels of PPARγ and AP2 were by far much higher
in EPA/DHA treated group when compared to control group (173 ± 86.4% P= 0.04064, 187±
56.3% P= 0.004606 respectively). However, the expression level of CEBPα was not significantly
different between control and group of treatment (P= 0.393167). In line with that, Oil red O stained
sections showed a dramatic increase in ectopic intramuscular accumulation of lipid in EPA and
DHA treated group in comparison to control group in neonates ( at day 1). The results of histology
were consistent with PCR results referring to the adipogenic role of EPA and DHA. (Figure 6).
5.4.3.4. Effect of EPA and DHA treatment on genes involved in lipid metabolism regulation
in liver
Obvious partial increase in the expression level of genes regulating fatty acid uptake and
β-oxidation such as carnitine acyltransferase I (CPT1α) and Peroxisomal bifunctional enzyme
(Ehhadh ) was observed in EPA/DHA treated group in comparison to control group (191± 56.9%
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P= 0.004253, 595± 89.7% P= 0.00003 respectively). However, the expression level of mediumchain acyl-CoA dehydrogenase (Mcad), acyl-CoA dehydrogenase, long chain (Lcad), very longchain specific acyl-CoA dehydrogenase (Acadvl), mitochondrial carnitine/acylcarnitine carrier
protein (Slc25a20), and Solute carrier family 22 member 5 (SLC22A5) showed a great similarity
between the differentially treated groups (P= 0.464667, 0.219827, 0.396513, 0.413866, and
0.219612 respectively). Moreover, non-significant differences were observed in expression level
of thermogenesis regulating genes including Peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1α) and Peroxisome proliferator-activated receptor alpha (PPARα) (P=
0.409632 and 0.437284 respectively). Our findings also exhibited non-significant differences
between tested groups in genes known to be involved in orchestrating lipid synthesis such as Fatty
acid synthase ( Fasn) and Sterol regulatory element-binding transcription factor 1 (Srebp1c) (P=
0.481307 and 0.315629 respectively). Further, the transcripts of lipolysis regulation genes
including Adipose triglyceride lipase (ATGL), Hormone-sensitive lipase (HSL), and
Monoacylglycerol lipase (MGL) were comparable between EPA/DHA and control treated groups
at this time point (P= 0.200105, 0.34237 , and 0.494122 respectively) (Figure 7).
5.4.4. Day 21 post-parturition (weaning day)
5.4.4.1. Effect of EPA and DHA treatment on genes regulating myogenesis, muscle
contractile proteins and muscle protein synthesis
Non-significant differences between control and EPA/DHA treated groups were observed
in the expression levels of genes regulation myogenesis process including MyoD1, MyoG, and
MRF4 ( P= 0.22122668, 0.26232362, and 0.17121615 respectively ). Similarly, the transcripts
levels of MHC4 and α-actin , genes encoding the main muscle structural proteins were comparable
between control and EPA/DHA treated groups (P= 0.358706 and 0.180359 respectively).
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Moreover, our findings exhibted a considerable increase in the expression level of insulin-like
growth factor 1 (IGF-1) in EPA/DHA treated group upon comparison to control group (62± 18 %
P= 0.01548417). However, the results of other genes regulating protein synthesis such as mTOR,
MURF1, IGF-2, and Atrogin-1 were comparable between the differentially treated groups (P=
0.164394, 0.473528, 0.27987, and 0.27987 respectively). Also, a significant increase in the
expression levels of gene encoding insulin receptor (INSR) was detected in EPA/DHA treated
group in comparison to control group (64 ± 18.9% P= 0.01789307). Further, the expression level
of glucose transporter-4 (GLUT-4) exhibited a tendency toward an increase in EPA/DHA treated
groups in (P= 0.07259825). (Figure 8).
5.4.4.2. Effect of EPA and DHA treatment on myotube formation
The histological analysis of muscle tissue exhibited non-significant differences in the
number of muscle fibers and number of nuclei per fiber between control and EPA/DHA treated
groups in weaned mice (P= 0.22 and 0. 1). However, the results analysis of fibers’ diameter and
length showed a tendency toward a decrease in EPA/DHA treated group (18.89 ± 0.41 µM and
87.8 ± 3.02 µM respectively) when compared to control (19.96 ± 0.31 µM and 100.4 ± 7.8 µM
respectively) (P= 0.074 and 0.096 respectively) (Figure 9).
5.4.4.3. Effect of EPA and DHA treatment on Intramuscular fat accumulation
The results exhibited a significant increase in the expression levels of PPARγ, CEBPα ,
and AP2, genes regulating the basal adipogenesis process in EPA/DHA treated group when
compared to control (P= 169 ± 16.7%, P=0.00001 , 195 ± 29.1% P= 0.00023445, and 203 ± 30.9%
P= 0.00013242 respectively). Correspondingly, a moderated to extensive increase in intramuscular
and sarcoplasmic infiltration of lipid was observed in muscle samples stained with Oil Red O stain
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in group treated with EPA/DHA rich diet throughout the entire period of gestation and lactation
when compared to control group (Figure 10).
5.4.4.4. Effect of EPA and DHA treatment on genes involved in lipid metabolism regulation
in liver
Our data revealed that feeding dams with EPA/DHA for 21 days was sufficient to
significantly increase the expression levels of all the genes involved in regulating the metabolic
machinery in liver represented by β-oxidation and thermogenesis. Considerable increase in the
transcripts of CPT1α, Ehhadh, Mcad, Lcad, Acadvl, Slc22a5, Slc25a20, and PPARα was clearly
observed in EPA/DHA treated group compared to control ; whereas, the expression of PGC1α
showed tendency toward an increase in maternal EPA/DHA group (165 ± 49.8% P= 0.003204476,
436 ± 78.2% P= 0.00004, 272± 76% P= 0.001566, 133 ± 39.5% P= 0.002697168, 86 ± 24.3% P=
0.006101698, 109 ± 54.2% P= 0.046671763 , 210 ± 81.3% P= 0.011363229, 86 ± 30.2% P=
0.008212401 , and P= 0.069331773 respectively). Our findings exhibted that EPA/DHA has no
effect on fatty acid synthesis in liver even though the treatment was sustained throughout the
lactation period. In this regard, non-significant differences between tested groups in genes
orchestrating lipid synthesis such as Fasn and Srebp1c (P= 0.32 and 0.114996 respectively) were
detected between groups. However, lipolysis regulation genes including: ATGL and HSL, MGL
and LPL (232 ± 46.3% P= 0.0072, 402 ± 57.6% P= 0.00001, 52 ± 21.4% P= 0.048, and 73.5 ±
34.4% P=0.03 respectively) were significantly up-regulated in EPA/DHA treated group. (Figure
11).
5.4.4.5. Effect of EPA and DHA treatment on brown adipogenesis
The mRNA and proteins levels of brown adipose tissue signature genes was measured to
identify the effect of maternal n-3 PUFA supplementation on offspring’s BAT development and
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activity. Significant increase was observed in transcripts of uncoupling protein 1(Ucp1), Cell
death-inducing DNA fragmentation factor α-like effector A (Cidea), PR domain containing 16
(Prdm16), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), Type
II iodothyronine deiodinase (Dio2), Zinc finger protein ZIC 1 (Zic1), Fibroblast growth factor 21
(Fgf21), P2X purinoceptor 5 (p2rx5), and Peroxisome proliferator-activated receptor
alpha (PPARα) in EPA/DHA treated group compared to control (101 ± 42.5% P= 0.03 , 45 ±
23.1% P= 0.04, 55 ± 23% P= 0.02 , 133 ± 50.2% P= 0.01, 141 ± 30.4%, P= 0.002, 114 ± 35.6%
P= 0.004, 182 ± 75.8% P= 0.019 , 172 ± 42.2% P= 0.03, 49 ± 22.3% P= 0.03 respectively). Then,
we assessed the effect of EPA/DHA treatment on genes known to serve as stimulators of BAT
thermogenic capacity. The results revealed an increase in the expression levels of Dio2, and
PGC1α while a tendency toward an increase in the expression levels of Cytochrome c oxidase
polypeptide 7A1 (Cox7α1) and Cytochrome c oxidase subunit 8B (Cox8β) was detected in
EPA/DHA treated group in comparison to control (141 ± 30.4%, P= 0.002, 133 ± 50.2% P= 0.01,
P= 0.076615, and 0.065654 respectively). However, no-significant differences were observed in
expression levels of 3-adrenergic receptor (Adrb1) and 1-adrenergic receptor (Adrb3) between
control and EPA/DHA treated groups (P= 0.117 and 0.22 respectively). (Figure 12).
5.4.4.6. Effect of EPA and DHA treatment on potential browning of sub-cutaneous white
adipose tissue
The response of the mice to EPA/DHA supplementation was confirmed by assessing its
effect on potential browning of sub-cutaneous fat. Beige gene profile was compared between
differentially treated groups. Our analysis indicated a significant increase in the expression levels
of beige specific markers such as UCP1, Short-stature homeobox 2 (Shox2), transmembrane
protein 26 (Tmem26), and Phosphate acetyltransferase (PAT2) and a tendency toward an increase
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in the expression levels of T-box transcription factor 1 (Txb1). (500 ± 92.2% P= 0.0001, 244 ±
60.7%, P= 0.0009, 116 ± 63.6% P= 0.050, 267 ± 43.2% P= 0.00004, and P= 0.09 respectively).
Also, the expression level of genes serving as stimulator of thermogenesis system, including
PGC1α, PPARα, Cox7α1, and Cox8β were remarkably up-regulated in response to EPA/DHA
treatment (311± 95.6% P= 0.003, 414 ± 46.7% P= 0.00002, 393± 56.2% P= 0.00001, and 469
±68.3% P= 0.0001 respectively). (Figure 13).
5.4.4.7. Effect of EPA and DHA treatment on fat pad (peri-renal fat)
The average adipocyte size was reduced in response to EPA/DHA treatment (20.32 ± 0.9
µM) when compared to control (39.76 ± 0.92 µM) (P=0.0001). However, adipocytes number was
comparable between differently treated groups (P= 0.248) indicating that EPA/DHA treatment
reduced adipocytes hypertrophy but has no effect on white adipocyte differentiation (hyperplasia).
(Figure 14).
5.5. Discussion
Anticipating its wide array of health benefits on offspring, maternal n-3 PUFAs intake has
been frequently addressed as an area of investigation by researchers (Egert et al., 2009, Zhao et
al., 2018, Wang et al., 2013b; Tateishi et al., 2009; Basford et al., 2013). An urgent necessity to
ensure the availability of n-3 PUFAs in appropriate amount in maternal diets was highly suggested
(Larque et al., 2006) because of lacking the ability of fetus to synthesize such fatty acids. It was
demonstrated that increasing the level of n-3 PUFAs in the diet of pregnant mothers is an effective
methods to increase the chance of their delivery to fetus via placenta (Ikeda et al., 2017). A notable
usefulness of n-3 PUFAs ingestion especially during pregnancy and early childhood has been
recently demonstrated (Rogers et al., 2013). Using C57BL/6 mice as an animal model, Rogers et
al., 2013 reported a positive correlation between maternal intake of excessive amount of n-3 PUFA
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and weight loss, improving plasma lipid profile, and reducing insulin resistance in 15 weeks
postnatal offspring. However, conducting a comprehensive study investigating the impact of n-3
PUFAs particularly EPA and DHA on fetal muscle development and energy handling is still
missing. Our study has provided valuable information on the effect of maternal intake of EPA and
DHA enriched diet on 1) the process of myogensis and myotubes formation in fetal and postnatal
offspring. 2) Activation of PPARγ and associated intramuscular lipid accumulation 3) regulation
of insulin sensitivity and protein synthesis in neonates and post-weaning offspring at the molecular
and proteomic level 4) development of fetal brown adipose tissue and enhancement of nonshivering thermogenesis 5) potential browning of white adipose tissue 6) regulation of fatty acids
oxidation and synthesis in liver in neonates and post-weaning offspring. Her, we demonstrated that
maternal supplementation of EPA and DHA induced excessive infiltration of intramuscular fat
through up-regulation of PPARγ and other adipogenesis regulatory key genes. However, the
adipogenic effect was not on the expense of myoblasts as having been reported by several ex-vivo
studies (Ghnaimawi et al., 2019; Ghnaimawi et al., 2020; Hsueh et al., 2018; Peng et al., 2012;
Zhang et al., 2019, Lacham-Kaplan et al., 2020) , but it apparently was an activation of PPARγ
that is ectopically expressed in muscle cells. Moreover, invalid association was observed between
EPA and DHA treatment and myotubes formation although it induced transient up-regulation of
myogenesis regulating genes in neonates at day 1 postpartum. The results also revealed that
maternal supplementation of EPA and DHA is of a great importance in up-regulation of genes
regulating muscle glucose metabolism indicating its inverse association to insulin resistance.
However, it has no effect on muscle protein synthesis even the treatment is sustained throughout
the gestation and lactation period. Further, our findings documented the significance of maternal
consumption of EPA and DHA enriched diet in promoting the development of fetal brown adipose
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tissue and thermogenic capacity, enhancing substrate oxidation in liver when it is supplemented
throughout the entire period of gestation and lactation, stimulating browning of sub-cutaneous
white adipose tissue, and reducing adipocytes size but not number. Our findings could be the
corner stone for further clinical trials to explain the beneficial role of maternal intake of n-3 PUFA
particularly EPA and DHA on offspring. Based on our observations, EPA and DHA ingestion
during pregnancy and lactation can be suggested as a therapeutic strategy to combat childhood
obesity. According to Gerrard and Grant 2003, myoblasts, progenitor of skeletal muscle tissue, can
be categorized into three classes including embryonic, fetal, and adult. During the early stage of
pregnancy, the first step of myogenesis, a process of muscle fibers formation, starts with the fusion
of clusters of embryonic myoblasts to form primary myofibers that will subsequently provide the
template for enhancing the differentiation of fetal myoblasts into secondary myofibers (Russell
and Oteruelo, 1981). Secondary myofibers are characterized by its hypersensitivity to the
intervention of dietary-derived components, considered of a vital importance in terms of clinical
trials as secondary myofibers compose the majority of muscle myofibers (Zhu et al. 2004). The
second phase of myogenesis starts at the period from the mid to the end of gestation in which the
proliferation of fetal myoblast occurs at its maximum rate followed by the formation of full mature
myotubes that requires sequential expression of helix-loop-helix transcription factors known as
MRFs including MyF5, MyoD1, MRF4, and MyoG (Berkes and Tapscott, 2005; Braun and
Gautel, 2011).
The effect of EPA/DHA supplementation on the process of myoblasts differentiation and
myotube formation has been frequently addressed in vitro using C2C12 as a representative model
of undifferentiated myoblasts with obvious inconsistency in the results. In relation to that, some
investigations have asserted the supportive effect of n-3PUFA on enhancing muscle strength and
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promoting the differentiation process (Dupont et al., 2019; Rodacki et al., 2012; Magee et al.,
2008; Saini et al., 2017); whereas, others including our previous studies have reported a negative
association between EPA/DHA supplementation and pathways regulating myogenesis and
terminal differentiation of myoblasts into mature myotubes (Ghnaimawi et al., 2019 ; Ghnaimawi
et al., 2020 Hsueh et al., 2018; Peng et al., 2012; Zhang et al., 2019, Lacham-Kaplan et al., 2020).
Nevertheless, no study has been conducted to evaluate the effect of maternal diet enriched with
EPA/DHA on fetal muscle development especially during the prenatal stage when de novo
myogenesis process is initiated and during early postnatal stage when fully mature myofibirs are
formed. Actually, per our knowledge, our study is the first to investigate the association between
maternal intake of EPA/DHA enriched diet throughout the entire period of gestation and lactation
and fetal and offspring’s muscle growth at three different time points, including the mid of
gestation, day 1 post- parturition (neonates), and 3 weeks post-parturition. Our in vivo results were
inconsistent with in vitro studies including our previous ones (Ghnaimawi et al., 2019; Ghnaimawi
et al., 2020; Hsueh et al., 2018; Peng et al., 2012; Zhang et al., 2019, Lacham-Kaplan et al., 2020).
Although it was not significantly different, EPA/DHA treated group exhibited a decrease in the
expression levels of myogenesis regulatory transcription factors such as MyoD1 and MyoG at day
13 of gestation (Figure5-3). However, EPA/DHA induced transient up-regulation of the
expression levels of, MtoD1, MRF4, MyoG, and MHC4 in day 1 newborn pups (Figure 5-4) but
not in weaned mice (Figure 5- 8) without any change in fibers’ number, fibers’ diameter, fibers’
length, and the number of nuclei per tubes (Figure5-5). The reason behind missing the
correspondence between in vivo and in vitro trials can be attributed to one fact that is the proposed
inhibitory effect of maternal EPA/DHA on myogenesis and myotube formation might be
antagonized by the high concentration of the reproductive hormones, mainly, 17β-estradiol (E2)
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during pregnancy. E2 is a well-known strong stimulatory factor of myoblast differentiation and
subsequent formation of full mature muscle fibers (Berio et al., 2017; Galluzzo, et al., 2009;
Murray et al., 2011, Lacham-Kaplan et al., 2020). Given that E2 plasma level during pregnancy is
100 times higher than EPA/ DHA (Berkane et al, 2017; Schock et al., 2016) and n-3PUFA
circulating level is 10 times less (Kawabata et al., 2017), we think that the inhibitory effect of EPA/
DHA on myotube formation was overturned as a result of the considerable reduction in EPA/ DHA
to E2 ratio during pregnancy. The transient postnatal increased in the expression of MRFs genes,
MHC4, and IGF-1 in EPA/DHA treated group observed in our study can be strongly linked to the
stimulatory effect of E2 on the genes involved in regulating myotubes formation and enhancement
of muscle contractile proteins production. Also, it may be a compensatory response to cope with
the negative intervention of EPA/DHA against myogenesis during prenatal stage (day 13 of
gestation) and associated tendency toward decrease the expression levels of MyoD1 and MyoG
observed in this report. In accordance with that, the process of postnatal fully compensation of
compromised muscle growth in response to maternal nutrient restriction or other inhibitory factors
have been frequently addressed in human and animal trials (Jimenez-Chillaron & Patti 2007;
Tudehope et al. 2013)
Maintaining muscle mass is an important process, massively influenced by balancing the
rate of muscle protein synthesis and degradation. Factors stimulating protein synthesis or blunting
protein degradation ultimately lead to muscle hypertrophy (Phillips et al., 1997). In contrast,
skeletal muscle atrophy is apparently the outcome of muscle injury-induced catabolism of muscle
proteins (Bodine, 2013). N-3 PUFAs is a kind of food-derived components strongly tied with
improving skeletal muscle performance and metabolism (Smith et al., 2015, Rodacki et al., 2011).
A well-established positive role of omega-3 in suppressing muscle loss in young and old aged
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individuals has been demonstrated by numerous studies (Ryan et al., 2009; You et al., 2010;
Alexander 1986). The proposed anabolic effect of N-3 PUFAs mainly EPA and DHA is prompted
through increasing the activity of target of rapamycin regulatory protein (mTOR). EPA/DHA
mediated mTOR phosphorylation enhances the activation of downstream signaling target P70S6K1, followed by promoting protein synthesis and muscle fibers’ hypertrophy (Baar, and Esser
1999, Drummond et al., 2009). This pathway is the main regulatory route of muscle protein
synthesis. An in vitro study reported an independent role for EPA and DHA in stimulating muscle
protein synthesis. Although both increase the activity of P70-S6K1 cascade, EPA but not DHA
was only able to increase protein synthesis by 25% in comparison to control referring to the
possible regulation of this process by another pathway (Kamolrat and Gray, 2013). On the other
hand, the anti-catabolic effect of N-3 PUFAs is mediated by the inactivation of NF-κB pathway
(Magee et al., 2012) via preventing its translocation to the nucleus and subsequent stimulation of
(MURF-1) (Huang et al., 2011) that is well-known ubiquitin protease involved in enhancing
muscle atrophy through ubiquitination of muscle proteins (Bodine et al., 2001; Baehr et al., 2011).
Also, it was reported that EPA and DHA are affective factors in up-regulating the expression of
IGF-1, well known muscle protein synthesis-related anabolic factor (Wei et al., 2013). However,
the underling mechanism is still unrevealed. Our study could be the first addressing the effect of
maternal diet enriched with EPA/DHA on genes profile relevant to protein synthesis or degradation
in postnatal and weaned offspring. Although IGF-1 was significantly up-regulated in EPA/DHA
treated group in comparison to control at day 1 and 21 post-parturition, no change in muscle mass
was observed. In other words, fish oil treatment did not confer neither hypergenesic nor
hypertrophic privileges on muscle cells. Also EPA/DHA treatment has no effect on genes
orchestrating muscle protein synthesis and degradation. Our results are consistent with other
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studies in which the basal rate of muscle protein synthesis was not effected by omega-3
supplementation (Smith et al., 2011a; Smith et al., 2011b; Da Boit et al., 2017, McGlory et al.,
2016). The divergence in the results can be underpinned by one truth that is omega-3
supplementation alone may not be sufficient to stimulate muscle protein synthesis. However, it
can considerably potentiate the effectiveness of protein synthesis stimulated by dietary
interventions such as in case of hyperinsulemia and hyper aminoacidemia. In line with such
hypothesis, Tipton, et al., 1999, Smith et al., 2011a , and Smith et al 2011b have reported that
combined supplementation of omega-3 (1.86 g EPA, 1.5 g DHA/day) and amino acids for 8-week
was notably helpful in enhancing the expansion of muscle mass
Muscle tissue gains a critical metabolic importance, in addition to its main function in
controlling movement, which is the participation in regulating glucose homeostasis inside the
body. Anticipating its role in clearing the majority of postprandial glucose, impairing muscle
efficiency in handling glucose overload is implicated in developing insulin resistance and related
type 2 diabetes (T2D) (Meyer et al., 2002, Thiebaud et al., 1982). Many pathophysiological
disorders accompany T2D in muscle tissue, encompassing lacking the ability of glucose uptake,
impairing glycogenesis, inhibiting substrate oxidation, and increasing intramuscular lipid
accumulation (Damsbo et al., 1991, Cline et al., 1999). Glucose uptake in skeletal muscle is
regulated by enhancing the translocation of glucose transporters -4(GLUT-4) to the membrane, the
process that is compromised in patients with insulin resistance although the transcriptional and
proteomic levels of Glut-4 are not affected (Pedersen et al., 1999; Ryder et al., 2000). Our data
indicated a promising role for EPA/DHA in reducing the potential incidence of insulin resistance
in offspring by up-regulation the expression level of genes involved in orchestrating glucose
metabolism such as insulin receptor (ISR) and IGF-1 but not Glut-4 in muscle samples culled at
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day 1 and 21 post-parturition (Figure 5-4 and 5-6 respectively). Our findings are consistent with
other meta-analysis studies that have found a positive association between n-3 PUFAs intervention
and improving muscle glucose metabolism and insulin sensitivity (Lanza et al., 2013; Wu et al.,
2012; Akinkuolie et al., 2011; Albert et al., 2014). According to Lanza et al., 2013, a significant
increase in the expression levels of ISR and GLUT-4 were detected upon the addition of omega-3
to high fat diet in mice. Another studies also have showed an increase in GLUT-4 expression only
at the transcriptome level without providing further information about the protein level in response
to omega-3 treatment (Figueras et al., 2011; Vaughan et al., 2012). However, no effect of omega3 on GLUT-4 expression level was observed in study conducted by (Le Foll et al., 2007).
Moreover, DHA was identified as a beneficial factor in improving insulin sensitivity by enhancing
glucose uptake through blunting palmitate mediated PKB inactivation, well known key player in
insulin pathway (Capel et al., 2015). EPA, on the other hand, may participate in decreasing the
risk of developing insulin resistance by targeting accumulated free fatty acid in muscle toward
triglyceride synthesis instead of being converted into deleterious lipid intermediaries known as
strong negative regulators of insulin sensitivity (Barber et al., 2013).
Our results also show a dominant increase in the expression levels of adipogenesis
regulating genes including PPARγ AP2, and CEBP/α at day 1 and 21 with moderate to
considerable infiltration of intramuscular fat in mice born from mothers fed fish oil enriched with
EPA and DHA ((Figure 5-6 and 5-10 respectively). It is apparent that intramuscular fat
accumulation observed in this animal model is mediated by stimulating the expression of key
regulators of the basal adipogenesis process at the molecular level. EPA/ DHA and eicosanoids
are well known activators of PPARγ, the master gene involved in adipogenesis regulation
(Tontonoz et al., 1998; Rosen et al., 2000, Dammone et al., 2018). It has been mentioned that up-
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regulating the expression of PPARγ is indispensable for the successful committing of Preadipocytes into mature adipocytes with full capacity of triglyceride synthesis and lipid storage
(Feige et al., 2006; Spiegelman, 1998; Tontonoz and Spiegelman, 1998). Moreover, enhancement
of fatty acid uptake and utilization in triglyceride synthesis and lipid droplets formation in vitro
requires increasing the expression of PPARγ and CEBP/α (Hu et al., 1995, Hu et al., 2012). The
established role of these transcriptional factors in promoting intramuscular lipid accumulation
observed in our study is consistent with other accumulative studies. An attempt to identify the
regulatory pathways associated with developing myosteatosis, a phenomena of increasing
intramuscular lipid overload, in some metabolic disorders such as obesity and diabetes
demonstrated the implication of such transcptional factors as PPARγ AP2, and CEBP/α in the
process (Ji-Ming et al., 2001). PPARγ and CEBP/α interact with the expression of several enzymes
critical in regulating many cell signaling pathways essential in orchestrating lipid homeostasis
inside the body such as lipid uptake, fatty acid synthesis, and lipolysis. These enzymes are
including lipoprotein lipase, hormone sensitive lipase, acetyl CoA carboxylase, fatty acid synthase,
and stearoyl coA desaturase (Ji-Ming et al., 2001; Muoio et al., 2002 ; Gilde and Bilsen, 2003;
Pandey et al., 2011). Overexpression of PPARγ in mice experiencing insulin resistance after longterm treatment with high-fat-diet has been accused with promoting excessive intramuscular lipid
accumulation (Ji-Ming et al., 2001; Chabowski et al., 2012). Further, myosteatosis frequently
observed in patient with colorectal cancer is mainly induced as a sequel of up-regulation the
expression of adipogenesis regulating genes mainly pparγ and CCAAT/enhancer-binding protein
gene family (Marchildon et al., 2015; Almasud et al., 2017). Another proposed mechanism for
increasing intramuscular lipid trapping in association to n-3 PUAF treatment was detected in an in
vitro model in which muscular fatty acid uptake was enhanced as a results of increasing the
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expression level of the transporters GLUT1 and CD36/FAT (fatty acid translocase) in response to
EPA treatment . Concurrently, the results also reported a significant increase of glucose oxidation
(Aas et al., 2006). Intramuscular lipid accumulation is a degenerative process accompanied many
pathophysiological such as sarcopenia dystrophies or rotator cuff tears, and cachexia (Gladstone
et al., 2007; Mankodi et al., 2016; Samagh et al., 2013; Sambasivan et al., 2001). However, it has
been recently demonstrated that ectopic lipid infiltration is a normal physiological process sparkled
once muscle tissue exposed to damaging injury. The process is turned on after immediate muscle
injury and last for few days before being stopped at the terminal stage of muscle repairing
(Lukjanenko et al., 2013; Pagano et al., 2015; Pisani et al., 2010; Wagatsuma, 2007). Lukjanenko
et al., 2013 and Dammone et al., 2018 have Provided an evidences of the vital participation of
PPARγ in regulating the regeneration process. Additionally, it was asserted that glucose disposal
could be improved upon adding omega-3 PUFAs to lipid infused intravenously. An increase of
50% in intra-myocellular lipids accumulation was detected in comparison to control group
referring to the potential investment of injected fatty acids into triglyceride synthesis instead of
being targeted to β-oxidation (Stephens et al., 2014). However, EPA induced incorporation of fatty
acids into triglyceride synthesis was a beneficial, as the findings claimed, in boosting muscle
insulin sensitivity as it prevented the accumulation of deleterious lipid intermediates such as
diacyglycerol and ceramides , well known of their inverse correlation to muscle response to insulin
(Barber et al., 2013). Taken together, we can conclude that EPA and DHA could be classified as
adipogeneic factors capable of turning on a set of genes implicated in starting the adipogenesis
process and enhancement of intramuscular lipid infiltration. Apparently, EPA and DHA exert their
effect through activating the gene PPARγ that is ectopically expressed in muscle tissue. However,
whether these fatty acids work synergistically or independently was not identified in this study. It
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will be exteremly interested to determine the isolated effect of EPA and DHA on fetal muscle
tissue development and myosteatosis. Also, considering the findings of aforementioned studies
linking usefulness of omega-3 in improving insulin sensitivity and muscle regeneration, we think
that EPA/DHA supplementation induced intramuscular lipid overload, detected in this study, could
not be marked as a deleterious process especially because no change in integrity of muscular tissue
was observed. Instead, an increase in glucose metabolism regulating genes was documented. It is
to be suggested that intramuscular accumulation of lipid is a physiological process regulated at the
molecular level and might be switched on and/or off to confer a plasticity on muscle tissue to cope
with surrounding environment.
Given the importance of regulating lipid homeostasis in liver and its close association to
multiple metabolic diseases mainly NAFLD, we investigated the effect of maternal EPA/DHA on
the expression of genes seem to be involved in orchestrating lipolysis, lipogenesis, mitochondrial
function , and thermogenesis in liver. The outcomes of our results can be considered as the
foundation for future research willing to find new therapeutic strategies capable of restricting the
ongoing soaring in liver diseases. NAFLD is widely widespreading worldwide where 10%-35%
have contracted the disease according to Bellentani and Marino, 2009, with the vast majority of
cases having been recorded was in Middle East and South America (Younossi et al., 2016). 18 %
of adult individuals in the U.S.A; obese people contribute to 90 % of them, was stricken by NAFLD
(Younossi et al., 2016) with a notable increase in the sharpness of the disease has been recently
identified based on Estes et al., 2018. Our results detected a considerable increase in the expression
of CPT1α and Ehhadh in EPA/DHA treated group at day1 postparturition without changing the
expression of other genes implicated in regulating mitochondrial fatty acids uptake and β-oxidation
(Figure 5- 7A). Also, no significant differences were observed in the expression of genes
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regulating thermogenesis (Figure 5-7B), lipogenesis, and lipolysis (Figure 5- 7C). However,
EPA/DHA induced up-regulation of fatty acids uptake and mitochondrial β-oxidation regulating
genes in weaned mice (day 21) (Figure 5-11A). Moreover, the expression of thermogenesis
regulation gene PPARα was significantly increased while PGC1α exhibited tendency toward an
increase (Figure 5-11C). Also, a significant increase in lipolysis regulating genes including
ATGL, HSL, and MGL, but not in Srebp1c and FSAN, adipogenesis stimulating genes was
observed in in EPA/DHA treated group (Figure 5-11B). The effect of EPA/DHA enriched diet
observed in our results showed a great similarity with other studies. In this context, Clarke, 2001
reported a positive correlation between EPA/DHA consumption and activation of the transcription
factor PPARα, followed by subsequent stimulation of lipolysis, fatty acid breakdown, and
excessive production of energy in liver tissue. However, this study is partially inconsistent with
our data as it stressed an inhibition in lipogenesis regulating genes in response to EPA/DHA
treatment. The beneficial role of EPA/DHA in promoting lipolysis and β-oxidation and inhibiting
fatty acid synthesis was also highlighted in series of animal studies in ruminants (Bionaz et al.,
2012) and sheep (Coleman et al., 2018a). Moreover, hepatic lipolysis has been revealed to be
positively regulated by dietary n-3 supplementation. PPAR α, a transcription factor predominantly
expressed in liver, was identified to play an established role in downstream regulation of the
expression of many genes well-known to be involved in stimulating peroxisomal and
mitochondrial β-oxidation process in liver (Yoon, 2009) . In line with our findings, Yang et al.,
2020 found an increase in the expression of PPARα, CPT-1α and CPT-2, the key regulators of βoxidation in response to fish oil dietary intervention. Further, EPA/DHA induced suppression of
lipid synthesis, stimulating fatty acid catabolism, and improving mitochondrial dysfunction in
patient with steatosis in liver has been frequently addressed in vivo and in vitro studies (Pachikian
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et al., 2011; Zhang et al., 2011). El-Badry et al., 2007, Scorletti E, Byrne et al., 2013; Da Silva et
al., 2014, on the other hand, have reported a strong association between reducing the dietary
content of n-3 PUFA or increasing the ratio of n-6/n-3 with the incidence of fatty liver. All the
aforementioned experimental evidences have been approved in adults while our findings
demonstrated, for the first time, the same beneficial role of n-3 PUFA in improving liver
parameters in postnatal and weaned offspring. Taken together, EPA/DHA supplementation
throughout the entire period of gestation is not sufficient to promote energy expenditure and
preventing lipid accumulation in liver. Instead, sustained ingestion of EPA/DHA enriched diet
during the period of pregnancy and lactation exhibited a great effectiveness in stimulating
lipolysis, fatty acids uptake and oxidation, thermogenesis and mitochondrial function. In other
words, maternal intake of omega-3 especially EPA/DHA could provide long-term metabolic
benefits and improve lifespan once extended along the period of pregnancy and lactation.
Moreover, it is to be included that maternal EPA/DHA promoted liver lipolysis independent of
affecting the lipogenesis process.
Finall, we investigated the effect of EPA/DHA supplementation on fetal BAT development
and activity and the potential browning of subcutaneous white adipose tissue (sWAT). We found
that maternal ingestion of EPA/DHA during pregnancy and lactation did not significantly
increased BAT mass (Figure 5-2B). However, an increase in the expression and protomeic levels
of master genes regulating brown adipogenesis was observed in EPA/DHA treated group (Figure
12A) indicating the effectiveness of EPA/DHA in potentiating fetal BAT development and activity
when they are supplemented throughout pregnancy and lactation. Moreover, browning of sWAT
(Figure 5-13) without changing adipose tissue mass was observed in response to maternal intake
of EPA/DHA enriched diet throughout the periods of pregnancy and lactation. The beneficial
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effect of EPA/DHA was mediated via increasing the expression of UCP1 and other genes involved
in regulating the thermogenic capacity and mitochondrial biogenesis in subcutaneous fat referring
to the potential reprogramming of sub-cutaneous white adipocytes into beige (or brite) adipocytes.
Based on many previous research, BAT activation is of a great importance in ameliorating the
proposed health risk induced by obesity and other metabolic disorders (Cypess et al., 2012; Cypess
et al., 2015). In this regard, Wang et al., 2015 demonstrated an improvement in insulin response,
lipid homeostasis, and body mass index in association with activating BAT transcriptional profile.
The well-established metabolic roles of BAT tissue can be attributed to its noncoupling respiration
function and associated heat production known as thermogenesis. Brown adipogenesis related heat
production is mainly regulated by uncoupling protein 1 (UCP1) gene, predominantly expressed in
brown adipocytes (Crichton, Lee and Kunji, 2017).
Given that BAT development is initiated early during the prenatal stage (Symonds et al.,
2012), factors propagating fetal BAT activity could be suggested as an effective therapeutic
approach to limit the mounting increase in childhood obesity and confer long-lasting metabolic
benefits on offspring. The observed effect of EPA/DHA on BAT development and activity in our
study is in agreement with Fan et al., 2018 who reported that maintaining the ingestion of n-3
PUFA throughout the pregnancy and lactation was apparently associated with promoting BAT
development and activity. They reported that the mechanism of EPA/DHA enriched fish oilinduced stimulation of browning signature genes and proteins followed by BAT development was
conducted through activating their receptor, GPR120, highly expressed in brown adipocytes.
GPR120 activation, in turn, was correlated with up-regulation the expression of brownadipogenesis regulating clusters of microRNAs, including microRNA 30b, microRNA 193b, and
microRNA 365, indicating that EPA/DHA-mediated BAT activation is a microRNA-dependent
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mechanism. Further, they reported that the transcriptional activation of fetal brown adipocytes
during differentiation was enhanced by histone modification as another mode of action of
EPA/DHA enriched fish oil. In accordance with our results, the stimulatory effect of omega-3 rich
in EPA and DHA on BAT specific genes and thermogenesis regulating genes in adult has been
indicated in accumulative studies (Bargut et al., 2016a; Pahlavani et al., 2017; Worsch et al., 2018,
Bargut et al., 2019; Quesada-Lopez et al., 2016, Ghandour et al., 2018). The Thermogenesis
process of BAT and sWAT can also be regulated by another two genes in addition to UCP1,
including PGC1α and PPARα. PGC1α is the key gene responsible for orchestrating mitochondrial
biogenesis through up-regulation the mRNA of a transcription factor known as nuclear respiratory
factor 1 (NRF1), followed by increasing the expression level of mitochondrial transcription factor
A (TFAM), the main regulator of mitochondrial DNA copy number inside the cell (Nadal-Casellas
et al., 2013; Yu, Zhang et al., 2015; Bargut, Souza-Mello et al., 2017a). The effect of maternal
EPA and DHA enriched diet on PGC1α expression in BAT and sWAT observed in our results
exhibited a great similarity with (Pahlavani et al., 2017, Worsch et al., 2018, Bargut et al., 2019).
PPARα is another ligand of EPA and DHA through which they modulate body metabolism.
PPARα activation has been linked to facilitate the incidence of many benefecial metabolic
activities, encompassing an increase mitochondrial content, fatty acids uptake and substrate
oxidation, and UCP1 expression (Hondares et al., 2011; Barbera, et al., 2001). EPA and DHA rich
treatment mediated up-regulation the expression of PPARα in sWAT and BAT observed in our
study is corresponding to another studies conducted by Huang et al., 2016 , Bargut et al., 2016a,
Bargut et al., 2016b, and Bargut et al., 2019. However, EPA and DHA treated mice exhibted nonsignificant changes in the expression of β-adrenergic receptors (Figure 5-12B) despite of their
well-known importance in regulating the thermogenesis process once activated by exogenous
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stimuli. The results refer to the effectiveness of EPA and DHA intake in improving BAT
thermogenic capacity independent of stimulating β-adrenergic receptors. Our results are
inconsistent with other studies having reported an important role of EPA and DHA rich fish oil in
stimulating the thermogenesis process through upregulation the expression of genes encoding the
synthesis of β-adrenergic receptors (Fan et al., 2018, Ghandour et al., 2018, Kim et al., 2015). We
may conclude that EPA and DHA mediated stimulation of β-adrenergic receptors could be dose
and time dependent. Thus, prolonged exposure to EPA and DHA is requisite to induce Adb1 and
Adb3 activation while maternal intake of fish oil enriched with EPA and DHA throughout the
entire period of gestation and lactation may not be sufficient to successfully carry out such
stimulation. Browning of sWAT can be verified by increasing the expression of UCP1 and other
thermogenesis regulating genes and beige specific markers. Therefore, the expression level of all
these markers were measured in this experiment. We found a considerable increase in the
transcripts of beige specific markers such as UCP1, Shox2, Tmem25, and PAT2; whereas, Txb1
exhibited tendency toward the increase (Figure 5-13A). Further, thermogenesis regulating genes
including PGC1α, PPARα, Cox7α1, and Cox8β were upregulated as well (Figure 5- 13B). It’s
well-known that brown and beige adipocyte share many morphological and genetic characteristics,
the most important one is both cells are enriched with large numbers of mitochondria that
predominantly express the non-shivering respiration regulating gene, UCP1 . The cytoplasm of
both cells are also filled with small multilocular lipid droplets (Scheele and Nielsen, 2017). Many
food-derived components such as fish oil composed mainly of EPA and DHA were highlight as
positive activators of the emergences of beige adipocyte within white adipose tissue (Okla et al.,
2017). In line with our outcomes, the beneficial role of EPA/DHA dietary intervention in
promoting the expression of genes regulating browning of sWAT has been addressed by several
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studies using animal models indicating their participation at least to some degree in countering
high fat induced obesity (Kim et al., 2015; Kim et al., 2016; Bargut et al., 2016a; Bargut et al.,
2016b; Pahlavani et al., 2017). Taken together, EPA/DHA exert the same stimulatory effect on
BAT function and beige adipocyte recruitment upon being supplied in sufficient amount in
maternal diet and in combination with high fat diet ; whereas, the effect could be mediated through
the activation of AMP-activated kinase (AMPK) as a mechanism of action (Lorente-Cebrian et al.,
2009; Abdul-Rahman et al., 2016). However, based on previous evidences, EPA and DHA
exhibited an independency in their effect on brown and beige adipocytes- mediated thermogenesis
enhancement. An increasing the activity of BAT and browning of white adipose tissue were
attributed to the presence of EPA. In this context, it has been demonstrated that EPA is closely
associated with activating the brown adipogenesis process (Kim et al., 2016; Zhao and Chen 2014,
Quesada-Lo’pez et al., 2016); whereas, DHA is not effective neither in enhancing the activity of
BAT (Zhao and Chen, 2014) nor in promoting the process of mitochondrial biogenesis (Pahlavani
et al., 2017). The divergent effect of EPA and DHA was highlight not only on BAT activation but
also on the development of beige adipogenesis. A positive correlation of EPA supplementation
and trans-differentiation of white preadipocytes into brite adipocytes was detected. DHA, in
contrast, has no effect on the potential origination of beige adipocytes from white adipocytes
precursors (Zhao and Chen 2014, Quesada-Lo’pez et al., 2016; Fleckenstein-Elsen et al., 2016).
In accordance with that, the stimulatory effect of EPA and DHA enriched diet on BAT activity
and browning of sWAT might be related to the presence of EPA.
5.6. Conclusion
We conclude that feeding fish oil enriched with EPA and DHA throughout gestation and
lactation is associated with activating PPARγ and downstream basal adipogenesis regulating
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genes, AP2 and C/EBPα, followed by intramuscular accumulation of fat. A transient increase in
the expression of genes regulating myogenesis and myosin heavy chain 4 detected in newborn
mice and the dominant up-regulation of protein synthesis stimulating gene, IGF-1, throughout
gestation and lactation were irrespective of inducing mtotubes hypertrophy or hyperplasia. It is to
be noticed that EPA/DHA supplementation-induced accumulation of fat between muscle fibers
was not relevant to expanding the adipose tissue by inducing myoblast trans-differentiation into
adipobcytes as it has been demonstrated by many in vitro trials. Instead, it was related to the ectopic
activation of PPARγ, the key regulator of adipogenesis. Persistent increase in the expression of
gene encoding ISR production was observed in offspring at the age of day 1 and 21 could be an
indicator of improving muscle glucose metabolism. It is to be suggested that the exposure to
maternal diet containing high ratio of EPA and DHA in comparison to n-6 fatty acids during
pregnancy is sufficient only to induced partial increase in substrate oxidation regulating genes in
livers of day 1 neonates. However EPA and DHA treatment throughout gestation and lactation
showed a great effectiveness in promoting the expression of fatty acids uptake, β-oxidation,
thermogenesis, and lipolysis orchestrating genes independent of changing the lipogenesis process.
Boosting brown adipogenesis transcriptional programme and promoting the potential browning of
sWAT were closely linked to sustain the ingestion of EPA/DHA during pregnancy and lactation.
An increasing the thermogenesis capacity of EPA/DHA treated group was accompanied with
decreasing the weight of weaned mice although it was not significant. Maternal intake of fish oil
has no effect on body weights and number of birth in day 1 newborns.
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Table 5.1: Primer sequences for real-time PCR
Primers
UCP1
PRDM16
MHC
DIO2
IGF1
PGC1α
mTOR
CIDEA
PPARγ
Atrogin-1
18S
COX7a1
COX8b
MuRF1
α-actin
Fasn
CPT1α
LPL
Scd1
Acadvl
Lcad
Mcad
Cpt1a
Slc25a20
ATGL
HSL
MGL
Srebp1c
Ehhadh
Adrb3
Adrb1
Slc22a5
Zic1
FGF21
Ptgs2
Shox2
P2RX5
PAT2
TMEM26
TBX1
MYF 5
MYOD 1
MyoG
MRF4

Forward sequence
TCTCTGCCAGGACAGTACCC
AAGGAGGCCGACTTTGGATG
CGCCCACCTGGAGCGGATGA
CAGTGTGGTGCACGTCTCCAATC
TCCTTATGAATTGGCTTATC
TCCTCTGACCCCAGAGTCAC
GCCCACGCCTGCCATACTTG
TGC TCT TCT GTA TCG CCC AGT
GATGTCTCACAATGCCATCAG
CGTGCACGGCCAACAACC
GTAACCCGTTGAACCCCATT
CAGCGTCATGGTCAGTCTGT
GAA CCA TGA AGC CAA CGA CT
GGCTGCGAATCCCTACTGG
CAGAGCAAGCGAGGTATCC
GCATTCAGAATCGTGGCATA
TATAACAGGTGGTTTGACA
TCTCCTGATGACGCTGATTTTG
GAG GCC TGT ACG GGA TCA TA
CACTCAGGCAGTTCTGGACA
GGA CTC CGG TTC TGC TTC CA
CAA CAC TCG AAA GCG GCT CA
CTCAGTGGGAGCGACTCTTCA
CCGAAACCCATCAGTCCGTTTAA
TTCCCCAAAGAGACGACGTG
CCCTCGGCTGTCAACTTCTT
ACTTCTCCGGCATGGTTCTG
ATC TCC TAG AGC GAG CGT TG
AAAGCTAGTTTGGACCATACGG
GCT GAC TTG GTA GTG GGA CTC
CGT CCG TCG TCT CCT TCT AC
TTGGAGACGAAGGACGGACG
CTGTTGTGGGAGACACGATG
CAAATCCTGGGTGTCAAAGC
CAAGACAGATCATAAGCGAGGA
TGGAACAACTCAACGAGCTGGAGA
TGATAGTTAATGGCAAGGCGG
AGCCACCCCTCTCAATCT
ACCCTGTCATCCCACAGAG
GGCAGGCAGACGAATGTTC
CCTGTCTGGTCCCGAAAGAAC
TCTGGAGCCCTCCTGGCACC
GCAATGCACTGGAGTTCG
GTGGACCCCTACAGCTACAAACC
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Reverse sequence
AGAAGCCACAAACCCTTTGA
TTTGATGCAGCTCTCCTGGG
CTTGCGGTCCTCCTCGGTCTGGT
TGAACCAAAGTTGACCACCAG
GTTTGTCATCTTCCATTCTGTT
CTTGGTTGGCTTTATGAGGAGG
TCAGCTCCGGGTCTTCCTTGTT
GCC GTG TTA AGG AAT CTG CTG
TCAGCAGACTCTGGGTTCAG
CCCGCCAACGTCTCCTCAAT
CCATCCAATCGGTAGTAGCG
AGAAAACCGTGTGGCAGAGA
GCG AAG TTC ACA GTG GTT CC
TGATCTTCTCGTCTTCGTGTTCCT
GTCCCCAGAATCCAACACG
TTGCTGGCACTACAGAATGC
CAGAGGTGCCCAATGATG
TCTCTTGGCTCTGACCTTGTTG
CAG CCG AGC CTT GTA AGT TC
TCCCAGGGTAACGCTAACAC
TGC AAT CGG GTA CTC CCA CA
ACT TGC GGG CAG TTG CTT G
GGCCTCTGTGGTACACGACAA
ACATAGGTGGCTGTCCAGACAA
CGGTGATGGTGCTCTTGAGT
GGTGCTAATCTCGTCTCGGG
GGGACATGTTTGGCAGGACA
TAT TTA GCA ACT GCA GAT ATC CAA G
ATGTAAGGCCAGTGGGAGATT
TAG AAG GAG ACG GAG GAG GAG
CAT GAT GAT GCC CAG TGT CTT G
GCTCAGAGAAGTTGGCGATGG
CCTCTTCTCAGGGCTCACAG
CATGGGCTTCAGACTGGTAC
GGCGCAGTTTATGTTGTCTGT
TTCAAACTGGCTAGCGGCTCCTAT
TTGTCTCGGTAAAACTCGCTC
TGCCTTTGACCAGATGAACC
TGTTTGGTGGAGTCCTAAGGTC
TTGTCATCTACGGGCACAAAG
GACGTGATCCGATCCACAATG
CGGGAAGGGGGAGAGTGGGG
ACGATGGACGTAAGGGAGTG
TGGAAGAAAGGCGCTGAAGAC

Table 5-2: Diet composition
Product #
Macronutrients

Control Diet (CON)
TD.160647
% by
% kcal
weight
from

EPA / DHA Diet (FA)
TD.190782
gm
kcal

Protein

18.8

21.4

18.8

21.4

Carbohydrate

51.6

58.7

51.6

58.7

Fat

7.8

19.9

7.8

19.9

Energy density

3.5

3.5

SFA

~15.4%

~22%

MUFA

~23.4%

~24.7%

PUFA

~61.2%

~53.3%

N-6 level

~53.5%

~36%

N-3 level

~7.6%

17.2%

7.1

2.1

Fatty acid composition % *

(n-6): (n-3) ratio
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Figure 5.1: Effect of maternal intake of EPA/DHA riched diet on number of births and body
weight of new born pups (Day 1 postpartum). The mothers were assigned to two groups, one
received control diet (CON) and the other was fed EPA/DHA enriched diet (FA). (A) Statistical
analysis of number of births (B) Body weight difference between tested groups. Body weight was
measured in gram. All data represent as mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by
Student’s t-test (n=10).
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Figure5.2: Effect of maternal EPA/DHA intake on body weight and fat depots ratios in weaned
mice (day 21). The mothers were assigned to two groups, one received control diet (CON) and the
other was fed EPA/DHA enriched diet (FA). Pups weaned 3 weeks postpartum. Sub-cutaneous fat,
visceral fat, and brown adipose tissue were dissected, weighted, and fat ratios were normalized to
body weight (A) Body weight difference between tested groups measured in gram. (B) Fat ratio
corrected by body weight. All data represent as mean ± SEM. *p < 0.05, **p < 0.01 and ***p <
0.001 by Student’s t-test (n=20).
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Figure 5.3: Effect of maternal intake of EPA/DHA on fetal genes regulating myogenesis, muscle
protein synthesis, glucose metabolism, muscle contraction, and adipogenesis on day 13 of
gestation. The mothers were assigned to two groups, one received control diet (CON) and the other
was fed EPA/DHA enriched diet (FA) (A) qPCR analysis of genes regulating myogenesis (B)
qPCR analysis of genes encoding muscle protein synthesis and degradation (C) The relative
expression of glucose metabolism regulating genes. (D) qPCR analysis of genes regulating muscle
contractile proteins.( E) The relative expression of adipogenesis regulating genes of fetal muscles
collected on day 13 of gestation .The Ct values of target genes were normalized to the values of
18s in each sample. All data represent as mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by
Student’s t-test (n=6).
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Figure 5.4: Effect of maternal intake of EPA/DHA on genes regulating myogenesis, muscle
protein synthesis, glucose metabolism, muscle contraction, and adipogenesis in day 1 neonates.
The mothers were assigned to two groups, one received control diet (CON) and the other was fed
EPA/DHA enriched diet (FA) (A) Quantitative RT-qPCR (n=8) and representative image and
densitometric analysis of western blot (n=4) of genes regulating myogenesis (B) Quantitative RTqPCR (n=8) and representative image and densitometric analysis of western blot (n=4) of genes
encoding muscle protein synthesis (C) The relative expression of glucose metabolism regulating
genes (n=8). (D) qPCR analysis of genes regulating muscle contractile proteins (n=8).The raw Ct
was normalized to the value of 18s. All data represent as mean ± SEM. *p < 0.05, **p < 0.01 and
***p < 0.001 by Student’s t-test.
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Figure5.5: Effect of maternal intake of EPA/DHA on myotubes formation in day 1 neonates. The
mothers were fed either control diet (CON) or EPA/DHA enriched diet (FA) during the entire
period of pregnancy and lactation. (A) Data show the difference in the diameter of muscle fibers
measured in micrometer between CON and FA groups. (B) Data show the difference in the length
of muscle fibers measured in micrometer between CON and FA groups. (C) The difference in the
number of muscle fibers between CON and FA groups. (D) The difference in the number of nuclei
per muscle fiber between CON and FA groups. The data represent as mean ± SEM. p < 0.05 (n=8);
eight samples per group were used in this measurement where the value of each samples represents
the average of the measurements of 8 cross section areas randomly selected from each sample (E)
a representative microscopic image of muscle tissue stained with H&E from differentially treated
groups. The magnification is 10x and scale bar is 100µm. black arrows refer to muscle fibers.
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Figure 5.6: Effect of maternal intake of EPA/DHA on ectopic lipid accumulation in muscles of
day 1 neonates. The mothers were fed either control diet (CON) or EPA/DHA enriched diet (FA)
during the entire period of pregnancy and lactation. (A) The relative expression of adipogenesis
regulating genes in neonatal muscles .The raw Ct was normalized to the value of 18s. All data
represent as mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test (n=8). (B)
A representative microscopic image of muscle samples stained with Oil red O in day 1 offspring
fed control diet or EPA/DHA rich diet. The magnification is 10x and scale bar is 100µm. Black
arrows refer to accumulated fat. (-) indicates absence the accumulation of fat neither in the
sarcoplasm of the fibers nor in endomysium (between fibers). (+) represents mild fat infiltration
(++) indicates a moderate load. (+++) indicates an overload of fat.
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Figure 5.7: Effect of maternal intake of EPA/DHA on lipid metabolism regulation in liver in day
1 neonates. The mothers were fed either control diet (CON) or EPA/DHA enriched diet (FA)
during the entire period of pregnancy and lactation (A) Quantitative RT-qPCR (n=8) and
representative image and densitometric analysis of western blot (n=5) of genes regulating fatty
acid uptake and a β-oxidation (n=8) (B) The relative expression of genes involved in regulating
the thermogenesis process in liver (n=8). (C) Quantitative RT-qPCR (n=8) and representative
image and densitometric analysis of western blot (n=4) of genes regulating lipogenesis and
lipolysis. The raw Ct was normalized to the value of 18s. All data represent as mean ± SEM. *p <
0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test.
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Figure 5.8: Effect of maternal intake of EPA/DHA on genes regulating myogenesis, muscle
protein synthesis, glucose metabolism, and muscle contractile proteins in weaned mice (21 days
postparturition). The mothers were assigned to two groups, one received control diet (CON) and
the other was fed EPA/DHA enriched diet (FA) (A) Quantitative RT-qPCR and representative
image and densitometric analysis of western blot of genes regulating myogenesis (B) Quantitative
RT-qPCR (n=8) and representative image and densitometric analysis of western blot (n=4) of
genes encoding muscle protein synthesis (C) The relative expression of muscle glucose
metabolism regulating genes. (D) qPCR analysis of genes regulating muscle contractile
proteins.The raw Ct was normalized to the value of 18s. All data represent as mean ± SEM. *p <
0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test.
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Figure 5.9: Effect of maternal intake of EPA/DHA on myotubes formation in day 21 weaned mice.
The mothers were fed either control diet (CON) or EPA/DHA enriched diet (FA) during the entire
period of pregnancy and lactation. (A) Data show the difference in the diameter of muscle fibers
measured in micrometer between CON and FA groups. (B) Data show the difference in the length
of muscle fibers measured in micrometer between control CON and FA groups. (C) The difference
in the number of muscle fibers between CON and FA treated groups. (D) The difference in the
number of nuclei per muscle fiber between CON and FA groups. The data represent as mean ±
SEM. p < 0.05 (n=8); eight samples per group were used in this measurement where the value of
each sample represents the average of the measurements of 8 cross section areas randomly selected
from each sample (E) a representative microscopic image of muscle tissue stained with H&E stain
from differentially treated group. The magnification is 10x and scale bar is 100µm. black arrows
refer to muscle fibers.
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Figure 5.10: Effect of maternal EPA/DHA on ectopic lipid accumulation in muscles of day 21
weaned mice. The mothers were fed either control diet (CON) or EPA/DHA enriched diet (FA)
during the entire period of pregnancy and lactation. (A) The relative expression of adipogenesis
regulating genes. The raw Ct was normalized to the value of 18s. All data represent as mean ±
SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test (n=6). (B) A representative
Microscopic image of muscle samples stained with Oil red O in day 21 offspring fed control diet
or EPA/DHA enriched diet. The magnification is 10x and scale bar is 100µm. Black arrows refer
to accumulated fat. (-) indicates absence the accumulation of fat neither in the sarcoplasm of the
fibers nor in endomysium (between fibers). (+) represents mild fat infiltration. (++) indicates a
moderate load. (+++) indicates an overload of fat.
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Figure 5.11: Effect of maternal intake of EPA/DHA on hepatic genes regulating lipid metabolism
in weaned mice (D21). The mothers were fed either control diet (CON) or EPA/DHA enriched
diet (FA) during the entire period of pregnancy and lactation (A) Quantitative RT-qPCR (n=8) and
representative image and densitometric analysis of western blot (n=4) of genes regulating fatty
acid uptake and a β-oxidation in neonates in weaned mice (D21) (B) ) Quantitative RT-qPCR
(n=8) and representative image and densitometric analysis of western blot (n=4) of genes involved
in regulating lipogenesis and lipolysis in weaned mice (D21) (C) Quantitative real-time PCR (n=8)
analysis of the expression of genes regulating the thermogenesis process in weaned mice (D21).
The raw Cts was normalized to the value of 18s. All data represent as mean ± SEM. *p < 0.05, **p
< 0.01 and ***p < 0.001 by Student’s t-test.
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Figure 5.12: Effect of maternal intake of EPA/DHA on brown signature genes expression in
weaned mice (D21). The mothers were fed either control diet (CON) or EPA/DHA enriched diet
(FA) during the entire period of pregnancy and lactation (A) Quantitative RT-qPCR (n=8) and
representative image and densitometric analysis of western blot (n=4) of key genes regulating
brown adipose tissue activity and development in weaned mice, 3 weeks postpartum (B) The
Quantitative RT-qPCR (n=8) and representative image and densitometric analysis of western blot
(n=4)relative expression of genes involved in regulating the thermogenesis activity in weaned
mice, 3 weeks postpartum. The raw Ct was normalized to the value of 18s. All data represent as
mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test.
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Figure 5.13: Effect of maternal intake of EPA/DHA on potential browning of sub-cutaneous fat
in weaned mice (D21). The mothers were fed either control diet (CON) or EPA/DHA enriched
diet (FA) during the entire period of pregnancy and lactation (A) Quantitative RT-qPCR (n=8) and
representative image and densitometric analysis of western blot (n=4) genes regulating beige
adipocytes development in sub-cutaneous fat of weaned mice, 3 weeks postpartum (B) The relative
expression (n=8) of genes involved in regulating the thermogenesis process in weaned mice, 3
weeks postpartum. All the raw Cts was normalized to the value of 18s. Data represent as mean ±
SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. (C) A representative microscopic
image of browning of sub-cutaneous fat. Yellow arrows refer to emerging beige adipocytes. The
magnification is 10x and scale bar is 100µm
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Figure 5.14: Effect of maternal intake of EPA/DHA on peri-renal fat pads of 21-day-old mice.
The mothers were fed either control diet (CON) or EPA/DHA enriched diet (FA) during the entire
period of pregnancy and lactation. (A) A representative microscopic image of H&E stained
sections from each group. The magnification is 10x and scale bar is 100µm. (B) The Difference in
adipocytes size measured in micrometer. (C) The tifferences in adipocyte number between
different groups. Data represent as mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by
Student’s t-test (n=8 pups). (C) Relative differences in adipocytes number. All data represent as
mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test (n=8).
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Appendix
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Conclusion
We can conclude in this dissertation that:
1. EPA and DHA are a potent activators of PPARγ and strong stimulators of adipognesis that
is strongly associated with ectopic intramuscular lipid overload. This feature could be
considered by food industries to increase meat marbiling and improve meat quality. The
prefential accretion of IMF as a results of PPARγ upregulation could be a compensatory
process to maintain insulin sensitivity and lipid homeostasis.
2. EPA and DHA supplementation induced myoblast reprogramming into adipocytes having
been demonstrated by many in vitro studies could not be confirmed in vivo although partial
consistency manifested by increasing intramuscular lipid infiltration was observed.
3. The divergence of in vivo and in vitro results cannot be linked to the methodology as most
of the studies have used C2C12 as an in vitro model. Principally, C2C12 is a wellestablished cell line closet to muscle cells that is extensively used to study cellular and
molecular mechanisms of muscle differentiation. Also, the dose of (50 µm) EPA and (50
µm) DHA used in our experiments is highly suggested as the most effective dose based on
multitude of pre-clinical and pilot trials. Instead, the inconsistency can be attributed to the
cross interaction of other endogenous factors such as pregnancy-associated over secretion
of estradiol that may neutralized the proposed inhibitory effect of EPA and DHA as it
asserted in this study although we did not measure the ratio of EPA and DHA to 17βestradiol. In this regard, an in vitro study investigating the concurrent effect of 17βestradiol with different doses of EPA and DHA is suggested for a future research.
4. Given the quite complexity of converting the dose from in vitro to in vivo or vice versa,
the concentration of (50 µm) EPA and (50 µm) DHA used in our invitro experiments might
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not be a representative of what was consumed in fish oil, especially in terms of both EPA
and DHA ratios and total amounts. Also, it is well- know that all the components used in
vitro experiments can be modified inside the body into different metabolite species with
various degree of potency.
5. Maternal ingestion of EPA and DHA or reducing the ratio of n-6: n-3 could be an effective
therapeutic option to mitigate the proposed deteriorating effect of childhood obesity.
6. EPA and DHA supplementation during pregnancy and lactation is an essential player in
promoting BAT development and activity.
7. Maternal ingestion of fish oil enriched with EPA and DHA induced increasing the
expression levels of clusters of genes regulating lipid uptake and catabolism and
thermogenesis in liver is a promising approach to counteract many hepatic disorders such
as non-alcoholic fatty liver disease (NAFLD) and hepatic steatosis although upregulation
of lipolysis regulating genes was independent of inhibiting the lipogenesis related genes.
8. Browning of sub-cutaneous white adipose tissue and reducing body weight in weaned
mice observed in this study indicate that the ingestion of fish oil enriched with EPA and
DHA for 3 weeks may contribute at least partially to countering obesity.
9. EPA and DHA supplementation cannot be used to expand brown adipose tissue in vitro as
the originated cells from myoblast trans-differentiation exhibited the characteristics of
white-like adipocyte capable of synthesizing and storing triglyceride with low density of
mitochondria. In this context, we disagree with the hypothesis saying that the isolated
myoblasts from obese individuals can be propagated and reprogrammed into brown
adipocytes ex-vivo in response to EPA and DHA treatment before being implanted back in
the same individuals to counteract obesity.
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10. Not only brown adipocytes but also white adipocytes can be originated from myoblasts
despite being demonstrated that MYF5+ cells can switch between two phenotypes
including muscle cells and/or brown adipocytes while white adipocyte derivation from
myoblast is not commonly feasible.
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